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Abstract 
Intro: The microbiome-gut-brain axis (MGBA) has been shown to be 
instrumental to brain and behaviour, including psychological disorders 
affecting stress, depression, and anxiety. Many of the aforementioned 
disorders are comorbid with substance abuse disorders, and on a larger 
scale with addiction. In this body of work, we seek to characterize addiction-
related phenotypes in the microbiome and correlate with measures of  
addiction-related behaviours, along with changes in the virome following 
chronic social stress.  
Aims: We first examined if vapor administration of ethanol is capable of 
altering the microbiome and to assess if substances of abuse, such as 
ethanol, can alter the microbiome outside of oral/gastrointestinal 
administration. To characterize addictive phenotypes behavioural measures 
of impulsivity, reward learning, and dopaminergic response to novelty were 
used.   
Methods: All studies were carried out in rodents. Following behavioural 
testing, gut microbiota samples were analysed with 16S rRNA gene amplicon 
sequencing. In the chronic social stress study, the virome was also 
sequenced via shot-gun metagenomic sequencing of faecal filtrate. 
Correlations were performed between microbiome measures and biological 
measures of behaviour, cytokines, corticosterone, and dopamine mRNA 
expression.   
Results: Chapter 2) Investigation of microbiome and vapor alcohol 
administration in mice showed significant alterations in microbiome; Chapter 
3) A pre-clinical model of alcohol-addiction showed no significant differences 
in the microbiome by grouped phenotype. However, low abundance genus-
level bacteria correlated to striatal dopamine mRNA expression. Chapter 4) 
A large heterogenous study of male and female rats revealed that females’ 
microbiome composition is more associated to addictive measures. 
However, within both male and female operational taxonomic units (OTUs) 
were significantly correlated to impulsivity measures. Chapter 5) Chronic 
social stress in male mice significantly affected bacterial and viral 
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composition. Viral richness was increased alongside decreases in bacterial 
richness.  
Discussion: Results from this body of work show that the microbiome may be 
impacted by addiction and psychosocial stress. Our findings suggest that 
there are subtle yet significant differences in microbiome composition 
between rats with different behavioural phenotypes. These findings indicate 
that associations to addictive-related behaviour occur in low-abundance 
(<5%) bacteria and are sex-specific. Furthermore, microbiome (bacteriome 
and virome) is impacted top-down, brain to gut via the hypothalamic-pituitary-
adrenal axis, during chronic psychosocial stress. These initial investigations 
into stress and gut bacteriophage (aka phage) indicate that increases in 
phage richness are associated to decreases in bacterial richness and alpha 
diversity during stress. These novel findings seed the foundation for new 
research investigating MGBA in stress, substance abuse, and addiction. 
Further research is necessary to elucidate the mechanisms involved in this 
cross-communication of the MGBA.  New insights into these challenging 
disorders of addiction and stress may provide unique therapies targeting the 
gut microbiome.
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1 General Introduction 
 
1.1 The Gut Microbiome 
In the last decade a new field of research has blossomed, demonstrating 
how interconnected our bodies are to the microbes that reside in and on us. 
Research on gut microbiota underpins just how connected organs and 
biological processes are to each other. The microbes populating the gut are a 
focal point in microbiota research. In a microbiota sample there also exist a 
large pool of bacteria, viruses --  largely bacteriophage, viruses that target 
bacteria --, archaea, fungi, and multi-cellular organisms, such as helminths. 
The microbiota is the community of organisms that inhabit a certain site in their 
host, while the microbiome is the total genetic composition of all organisms 
within that community. Research into the microbiome has revealed 
connections between host health and composition of microbiome. This 
includes the immune system (Kau, Ahern et al. 2011, Honda and Littman 2016, 
Thaiss, Zmora et al. 2016), gastrointestinal function and disease (Benjamin, 
Hedin et al. 2012, Fraher, O'Toole et al. 2012, Mayer, Labus et al. 2015, 
Moloney, Johnson et al. 2016), metabolomic processes (Joyce, MacSharry et 
al. 2014, Lin, An et al. 2016, Barton, Penney et al. 2017), and brain and 
behaviour (Bercik, Verdu et al. 2010, Bravo, Forsythe et al. 2011, Dinan, 
Stanton et al. 2013, Kelly, Borre et al. 2016). Bacteria in the gastrointestinal 
system have been shown to alter immune signalling, such as T-regulatory cells 
(Round and Mazmanian 2010, Hsiao, McBride et al. 2013), and linked to 
inflammatory cytokine production (Bailey, Dowd et al. 2011, Kelly, Borre et al. 
2016, Scott, Ida et al. 2017). Gastrointestinal function has particularly been 
associated with gut microbiome in inflammatory bowel disease (Scanlan, 
Shanahan et al. 2006, Gevers, Kugathasan et al. 2014). Gut microbiome has 
been shown to alter metabolomic profiles of the host, particularly in conditions 
such as exercise (Barton, Penney et al. 2017, Cronin, Barton et al. 2018) and 
obesity (Everard, Belzer et al. 2013, Joyce, MacSharry et al. 2014, Thaiss, 
Zeevi et al. 2014, Ryan, Patterson et al. 2017).   
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The bacteriome has been the focal point of the host microbiome. Gut 
microbiota are involved in intestinal integrity, digestion, and utilization of 
nutrients (Kau, Ahern et al. 2011, Mutlu, Gillevet et al. 2012, Leclercq, 
Matamoros et al. 2014). Bacteria have been most characterized in terms of 
disease versus healthy conditions; however efforts have been made to 
understand the microbiome within the entirety of the human population (Lloyd-
Price, Abu-Ali et al. 2016, Zhernakova, Kurilshikov et al. 2016). At the phylum 
level Bacteroidetes and Firmicutes are commonly the most highly abundant 
bacteria. Both in human and animal studies alterations in enteric microbiota 
impact critical areas of health. Major functions effected by the gut microbiota 
include the metabolic pathway (Barton, Shanahan et al. 2015), endocrine 
system (Clarke, Stilling et al. 2014), intestinal permeability (Miele, Valenza et 
al. 2009), immune system and inflammatory pathway (Littman and Pamer 
2011, Honda and Littman 2012, El Aidy, Dinan et al. 2014).  
  
1.1.1 Bacteriome 
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Figure 1.1.1: Factors influencing microbiome composition: 
Images in white boxes indicate factors that have a positive (blue, left) or 
negative (red, right) impact on a healthy microbiome. Most factors known to 
have an impact on overall health (i.e., diet, exercise, mental health) also 
impact on the gut microbiome in the same manner. Figure designed by 
Veronica L. Peterson. 
  
1-18 
 
 
1.1.2.1 Bacteriophage 
Over the past 100 years, bacteriophage have been instrumental in 
fundamental scientific discoveries, such as the Hershey-Chase experiments 
which demonstrated that DNA, not protein, was the genetic material of life 
(Hershey 1952). Bacteriophages are a virus which only targets bacteria. 
Therefore, they are benign to other living organisms, and beneficial in some 
instances. Research into phage therapy began soon after the discovery of 
bacteriophage as scientists, such as George Eliava (Kutateladze 2015), 
recognized the therapeutic potential of a virus which specifically eliminates 
pathogenic bacteria. To date, phage therapy is used in food production 
(Lipson, Sethi et al. 2007, Catel-Ferreira, Tnani et al. 2015) and is used in 
former Soviet countries, such as Georgia, for antibiotic resistant infections 
(Biswas 2002, Cao, Wang et al. 2015, Broecker, Klumpp et al. 2016). 
Bacteriophage contribute to the stability and dynamics of bacterial 
populations and represent a targeted approach to influencing specific 
populations of bacteria in the gut (Chevallereau, Blasdel et al. 2016, Wahida, 
Ritter et al. 2016). Identification of specific bacteriophage and their target 
bacteria involved in disease may significantly advance therapeutic 
treatments for a broad range of disorders. 
Research into the role of gastrointestinal microbiota in health focuses almost 
exclusively on bacteria (> 95% of publications), yet the number of 
bacteriophages vastly outnumber bacteria in the gut. Available research has 
shown alterations in bacteriophage associated to Crohn’s disease (Broecker, 
Klumpp et al. 2016), Immunodeficiency Syndrome (Monaco, Gootenberg et 
al. 2016), and Clostridium difficile infection (Pérez-Brocal et al., 2015) with 
effects attributed to host immunity (Stashak, Baker et al. 1970), intestinal 
permeability (Tetz and Tetz 2016), and maintaining a bacteriome stability 
(Stashak, Baker et al. 1970, Dalmasso, Hill et al. 2014, De Paepe, Leclerc et 
al. 2014, Manrique, Bolduc et al. 2016). There are no published studies on 
the role of bacteriophage in the microbiota-gut-brain axis. Novel investigation 
1.1.2 Virome - Bacteriophage and Other Viruses 
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of bacteriophage and its involvement in brain and behaviour may lead to 
therapies for psychological disorders involving the microbiota-gut-brain axis.  
 
1.1.2.2 Other Viruses 
While bacteriophages are strictly prokaryotic viruses, only infecting bacteria, 
other viruses exist in the virome. Commensal eukaryotic viruses have not 
been extensively characterized in the mammalian microbiome. Research has 
found pathogenic giant viruses (Mimivirus, Marseillevirus)  in clinical samples 
of human microbiome (Lagier, Drancourt et al. 2017). Other eukaryotic 
viruses that dwell in the microbiome are potentially pathogenic to the host. Of 
note, the genus Flavivirus which evades detection by inhibiting host cellular 
inhibition, such as interferon (Munoz-Jordan, Laurent-Rolle et al. 2005). 
Furthermore, eukaryotic viruses, such as Flavivirus, are sensitive to cellular 
stress and oxidation (Gullberg, Jordan Steel et al. 2015), similar to temperate 
bacteriophages (Dalmasso, Hill et al. 2014).  Overall composition of the 
microbiome has been shown to influence viral infections. AIDS disease 
progression was linked to microbiome composition and changed 
independently from treatment (Monaco, Gootenberg et al. 2016), revealing 
that AIDS treatment did not correct alteration in microbiome. Finally, 
psychological stress can induce virulence of viruses through 
immunosuppression (Freeman, Sheridan et al. 2007).   
 
1.1.2.3 Other Organisms 
While the majority of microbiome research focuses on bacteria, other 
organisms exist within this community including fungi, archaea, protozoa, 
and intestinal worms, such as helminths. Like viruses, these organisms have 
been researched to a lesser extent in terms of the mammalian microbiome. 
However, these organisms may be as important as bacteria and viruses in 
terms of influencing host health. 
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1.1.2.3.1 Fungi - Mycobiome 
Of the other microbes, fungi have been most researched and characterized 
in the microbiome (termed the mycobiome). Fungi in the human mycobiome 
consist of both commensal and pathogenic species, for example the genus 
Candida (Huffnagle and Noverr 2013, Huseyin, O'Toole et al. 2017). While 
fungal communities are much less abundant, relative to the entirety of the 
microbiome, many of these communities are implicated in health and diet 
(Hoffmann, Dollive et al. 2013, Huffnagle and Noverr 2013, Huseyin, O'Toole 
et al. 2017). Noteworthy is the genus Saccharomyces, which includes 
Saccharomyces cerevisiae and Saccharomyces buyanus that are used in the 
fermentation of creating alcoholic beverages. A variety of the 
Saccharomyces cerevisiae species has also been used as probiotic 
treatment for gastroenteritis (Huffnagle and Noverr 2013). As with the 
majority of organisms inhabiting the host, fungi are able to alter immune 
response and pathogenic fungi increase opportunistically in immune-
compromised subjects (Huseyin, O'Toole et al. 2017).  
 
1.1.2.3.2 Archaea 
Archaea are prokaryotic microorganisms, like bacteria, which are also seen 
in the mammalian gastrointestinal tract. Methanogens are highly abundant in 
the gastrointestinal tract, for example genus Methanobrevibacter (Eckburg, 
Bik et al. 2005, Samuel and Gordon 2006). Furthermore, these methanogens 
for mutualistic relationships with bacteria to enhance fermentation of dietary 
compounds, thus increasing nutrients available for the host (Samuel and 
Gordon 2006, Turner, Ramakrishnan et al. 2013). 
 
1.1.2.3.3  Protozoa 
Protozoa are a eukaryotic single-celled organism occasionally identified in 
the gut microbiome (Turner, Ramakrishnan et al. 2013). Most protozoa 
known to inhabit mammals are pathogenic, such as malaria. However, in 
livestock commensal protozoa have been characterized and believed to 
metabolize plant carbohydrates (Turner, Ramakrishnan et al. 2013). Like 
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archaea, these commensal protozoa are believed to have a mutualistic 
relationship with certain bacteria. 
1.1.2.3.4 Helminths 
Other multicellular organisms are known to inhabit the mammalian 
gastrointestinal system, notably intestinal worms. Helminths inhabiting the 
intestines can be both beneficial and harmful to the host, however the 
majority are considered to be parasitic. In most developed countries, 
helminths are not seen in the human gastrointestinal tract. However, this 
decrease in intestinal worms has been associated with decreased alpha 
diversity of bacteria (Broadhurst, Ardeshir et al. 2012, Lee, Tang et al. 2014) 
and, thus, a hygiene hypothesis has been proposed for helminths to explain 
proliferation of certain autoimmune diseases (Weinstock and Elliott 2009, 
Williamson, McKenney et al. 2016).  Various studies have shown therapeutic 
applications of helminths for treating inflammatory bowel disorders by 
regulating the immune system and reducing mucosal inflammation 
(Weinstock 2004, Broadhurst, Ardeshir et al. 2012, Osborne, Monticelli et al. 
2014). Additionally, colonization of pregnant rats attenuates excessive 
cytokine response in the brain during pathogenic bacterial infection in 
offspring, which is mediated through microglia, thus preventing cognitive 
dysfunction (Williamson, McKenney et al. 2016).   
 
1.2 The Microbiome-Gut-Brain Axis (MGBA) 
 
The gut-brain axis is a complex cellular network that connects the central 
and enteric nervous system. This communication network in the gut is 
affectionately termed ‘the second brain’ because it can function 
autonomously from the central nervous system (CNS).  Descending signals 
from the brain communicate to the gut via the autonomic nervous system 
and more directly through the dorsal motor nucleus of the vagus. Ascending 
signals from the gut are sent directly to the vagus, reaching the nucleus 
tractus solitarius in the dorsal medulla oblongata.  This bidirectional network, 
the gut-brain axis, mediates many vital processes necessary for homeostasis 
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and response to environmental stimuli in the periphery and CNS (Mayer 
2011, Mussa and Verberne 2013). 
The gut microbiota involvement in gut-brain communication is termed the 
microbiota-gut-brain axis (MGBA) (Burokas, Moloney et al. 2015). 
Interestingly, brain and behaviour have been linked to gut microbiota 
composition. Through this axis it has been demonstrated that bacteria that 
reside in the gut are capable of influencing cognition and behaviour (Dinan 
and Cryan 2015). Communication between the gut microbiota and the brain 
include the inflammatory pathway (Leclercq, De Saeger et al. 2014), vagus 
nerve (Bravo, Forsythe et al. 2011), and hypothalamic-pituitary-adrenal 
(HPA) axis (Clarke, Stilling et al. 2014). A large array of psychiatric disorders 
have been linked to gut microbiota, including depression (Kelly, Borre et al. 
2016, Zheng, Zeng et al. 2016), neurodevelopmental disorders such as 
autism (Hsiao, McBride et al. 2013, Golubeva, Joyce et al. 2017), and the 
stress response (Bailey, Dowd et al. 2011, Bharwani, Mian et al. 2016, 
Burokas, Arboleya et al. 2017). Animal research has shown that changes in 
gut microbiota can influence gene expression in key brain regions critical for 
mood and behaviour (Bravo, Forsythe et al. 2011, Stilling, Dinan et al. 2014). 
It has also been shown that the animal behavioural phenotype can be 
transferred from one animal to another through faecal microbiota 
transplantation (Collins et al., 2013; Kelly et al., 2016). However, these 
studies have focussed on the bacteria in the transferred material as being 
the main determinants influencing behaviour. Bi-directional communication 
between host and gut microbiome can influence one another, thus must be 
considered when investigating the microbiota-gut-brain axis (bottom up) or 
brain-gut-microbiome axis (top down).  
 
Numerous studies have shown that aspects of animal behaviour, including 
anxiety and depressive-like behaviours can be influenced by the bacteria that 
inhabit the gastrointestinal tract (Bailey, Dowd et al. 2011, Bravo, Forsythe et 
al. 2011, Collins, Kassam et al. 2013). Previous research reveals that 
1.2.1 Overview: Bacteria & MGB Axis 
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treatment with a particular strain of bacteria can induce anxiolytic properties 
by altering inhibitory GABAergic innervations (Bravo, Forsythe et al. 2011). 
Clinical trials have begun looking at the effects of probiotics on mood and 
cognition (Tillisch, Labus et al. 2013, Schmidt, Cowen et al. 2015). Notably, 
fMRI studies by Tillisch and colleagues found that women who consumed a 
fermented milk product had decreased activity in the insular cortex -- a 
region active during drug craving (Tillisch, Labus et al. 2013). 
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Figure 1.2.1: Anatomy of the Microbiome-Gut-Brain Axis 
(MGBA) and pathways of communication: MGBA signalling from 
microbiota to intestinal epithelium, on to neurons of the vagus nerve, 
influencing HPA axis and Cerebral Circulatory System  (Artwork hand-drawn 
by Veronica L. Peterson). 
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To date, links between viral infections and psychological disease have only 
been observed and may be primarily caused by systemic inflammation or 
psychological distress associated with diagnosis of infection. Epidemiological 
analysis has found links between anxiety/depression and viral infections, 
including influenza, herpes simplex, hepatitis C, and AIDs/HIV (Coughlin 
2012). The neurovirologist Dr. Robert Yolken has published several studies 
suggesting a link between viruses and incidence of schizophrenia, cognitive 
dysfunction, and bipolar disorder (Shirts, Prasad et al. 2008, Yolken, Jones-
Brando et al. 2014, Tanaka, Matsuda et al. 2017). While many of Yolken’s 
studies have investigated herpes simplex, he has also published work 
showing alterations in the oropharyngeal phageome in schizophrenic 
patients (Yolken, Severance et al. 2015). 
  
For further growth of the gut microbiome field, it is now critical that new 
studies focus on methods/mechanisms of how gut microbiota communicate 
with the brain. Recent studies have begun to reveal methods of 
communication in the microbiome-gut-brain axis.  
 
1.2.3.1 Immune system 
One of the most characterized mechanisms of how the bacteriome influences 
host health is via the immune system (Littman and Pamer 2011). Certain 
bacteria inhabiting the host gut microbiome can promote either an anti-
inflammatory or pro-inflammatory profile in the host (Li, Lin et al. 2016). 
Furthermore, gut microbiota can regulate host immunity by altering immune 
cell activity. The interface between host immune system and microbiome is a 
focus of interest, not only for inflammatory-related disorders, but also for 
psychiatric diseases associated to systemic inflammation – such as 
depression (Miller and Raison 2015).  
1.2.2 Overview: Viruses & Microbiome-Gut-Brain Axis 
(MGBA) 
1.2.3 Methods of Communication 
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Regulatory T cells (Treg) are a suppressor T cell within a subpopulation of T 
cells that modulate the immune system. These Treg cells are, generally, 
immunosuppressive and therefore implicated in autoimmune disease. 
Furthermore, the immunosuppressive activity of Treg cells has been shown to 
be beneficial in neurological diseases associated with inflammation, such as 
Alzheimer’s (Kunis, Baruch et al. 2013). Chronic social stress has been 
associated to trends in reduced Treg cells and IL-10 alongside altered 
microbiome composition (Bharwani, Mian et al. 2016). Reductions in Treg cells 
and anti-inflammatory cytokines in peripheral blood have also been 
characterized in depression (Miller and Raison 2016). In the brain, Treg cells 
can reduce inflammation and promote neural integrity (Kipnis, Avidan et al. 
2004, Miller and Raison 2016). Gut bacteria have been shown to alter Treg 
cells within the intestine (Round and Mazmanian 2010, Honda and Littman 
2016). Indeed, colonization of a human isolated Bacteriodes fragilis 
NCTC9343 and Clostridium species (clusters IV, XIVa, XVIII) in germ-free 
mice increased differentiation of Treg cells, immunosuppressive activity, and 
increased anti-inflammatory cytokine production in the gut (Round and 
Mazmanian 2010, Atarashi, Tanoue et al. 2013). The mechanism of this action 
was shown to be mediated through polysaccharide A and short-chain fatty 
acids (SCFAs) altering conversion of CD4+ T cells to FOX3+ Treg cells which 
produce the anti-inflammatory cytokine IL-10 (Round and Mazmanian 2010, 
Atarashi, Tanoue et al. 2013, Smith, Howitt et al. 2013).  
 
1.2.3.2 Microbial Toxins and Sickness Behaviour 
Many bacteria in the gut microbiome have compounds toxic to the host, when 
released. The most common example is the endotoxin lipopolysaccharide 
(LPS), a large molecule lipoglycans in gram-negative bacteria. Binding of LPS 
to host immune cells triggers production of pro-inflammatory cytokines. Shiga 
toxins, although released by bacteria, originate from the genome of lambda 
prophage (Friedman 2001). These highly toxic compounds are associated to 
dysentery (Shigella dysenteriae) and certain Escherichia coli infections.  Shiga 
toxin, once entered into the host cell, halts protein synthesis thus causing 
cascade of cell death and inflammation (Sandvig and van Deurs 2000, Melton-
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Celsa 2014).  Other bacterial toxins include those produced only within certain 
strains of bacterial species. Bacterial species Bacteroides fragilis, for example, 
contains some strains that secret a metalloprotease toxin (termed B. fragilis 
toxin – BFT). Mutation from a commensal to toxic B. fragilis appears to be 
dependent on many external, currently unidentified, factors. BFT cleaves tight 
junction proteins in the host epithelium, causing diarrhoea and haemorrhage 
(Sears 2001).  
Bacterial toxins are capable of inducing an anxious, lethargic, and/or 
depressive state termed as sickness behaviour. Sickness behaviour is 
characterized as a pro-inflammatory cytokine profile affecting the central 
nervous system. Cortical inflammation brings on symptoms of depression 
and/or anxiety, lack of concentration, fatigue, reduced sociability, altered sleep 
and appetite. Bacterial toxins and immune response to pathogen-associated 
molecular patterns (PAMPs) have been shown to cause sickness behaviour in 
humans and other animals (Kelley, Bluthé et al. 2003).  
 
1.2.3.3 Bacterial Metabolites & Host Metabolism 
Metabolism is another important mechanism linking gut bacteria to host health. 
Metabolites produced by gut bacteria are capable of influencing host biological 
processes. Additionally, gut microbiota is linked to alterations in host 
metabolism. Research employing the metabolic effects of gut microbiome has 
been explored in diabetes (Plovier, Everard et al. 2017, Ryan, Patterson et al. 
2017), obesity and weight loss (Joyce, MacSharry et al. 2014, Plovier, Everard 
et al. 2017, Ryan, Patterson et al. 2017), exercise (Barton, Penney et al. 2017, 
Cronin, Barton et al. 2018), and drug use (Davey, Cotter et al. 2013, Elamin, 
Masclee et al. 2013).  
Importantly, short-chain fatty acids (SCFAs) are influential metabolites 
produced by bacteria. SCFAs, which include propionate, butyrate, and 
acetate, are produced by the fermentation of dietary fibre in the colon. SCFAs 
have been linked to reduced inflammation (Smith, Howitt et al. 2013, Erny, 
Hrabe de Angelis et al. 2015), stress resilience (Burokas, Arboleya et al. 
2017), and mental/neurological health (Erny, Hrabe de Angelis et al. 2015, 
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Kelly, Kennedy et al. 2015, Stilling, van de Wouw et al. 2016). Hence, this 
promising data makes SCFA-producing probiotics and prebiotics (dietary fibre 
precursors) marketable therapeutic products to pursue. Another metabolite 
that must be considered in the microbiome is the production of gaseous 
hydrogen sulphite by sulfate-reducing bacteria (SRBs).  A majority of these 
bacteria are classed into the genus Desulfovibrio. Hydrogen sulphite has been 
shown to impure working memory and navigation (Ritz, Burnett et al. 2016).  
A large body of work has been done on the effect of diet on gut microbiome. 
Investigation of how gut microbes alter nutrient availability and host 
metabolism is one of the key topics in this field, particularly in relation to obesity 
and diabetes. Indeed, certain gut microbes are capable of influencing various 
metabolic pathways including neutralization of reactive oxygen species 
(Olson, Vuong et al. 2018), glycolysis and gluconeogenesis (Everard, Belzer 
et al. 2013, Ryan, Patterson et al. 2017).  
 
1.2.3.4 Bacteriome & Intestinal and BBB Permeability  
Tight-junction proteins, such as occludin and claudins, creates a protective 
barrier within the intestinal epithelium and endothelium of the blood-brain-
barrier (BBB). Increases in intestinal permeability have been characterized 
alongside a pro-inflammatory state, altered microbiome composition, and 
psychological illness (Forsyth, Farhadi et al. 2009, Mutlu, Keshavarzian et al. 
2009, Forsyth, Shannon et al. 2011, Leclercq, Cani et al. 2012, Moreira, 
Texeira et al. 2012, Summa, Voigt et al. 2013, Leclercq, Matamoros et al. 
2014, Kelly, Kennedy et al. 2015, Leclercq, de Timary et al. 2017). Germ-free 
mice have increased BBB permeability, which decreased when colonized with 
a pathogen-free gut microbiota believed to harbour butyrate-producing 
bacteria (Braniste, Al-Asmakh et al. 2014). Recent research has shown that 
beneficial effects of a ketogenic diet on neurovascular function may be 
mediated through the microbiome (Ma, Wang et al. 2018). Akkermansia 
muciniphila inhabits the mucosal layer of the intestine and capable of mucin 
degradation, thus its proximal relationship has implications for intestinal 
permeability. Indeed, Akkermansia has a profound impact on both 
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permeability in the intestine and brain (Li, Lin et al. 2016, Ma, Wang et al. 
2018, Olson, Vuong et al. 2018). This work exemplifies how gut microbiome is 
capable of altering host health, through intestinal and brain barrier function. 
 
1.3 Psychological Stress 
Psychological stress causes systemic changes in the brain and the 
periphery. Acute stress activates the sympathetic nervous system. Acute 
stress in humans activates the sympathoadrenal-medullary system, resulting 
in norepinephrine and glucocorticoid release, pupil dilation, and increases in 
heart rate, blood pressure and respiration. If the acute stressor is severe, 
neural signalling becomes sensitized and overactive resulting in a condition 
known as post-traumatic stress disorder (Hammamieh, Chakraborty et al. 
2012). Chronic psychological stress activates the hypothalamic-pituitary-
adrenal (HPA) axis and has profound implications to health, causing 
inflammation (Bailey, Dowd et al. 2011), increased intestinal permeability 
(Kelly, Kennedy et al. 2015), and impaired neurogenesis, memory and 
cognitive function (Pittenger and Duman 2008). Many physical and 
psychological symptoms are paralleled in sickness behaviour. Indeed, 
chronic psychological stress alters gut bacteria and is linked to pro-
inflammatory cytokines and changes in immune cells (Bailey, Dowd et al. 
2011, Bharwani, Mian et al. 2016, Burokas, Arboleya et al. 2017).  
 
The diversity of experimental models of stress are as numerous as the 
bacteria in the microbiome. They include physical stress, chemical stress, 
psychological stress, immune stress, and environmental stress. Each has 
applications in a variety of research fields, however all stress regardless of 
paradigm activates the hypothalamic-pituitary-adrenal (HPA) axis, alterations 
in vagal signalling, and in the immune system.  
 
1.3.1 Animal Models of Stress 
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1.3.1.1 Chronic Stress 
Chronic stress is the repeated exposure of a noxious stimulus over an 
extended period. In rodent models the use of repeated exposure to 
water/moisture, bright light, loud sounds, altered night/day cycles, and 
restraint or confinement in a small space are used. The chronic 
unpredictable stress model employs a battery of these stressful stimuli 
randomly and repeatedly. A random schedule is often implemented as it 
prevents the rodent from habituating to one type of stressful stimulus. 
 
1.3.1.2 Chronic Social Stress 
Chronic social stress is one of the most widely used animal models to 
investigate the psychological stress, biological impact of psychological 
stress, and progression of chronic psychological stress to depression. 
Response to social stress is inherent in animals, therefore social stressors 
are more resistant to habituation. Protocols for chronic social stress vary, 
however all involve repeated exposure of a smaller experimental rodent to a 
larger, more aggressive rodent. The repeated social defeats of the 
experimental rodent by the aggressor result in a highly stressed phenotype 
showing depressive behaviour, elevated corticosterone and pro-inflammatory 
cytokines, alongside other deleterious alterations in brain, gut, and immune 
system (Reber, Obermeier et al. 2006, Finger, Dinan et al. 2011, Finger, 
Dinan et al. 2012, Tramullas, Dinan et al. 2012, Bharwani, Mian et al. 2016, 
Huang, Zhao et al. 2016, Lehmann, Cooper et al. 2016, McKim, Patterson et 
al. 2016, Watanabe, Arase et al. 2016, McCann, Rosenhauer et al. 2017). 
 
1.3.1.3 Behavioural Tests of Anxiety and Depression 
Anxious and depressive phenotypes are common in animal models of stress 
(described above). Furthermore, addiction is often co-morbid with anxiety 
and depression, and hence both are often measured in addiction models. In 
this thesis a number of behavioural tests of anxiety and depression are used.  
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1.3.1.3.1 Behavioural Tests of Anxiety 
Tests of anxiety behaviour include exploratory approach-avoidance 
behaviour in an open field arena or elevated plus maze (EPM) (Cryan and 
Holmes 2005). Anxiety induced by novelty can also be measured in the 
marble burying test and novelty supressed feeding (Cryan and Sweeney 
2011). These behavioural tests are based on thigmotaxis, the response of 
the animal to a certain stimulus. These behaviours are affected by the 
dopaminergic system, one of the major pathways associated to addiction 
(Simon, Dupuis et al. 1994). 
1.3.1.3.2 Behavioural Tests of Depression 
 Depression is measured in paradigms resembling learned-helplessness in 
humans, two versions include the forced swim test (FST) and tail-suspension 
test (TST), both measuring time immobile following an allotted struggle time. 
These tests of learned helplessness are purposed to be mediated through 
the serotonergic neurochemical pathway, as administration of serotonergic 
antidepressants reduces immobility time (Cryan and Holmes 2005). 
Depression is often accompanied by anhedonia (Slattery, Markou et al. 
2007); thus, behavioural tests of depression also assess interest in 
rewarding stimuli, such as time male rodents spend smelling the 
pheromones of a female in oestrus, amount of sucrose water consumed, and 
interest in socializing with a new conspecific.  
 
1.4 The Addicted Microbiome: Role of Gut 
Microbiota in Addiction 
 
Drug addiction is a chronic relapsing disorder in which compulsive drug-
seeking and drug-taking behaviours persist despite serious negative 
consequences (Koob and Volkow 2010). The addiction cycle is broken up into 
three stages: binge/intoxication, withdrawal/negative affect, and 
preoccupation/anticipation (Koob 2015). Many factors increase the risk of 
1.4.1 Drug Addiction and Substance Abuse Disorders 
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addiction including heredity (Epps and Wright 2012), childhood trauma 
(Enoch, Hodgkinson et al. 2010), and psychological comorbidities (Samaha 
and Potvin 2014). 
1.4.1.1.1 Cortical Physiology of Addiction 
The major brain neurochemical pathway involved in addiction is the 
mesolimbic dopaminergic pathway, also known as the brain reward pathway 
(Pierce and Kumaresan 2006). Regions in this circuitry include the ventral 
tegmental area (VTA), nucleus accumbens (NAc) as well as other key regions 
such as the hippocampus, prefrontal cortex (PFC), and amygdala which are 
altered by chronic drugs of abuse (Koob and Volkow 2010). Chronic drug 
abuse is associated with alterations in gene expression and dendritic 
morphology in regions that reinforce drug-related cues and drug-seeking 
behaviour (Farris, Harris et al. 2015, Peterson, McCool et al. 2015, Radke, 
Jury et al. 2015). Additionally, drugs of abuse are known to alter behaviours 
and neuroplasticity of the PFC (Kroener, Mulholland et al. 2012) which 
contributes to the persistence of addictive behaviours (Koob 2013). 
1.4.1.1.2 Behavioural Phenotype of Addiction 
The addictive phenotype can be characterized by impulsive behaviours and 
compulsive reward seeking (Koob 2013). These aberrant behaviours have 
been linked to altered function in the prefrontal cortex (PFC) and dopaminergic 
pathways (Dalley, Everitt et al. 2011). Loss of executive function by damaging 
the PFC is associated with overeating, gambling, and substance abuse (Crews 
and Boettiger 2009). In animal models of addiction, research has revealed that 
increased impulsivity, incentive-salience, and attentional deficits can confer an 
addictive phenotype, known as goal/sign-tracking (Tomie, Grimes et al. 2008, 
Lovic, Saunders et al. 2011, Nasser, Chen et al. 2015, King, Palmer et al. 
2016). 
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Figure 1.4.1: Gut Microbiota in the cycle of addiction: purposed 
mechanisms of how gut microbiota affect the addiction cycle; adapted from a 
figure by Wise & Koob (Wise and Koob 2014).  
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The co-occurrence of mental health disorders in populations suffering from 
substance abuse cannot be overlooked. In the United States 8.9 million adults 
have been diagnosed with co-occurring substance use and mental health 
disorders (Priester, Browne et al. 2016). Moreover, co-occurring psychological 
disorders cannot easily be disentangled from addiction. Among these, stress, 
anxiety, and depression are commonly comorbid in patients with substance 
abuse disorders (Samaha and Potvin 2014) and are influenced by gut 
microbiota (Dinan and Cryan 2013, Naseribafrouei, Hestad et al. 2014, Jiang, 
Ling et al. 2015, Kelly, Borre et al. 2016, Morell Miranda, Bertolini et al. 2018).  
 
Addiction has been purposed to be a stress surfeit disorder where over-
activation of the HPA axis drives the addiction cycle (Koob 2015). Exposure to 
stress is known to enhance craving, drug seeking, drug-related anxiety, and is 
believed to be one of the leading factors in relapse (Goeders 2003, Koob, Buck 
et al. 2014). Administration of corticosterone increases sensitivity to low doses 
of cocaine, mediated through the HPA axis, and by severing this connection 
with adrenalectomy, administration of cocaine ceases (Goeders 2003). Acute 
drug abuse activates the HPA axis thereby increasing sensitivity to stress 
(Koob, Buck et al. 2014), which can then cause dysbiosis of the gut microbiota 
(Bailey, Dowd et al. 2011, Bharwani, Mian et al. 2015). Glucocorticoids and 
catecholamines alter intestinal barrier function, bacterial adherence to 
mucosa, and populations of microbes within the gut (Lyte, Vulchanova et al. 
2011). In animal studies, an anxious phenotype can be transferred into a new 
host via faecal microbiota transplantation (Collins, Kassam et al. 2013). It begs 
the question, could compulsive drug administration behaviour be increased by 
an anxious microbiota when exposed to stress?  
 
Certain microbes have been shown to have psychoactive properties in the host 
(Dinan, Stanton et al. 2013). In our lab, Lactobacillus rhamnosus was shown 
to have anxiolytic properties mediated through the vagus nerve which alters 
GABA receptors expression in cortical regions (Bravo, Forsythe et al. 2011). 
1.4.2 Psychological Comorbidities 
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Given the shared use of the HPA axis in stress, drug abuse, and microbiota-
gut-brain communication it is likely that gut microbiota could influence 
addiction through this pathway.  
 
Eating disorders share behavioural, neurochemical and genetic similarities to 
drug addiction (Mancino, Burokas et al. 2015). Rodent behavioural models 
assessing the goal/sign-tracking phenotype show that the more addictive sign-
tracking phenotype assign higher motivational value to food rewards (Pitchers, 
Flagel et al. 2015, Yager and Robinson 2015, Flagel and Robinson 2017). 
Data suggests a link between eating behaviours and the microbiome 
(Schellekens, Dinan et al. 2013, Alcock, Maley et al. 2014). Human studies 
have found eating disorders comorbid with alcohol abuse (Avena, Carrillo et 
al. 2004), increased incidence of eating disorders with heightened antibiotic 
usage (Raevuori, Lukkariniemi et al. 2016), and alterations in microbiome in 
eating disorders linked to increased depression and anxiety severity (Kleiman, 
Watson et al. 2015). The microbiota affect ghrelin, a protein critical in hunger 
and satiety as well as natural and drug-related rewards (Vengeliene 2013).  In 
rodent studies, antagonism of the ghrelin receptor reduced alcohol intake 
(Suchankova, Steensland et al. 2013) and decreased operant responding for 
sucrose (Skibicka, Hansson et al. 2012).  
 
Genetics is also an important aspect of addiction (Palmer and de Wit 2012). 
Implications for the gut microbiota on the genetic level include epigenetic 
modulation and host genetics shaping the gut microbiota. It has been shown 
that bacterial production of butyrate can alter DNA histone methylation in the 
host (Stilling, Dinan et al. 2014). Interestingly, a study has demonstrated that 
host miRNAs can promote the growth of bacteria commonly found in 
mammals (Liu, da Cunha et al. 2016). In an animal model of addiction, 
antibiotic-treated subjects had increased locomotor response and place 
preference to cocaine which correlated to alterations in synaptic protein 
transcripts in the brain (Kiraly, Walker et al. 2016). Alterations in gut 
1.4.3 Genetics in Addiction 
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microbiota may induce neuroplasticity associated to addiction. Furthermore, 
gut microbiota are able to alter gene expression in cortical regions such as 
BDNF and GABA (Bravo, Forsythe et al. 2011, Dinan, Stanton et al. 2013). 
 
The human brain has several critical periods of neurodevelopment, during the 
embryonic stage, childhood and at puberty (Borre, O'Keeffe et al. 2014, 
Neufeld, Luczynski et al. 2016). Research during the embryonic stageshowed 
altered reward behaviour in offspring through maternal immune activation by 
administering LPS to pregnant rodents (Straley, Van Oeffelen et al. 2016). The 
connection between childhood trauma and the incidence of drug abuse is well 
documented (Enoch, Hodgkinson et al. 2010). In animal studies, early life 
stress alters dendritic morphology of the NAc and PFC (Muhammad, Carroll 
et al. 2012) as well as causing marked changes in gut microbiota (Golubeva, 
Crampton et al. 2015) that lead to increased anxious behaviours in adulthood 
(Clarke, Grenham et al. 2013, Hsiao, McBride et al. 2013, Desbonnet, Clarke 
et al. 2015, Stilling, Ryan et al. 2015). A link between childhood trauma and 
neurodevelopment mediated through the gut microbiota may be involved in 
addiction. Disruption of the microbiota during puberty may also have profound 
effects on mental health, including risk of substance abuse (McVey Neufeld, 
Luczynski et al. 2016).  In particular, myelination in the PFC persists to 20 
years of age (Bartzokis 2005) during which time humans continue to develop 
executive control over behaviours. Intriguing research from our lab shows that 
an absence of gut microbiota in germ-free mice disrupts normal myelination in 
the PFC which can be corrected with transplantation of a conventional mouse 
microbiota at postnatal day 21 (Hoban, Stilling et al. 2016). It has been 
proposed that abnormal myelination of the PFC may result in a lack of 
inhibitory control, thus producing addictive behaviours (Bartzokis 2005). In 
addition to perpetuating the cycle of addiction by exacerbating stress and 
inflammation, the gut microbiota may be a factor in risk of addiction by altering 
neurodevelopment in cortical regions critically involved in addiction.  
 
1.4.4 Neurodevelopment and Addiction 
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Severe inflammation caused by pathogenic microbes have been reported in 
intravenous heroin use (Collignon 1983, Finn 2003) and alcohol abuse 
(Happel and Nelson 2005). Studies have implicated inflammation in several 
psychiatric diseases (Grenham, Clarke et al. 2011, Felger and Lotrich 2013) 
including alcohol dependence (Kelley and Dantzer 2011, Gorky and Schwaber 
2016) and depression (Miller and Raison 2015). Drugs of abuse activate 
microglia and increase innate immune genes in the brain, which can enhance 
negative affect and cause persistence of drug-seeking behaviours (Miguel-
Hidalgo 2009, Crews, Zou et al. 2011). Commensal microbes in the gut are 
capable of regulating the immune system and this immune modulation is 
known to impact the CNS (El Aidy, Dinan et al. 2014). Recent research has 
shown that gut microbiota can regulate microglia (Erny, Hrabe de Angelis et 
al. 2015, Lee, Vuong et al. 2018). Gut microbiota may also influence aspects 
of addiction through brain-immune system interactions (Cryan and Dinan 
2015, Plein and Rittner 2018). 
 
1.4.6.1  Alcohol Abuse Disorder and the Gut Microbiota 
Alcohol use disorder is a substance abuse disorder in which an individual is 
physically or psychologically dependent upon drinking alcohol, irrespective of 
the consequences. Research shows that chronic alcohol abuse alters the 
composition of the gut microbiota, causing overgrowth of harmful bacteria 
(Nilsson 2007, Mutlu, Keshavarzian et al. 2009, Yan, Fouts et al. 2011, Mutlu, 
Gillevet et al. 2012, Bull-Otterson, Feng et al. 2013, Lowe, Gyongyosi et al. 
2017, Kosnicki, Penprase et al. 2018). Alcoholic liver disease is the most 
prevalent illness associated to chronic alcohol abuse (O'Shea, Dasarathy et 
al. 2010). Consumption of alcohol irritates the gastrointestinal tract, which 
injures the lining of the intestines (Bull-Otterson, Feng et al. 2013, Elamin, 
Masclee et al. 2013, Leclercq, Matamoros et al. 2014). Poor intestinal barrier 
function allows bacterial endotoxins to pass from the intestines into the blood 
circulation (Bode 2003, Leclercq, Matamoros et al. 2014, Lowe, Gyongyosi et 
1.4.5 Inflammation and Addiction 
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al. 2017). Circulating toxins reach the liver causing inflammation, injury, and 
impaired hepatic function. A study in rodents found that increased intestinal 
permeability is one of the leading causes of alcohol-induced liver damage and 
this effect is mediated through gut bacteria (Bull-Otterson, Feng et al. 2013, 
Canesso 2014).  Furthermore, human studies have found that altered 
microbiota composition correlated to increased intestinal permeability, 
resulting in increased inflammation and negative affect during alcohol 
withdrawal (Leclercq, Matamoros et al. 2014). This research by Leclercq 
suggests that alterations in gut microbiota can result in enhanced craving, 
which is mediated through the gut-brain-liver axis. Similar alterations in 
bacterial taxa occur in human studies of alcohol abuse, chronic inflammation, 
and psychological disorders (Table 1). 
 
1.4.6.2 Other Substances of Abuse and the Gut Microbiota 
Available data on the effects of other substances of abuse on the gut 
microbiota indicate similar effects as alcohol. Clinical studies investigating 
tobacco smokers have associated smoking and cessation to changes in the 
gut microbiome and inflammation (Benjamin, Hedin et al. 2012, Biedermann, 
Zeitz et al. 2013, Biedermann, Brulisauer et al. 2014, Allais, Kerckhof et al. 
2016). Changes in gut microbiota following smoking cessation share 
similarities to the bacterial composition in an obese phenotype; this finding 
offers an explanation as to why individuals who stop smoking commonly gain 
weight (Biedermann, Zeitz et al. 2013). Chronic exposure to tobacco smoke in 
mice alters microbiome and mucin gene expression (Allais, Kerckhof et al. 
2016). Murine-models of opioid use has suggested a role of gut microbiota in 
the progression of morphine-dependence and disruption of gastrointestinal 
function (Kang, Mischel et al. 2017, Lee, Vuong et al. 2018, Plein and Rittner 
2018, Wang, Meng et al. 2018). In addition to these studies linking microbiota 
to altered intestinal permeability, inflammation, and metabolic processes in 
opioid-treated mice (Kang, Mischel et al. 2017, Lee, Vuong et al. 2018, Wang, 
Meng et al. 2018). Intermittent morphine exposure increased bacterial genus 
Ruminococcus, intestinal permeability, and pro-inflammatory microglia (Lee, 
Vuong et al. 2018). Volatilized cocaine – commonly referred to as “crack” – 
1-39 
 
alters gut microbiota in mice, including reduced alpha diversity, decreases in 
bacteria in family Ruminococcaceae and Veillonallaceae, and increased in 
Lachnospiraceae, Prevotellaceae, and Peptococcaceae (Scorza, Piccini et al. 
2018). Methamphetamine administration during conditioned place preference 
training decreased the propionate-producing genus Phascolarctobacterium 
alongside reduced propionate levels in faecal matter (Ning, Gong et al. 2017). 
Animal studies investigating the effects of an antipsychotic drug, olanzapine, 
on the microbiota has also linked changes to altered metabolism (Davey, 
Cotter et al. 2013). Interestingly, a study in mice showed that chronic treatment 
with the major psychoactive constituent of cannabis, Δ9-tetrahydrocannabinol 
(THC), changed gut microbiota and these changes contributed to reduction in 
energy intake and prevention of high fat diet-induced increases in body weight 
and adiposity (Cluny, Keenan et al. 2015). 
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Table 1.4.6: Arrows indicate 1) ↑ increases, 2) ↓ decreases, or 3) ↑↓ increases 
and decreases in microbiota. Changes in bacteria seen across human studies 
of substance abuse, psychological conditions, and inflammation. 
  
M
ic
ro
b
io
ta
S
u
b
s
ta
n
c
e
 A
b
u
s
e
P
s
y
c
h
o
lo
g
ic
a
l C
o
n
d
it
io
n
s
In
fl
a
m
m
a
ti
o
n
P
h
y
lu
m


   
  B
a
c
te
ro
id
e
te
s
To
ba
cc
o 
(B
en
ja
m
in
 e
t a
l.,
 2
01
2;
 B
ie
de
rm
an
n 
et
 a
l.,
 2
01
3)
D
ep
re
ss
io
n 
(J
ia
ng
 e
t a
l.,
 2
01
5;
 N
as
er
ib
af
ro
ue
i e
t a
l.,
 
20
14
)
A
lc
oh
ol
ic
 H
ep
at
it
is
 (C
he
n 
et
 a
l.,
 2
01
1;
  M
ut
lu
 e
t a
l.,
 2
01
2)
A
lc
oh
ol
 (K
os
ni
ck
i e
t a
l.,
 2
01
8;
 M
ut
lu
 e
t a
l.,
 
20
12
)
IB
D
 (B
en
ja
m
in
 e
t a
l.,
 2
01
2)


 
F
ir
m
ic
u
te
s
To
ba
cc
o 
Ce
ss
at
io
n
 (B
ie
de
rm
an
n 
et
 a
l.,
 2
01
3)
D
ep
re
ss
io
n 
(J
ia
ng
 e
t a
l.,
 2
01
5)
IB
D
 (B
en
ja
m
in
 e
t a
l.,
 2
01
2)

 
P
ro
te
o
b
a
c
te
ri
a
 
A
lc
oh
ol
 (C
he
n 
et
 a
l.,
 2
01
1)
D
ep
re
ss
io
n 
(J
ia
ng
 e
t a
l.,
 2
01
5)
Li
ve
r 
Ci
rr
ho
si
s 
(C
he
n 
et
 a
l.,
 2
01
1)
To
ba
cc
o 
(B
ie
de
rm
an
n 
et
 a
l.,
 2
01
3)
F
a
m
ily

 
E
n
te
ro
b
a
c
te
ri
a
c
e
a
e
 
A
lc
oh
ol
 (L
ec
le
rc
q 
et
 a
l.,
 2
01
4;
 L
lo
pi
s 
et
 a
l.,
 
20
15
)
D
ep
re
ss
io
n 
(J
ia
ng
 e
t a
l.,
 2
01
5)
A
lc
oh
ol
ic
 H
ep
at
it
is
 (L
ec
le
rc
q 
et
 a
l.,
 2
01
4;
 C
he
n 
et
 a
l.,
 2
01
1;
 
Ll
op
is
 e
t a
l.,
 2
01
5)


 
L
a
c
h
n
o
s
p
ir
a
c
e
a
e
A
lc
oh
ol
  (
Ch
en
 e
t a
l.,
 2
01
1)
D
ep
re
ss
io
n 
(N
as
er
ib
af
ro
ue
i e
t a
l.,
 2
01
4)
A
lc
oh
ol
ic
 H
ep
at
it
is
 (C
he
n 
et
 a
l.,
 2
01
1)
IB
D
 (H
on
da
 &
 L
itt
m
an
, 2
01
2;
 M
or
el
l M
ira
nd
a 
et
 a
l.,
 2
01
8)


   
  P
re
v
o
te
lla
c
e
a
e
A
lc
oh
ol
 (C
he
n 
et
 a
l.,
 2
01
1)
D
ep
re
ss
io
n 
(K
el
ly
 e
t a
l.,
 2
01
6)
Li
ve
r 
Ci
rr
ho
si
s 
(C
he
n 
et
 a
l.,
 2
01
1)
To
ba
cc
o 
(B
en
ja
m
in
 e
t a
l.,
 2
01
2)
IB
D
 (B
en
ja
m
in
 e
t a
l.,
 2
01
2)


 
R
u
m
in
o
c
o
c
c
a
c
e
a
e
A
lc
oh
ol
 (K
os
ni
ck
i e
t a
l.,
 2
01
8;
 L
ec
le
rc
q 
et
 a
l.,
 
20
14
)
N
eg
at
iv
e 
af
fe
ct
 d
ur
in
g 
w
it
hd
ra
w
al
 (L
ec
le
rc
q 
et
 a
l.,
 
20
14
)
In
cr
ea
se
d 
Cy
to
ki
ne
s 
(L
ec
le
rc
q 
et
 a
l.,
 2
01
4;
 Ji
an
g 
et
 a
l.,
 2
01
5)
Bi
po
la
r,
 D
ep
re
ss
io
n 
an
d 
A
nx
ie
ty
 (E
va
ns
 e
t a
l.,
 
20
16
; L
ec
le
rc
q 
et
 a
l.,
 2
01
4;
 K
le
im
an
 e
t a
l.,
 2
01
5)
IB
D
 (M
or
el
l M
ira
nd
a 
et
 a
l.,
 2
01
8)
G
e
n
u
s

 
A
lis
ti
p
e
s
 
A
lc
oh
ol
 (L
lo
pi
s 
et
 a
l.,
 2
01
5)
A
lc
oh
ol
ic
 H
ep
at
it
is
 (L
lo
pi
s 
et
 a
l.,
 2
01
5)
IB
D
 (M
or
el
l M
ira
nd
a 
et
 a
l.,
 2
01
8)

 
B
if
id
o
b
a
ct
e
ri
u
m
A
lc
oh
ol
 (L
ec
le
rc
q 
et
 a
l.,
 2
01
4)
In
cr
ea
se
d 
Cy
to
ki
ne
s 
(L
ec
le
rc
q 
et
 a
l.,
 2
01
4)
To
ba
cc
o 
(B
ie
de
rm
an
n 
et
 a
l.,
 2
01
4)
S
p
e
c
ie
s


   
  C
lo
s
tr
id
iu
m
 s
p
p
.
A
lc
oh
ol
 (K
os
ni
ck
i e
t a
l.,
 2
01
8;
 L
ec
le
rc
q 
et
 a
l.,
 
20
14
; L
lo
pi
s 
et
 a
l.,
 2
01
5)
N
eg
at
iv
e 
af
fe
ct
 d
ur
in
g 
al
co
ho
l w
it
hd
ra
w
al
 
(L
ec
le
rc
q 
et
 a
l.,
 2
01
4)
In
te
st
in
al
 In
fla
m
m
at
io
n 
(H
on
da
 &
 L
itt
m
an
, 2
01
2;
 B
en
ja
m
in
 e
t 
al
., 
20
12
)
To
ba
cc
o 
Ce
ss
at
io
n
 (B
ie
de
rm
an
n 
et
 a
l.,
 2
01
4)
In
cr
ea
se
d 
Cy
to
ki
ne
s 
(L
ec
le
rc
q 
et
 a
l.,
 2
01
4;
 Ji
an
g 
et
 a
l.,
 2
01
5)
 

 
F
a
e
ca
lib
a
ct
e
ri
u
m
 s
p
p
.
A
lc
oh
ol
 (L
ec
le
rc
q 
et
 a
l.,
 2
01
4)
N
eg
at
iv
e 
af
fe
ct
 d
ur
in
g 
al
co
ho
l w
it
hd
ra
w
al
 
(L
ec
le
rc
q 
et
 a
l.,
 2
01
4)
IB
D
 (H
on
da
 &
 L
itt
m
an
, 2
01
2,
 B
en
ja
m
in
 e
t a
l.,
 2
01
2;
 M
or
el
l 
M
ira
nd
a 
et
 a
l.,
 2
01
8)
Bi
po
la
r 
an
d 
D
ep
re
ss
io
n
 (E
va
ns
 e
t a
l.,
 2
01
6;
 Ji
an
g 
et
 
al
., 
20
15
; K
le
im
an
 e
t a
l.,
 2
01
5;
 M
or
el
l M
ira
nd
a 
et
 a
l.,
 
20
18
)
In
cr
ea
se
d 
Cy
to
ki
ne
s 
(L
ec
le
rc
q 
et
 a
l.,
 2
01
4)
D
ep
re
ss
io
n 
(J
ia
ng
 e
t a
l.,
 2
01
5;
 N
as
er
ib
af
ro
ue
i e
t a
l.,
 
20
14
)
N
eg
at
iv
e 
af
fe
ct
 d
ur
in
g 
w
it
hd
ra
w
al
 (L
ec
le
rc
q 
et
 a
l.,
 
20
14
)
R
e
c
u
rr
e
n
t 
C
h
a
n
g
e
s
 i
n
 G
u
t 
M
ic
ro
b
io
ta
 i
n
 H
u
m
a
n
 S
tu
d
ie
s
 R
e
la
te
d
 t
o
 A
d
d
ic
ti
o
n
 
1-41 
 
Modelling a complex disorder, such as addiction, in rodents is an example of 
the challenge in modelling a strictly human disorder in laboratory animals 
(Singer, Fadanelli et al. 2018). Therefore, many rat and mouse models are 
implemented to get a broader understanding of the multiple factors 
associated to addiction. There are three major models employed to 
investigate addiction in rodents: 1) passive administration of a substance of 
abuse to assess biological changes associate to the pharmacodynamics of 
the substance (Holmes, Fitzgerald et al. 2012, Peterson, McCool et al. 2015, 
Radke, Jury et al. 2017); 2) use of an addiction model analogous to 
behaviour matching the DSM-V criteria for addiction in humans which selects 
rats that compulsively self-administer a substance of abuse after a training 
period (Deroche-Gamonet, Belin et al. 2004, Jadhav, Magistretti et al. 2017);  
3) behavioural phenotyping of rodents, predominantly rats, to reveal 
variations in neural processes known to be associated with addiction, such 
as dopaminergic activity (Flagel, Watson et al. 2008, Flagel, Akil et al. 2009, 
Gancarz, San George et al. 2011, Palmer and de Wit 2012, Versaggi, King et 
al. 2016). 
 
1.4.7.1 Chronic-Intermittent Vapor Alcohol Exposure 
Chronic intermittent vapor ethanol exposure (CIE) is a commonly employed 
model to examine the effects of prolonged, repeated ethanol exposure in 
rodents similar to patterns of intoxication seen in humans (Radke, Jury et al. 
2017). This model is advantageous as it induces a high blood ethanol 
content (BEC) which most rodents would not achieve through self-
administration and reduces BEC variability between subjects, as well as 
eliminating the confound of caloric effects from oral ingestion. Briefly, rodents 
are placed in sealed plexiglass chambers with vaporized ethanol pumped 
into each chamber for an extended portion of the day (12-16 hours) for a 
variable period of weeks (Peterson, McCool et al. 2015, Peterson, Jury et al. 
2017). During ethanol exposure, BECs are achieved in the range of 150-200 
mg/dL. To put this measurement in the context of human alcohol 
consumption, if an average 73kg (160lb) man consumed 5 shots (~44ml) of 
1.4.7 Animal Models of Addiction 
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whiskey (40% ethanol) in a 10-minute interval his BEC would be 140 mg/dL 
for the next 30min (assuming he did not consume more alcohol). If this man 
chose to drive following those 5 drinks, he would be 1.4x over the limit in the 
US and 2.8x over the limit in Ireland (aka serious trouble for the fellow). For 
this same man to achieve the 150-200 mg/dL BEC in the ethanol exposure 
paradigm, he would need to drink 7-8 shots of whiskey in an hour (half of a 
standard 700ml bottle sold in shops!). 
 
1.4.7.2 Preclinical Model of DSM-V Alcohol Addiction Criteria 
The Diagnostic and Statistical Manual of Mental Disorders version 5 (DSM-
V) is produced by the American Psychiatric Association with a set of 
symptomatic criteria that must be met to diagnose a patient with a certain 
disorder. Defined as “Substance-Related and Addictive Disorders”, several 
criteria that must be met for diagnosis, include hazardous use, 
social/interpersonal problems with use, legal problems, withdrawal, craving, 
tolerance, use of larger amounts or longer periods of use, physical or 
psychological problems associated to use, and neglect of other activities for 
use (Grant, Goldstein et al. 2015). Some of these criteria have been 
translated into a preclinical model, where high-criteria ranking rats display 
enhanced motivation to self-administer drug measured on a progressive-ratio 
schedule, willingness to endure aversive conditions to self-administer drug, 
relapse behaviour measured as reinstatement of lever-pressing after an 
extended period of abstinence, and inability to abstain from lever-pressing 
during a signal period of drug unavailability (Deroche-Gamonet, Belin et al. 
2004, Jadhav, Magistretti et al. 2017). In brief, all rats can freely self-
administer the drug in a neutral environment during a “training period”. 
Following the period of free drug use, rats are tested for the outlined criteria, 
scores, and classed in to groups based on addiction severity scoring.  
 
1.4.7.3 Addiction-Related Behavioural Tests 
Behavioural tests related to addiction are carried out in rodent models of 
addiction to examine behavioural phenotypes indicative of addiction. Similar 
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behavioural phenotypes have been associated with humans at-risk of 
addiction. 
 
1.4.7.3.1 Reward-Learning and Incentive-Salience 
Reward learning behavioural tests include both operant and classical 
conditioning. Reward learning tasks that implement operant conditioning 
includes light reinforcement (LR) where light is the rewarding stimulus and 
choice reaction time (RT and 5CSRTT) which requires the rat to learn to 
nose poke based on light/tone cues for a water reward. Operant chambers 
are used to assess motivation and incentive-salience for a reward measured 
by lever presses either on a fixed-, random-, or progressive-ratio schedule, 
and can also incorporate aversive conditions such as crossing water or an 
electric-shock floor to lever press for a reward. Conditioned Place Preference 
(CPP) and Cocaine Cue Preference (CCP) are frequently used tests of a 
subject’s vulnerability to the classical conditioning of a recreational drug. In 
both paradigms, an animal is introduced to a chamber with three floor types 
during multiple sessions where injection of a drug or saline is paired with a 
particular floor type. On the final day of testing, the subject is allowed to 
freely choose how much time is spent in the different floor types. Animals 
that choose to spend more time in the cocaine-paired floor type also show 
increases in drug self-administration, and alterations in dopamine activity 
(Meyer, Ma et al. 2012, Kiraly, Walker et al. 2016, Ning, Gong et al. 2017). 
Another behavioural test based on classical conditioning includes Pavlovian 
conditioned approach (PavCA) and reinforcement (CRF) wherein a lever cue 
is repeatedly paired with the presentation of a magazine dispensed food 
reward, following training rats are tested for lever or magazine associations 
which assesses the salience of the lever vs. magazine. Rats that assign 
incentive-salience to the lever cue (aka sign-trackers) have been shown to 
have greater propensity to self-administer substances of abuse and show 
alterations in striatal dopamine activity (Flagel, Watson et al. 2008, Flagel, 
Clark et al. 2011, Meyer, Lovic et al. 2012). 
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1.4.7.3.2 Impulsivity 
Impulsivity is a behaviour mediated through the prefrontal cortex (PFC), 
which requires the executive ability to control behaviours and impulses by 
inhibiting signals in other cortical regions. A common test of impulsivity used 
in both human and animal studies is Delay Discounting (DD). Like the 
operant progressive-ratio (PR) test, a breaking point or indifference point is 
assessed by incrementally increasing time in-between subsequent rewards 
until the subject is no longer interested in the reward. However, in DD the 
reward increases with time. Thus, in DD a subject may choose a smaller 
reward for a shorter delay time or a larger reward with a longer delay time. 
The choice of increased reward vs. increased wait time is plotted and the 
area under the curve (AUC) is calculated by subject’s selection. A lower AUC 
value in delay discounting is associated to increased impulsivity and 
addictive-behaviour (Reynolds, Richards et al. 2004, Perry, Larson et al. 
2005, de Wit 2009). In the choice reaction time task, a measure of impulsivity 
is assessed by counting every instance that a rat attempts to poke its snout 
in the reward hole , prematurely, before the indication light/tone, defined as 
false alarms per opportunity.  
 
1.4.7.3.3 Locomotor Behaviour 
In the context of addiction-related behaviour, locomotor activity is measured 
in response to novelty and following drug administration. These locomotor 
measures provide an indication of dopaminergic activity in response to 
stimuli. Increased locomotor response to these novel stimuli are associated 
with enhanced dopamine release and increased addiction potential 
(Gancarz, San George et al. 2011). This locomotor response to novelty is 
usually conducted in a low-lit open field arena. Locomotor response to drug 
injection is often an additional measure taken in the conditioned place 
preference test.  
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1.5  Mining the Microbiome – Next-Generation 
Sequencing, Bioinformatics, and 
Biostatistics 
 
At every step of microbiome analyses, careful planning and consultation with 
experts is required to properly execute microbiome analysis appropriate for 
experimental aims. Starting with sample collection and storage, DNA 
extraction, library preparation, sequencing, to selection of bioinformatic 
pipelines, classifier, reference database, and biostatistical analysis -- every 
step can potentially alter microbiome results (Clooney, Fouhy et al. 2016). 
While many microbiome researchers have called for a unification of 
methodology, consensus on ‘proper’ analysis seems to depend, in part, on 
experimental design and aims. The following sections will outline basic 
methodologies and touch on protocol and/or procedural disparities that may 
result in altered results.  
 
Researchers of the gut microbiome, particularly those collecting and 
processing samples, inevitably realize the nature of their work. Thus, a jovial 
approach, ripe with witticism, assists in coming to terms with the samples 
necessary for this scientific research. However, execution of this phase in 
microbiome analysis must not be carried out flippantly. 
 
Next-generation sequencing (NGS) is currently the common method used in 
microbiome analysis. The Illumina platform will be overviewed herein, 
however other platforms exist such as the Ion Torrent. Three Illumina 
sequencers are predominantly used for microbiome sequencing: 1) the least 
expensive MiSeq which is predominantly used for 16S rRNA gene 
sequencing, however is also capable of virome shot-gun metagenomic 
1.5.1 “The Poop Phase” 
1.5.2 Sequencing 
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(SGM) sequencing 2) the mid-cost NextSeq capable of SGM microbiome 
sequencing and deep 16S sequencing, 3) most expensive HiSeq used for 
SGM sequencing in large-sample studies and transcriptome sequencing. 
The Selection of the sequencing platform can alter microbiome results 
because different sequencing machines read a mixture of DNA differently, 
resulting in altered proportions of bacterial DNA read (Fouhy, Clooney et al. 
2016). Cost is often the major consideration when selecting a sequencing 
method, however the method that provides the most relevant data to address 
experimental aims and sequencing depth (how much data per sample) 
should be the major deciding factors.  
Consideration of primer selection for amplification of 16S rRNA gene region 
is necessary. For 16S rRNA gene sequencing on the MiSeq, the maximum 
read length is 2x300bp with read lengths of 2x250bp commonly selected. For 
higher sequencing reads per sample (i.e., more microbiome community 
data/depth) or larger sample pools, the NextSeq can be used. The NexSeq 
maximum read length is 2x150bp, affecting 16S rRNA gene primer selection, 
which is preferable for studies interested in accuracy at the genus level 
(Claesson, Wang et al. 2010). The Illumina Nextera library prep kit for the 
MiSeq includes a protocol for 16S rRNA gene primers which covers the V3-
V4 hypervariable regions of the 16S rRNA gene, resulting in ~500bp 
amplicon suitable for sequencing at 2x250bp. This primer has been selected 
based on appropriate amplicon size and high bacterial coverage (~94.5%) 
and can amplify archaea (Klindworth, Pruesse et al. 2013). Importantly 
though, V3-V4 primers have shown low efficiency in classifying sequences at 
certain taxonomic levels and drastically bias relative taxa abundancies 
compared to other 16S rRNA gene primer regions (Claesson, Wang et al. 
2010, Zheng, Tsompana et al. 2015). Primer selection can have a significant 
impact on resulting microbiome composition, depending on the hypervariable 
regions amplified on the 16S rRNA gene (Claesson and O'Toole 2010, 
Fouhy, Clooney et al. 2016). 
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1.5.2.1 Metagenomic vs 16S 
Shot-gun metagenomic (SGM) and 16S rRNA gene microbiome sequencing 
both have benefits and limitations. 16S rRNA gene sequencing is limited to 
taxonomic characterization of bacteria and archaea, yet provides a greater 
resolution at higher taxonomic levels, including phylum, class, order, family, 
and genus (Zhernakova, Kurilshikov et al. 2016, Barton, Penney et al. 2017). 
SGM sequencing provides higher resolution at species and strain level, 
allowing for more accurate predictions of functionality, as well as covering 
genes of all organisms in the microbiome. Unlike 16S rRNA gene 
sequencing, SGM provides a more accurate representation of true 
community proportions, as sequencing is not biased by primer selection. 
1.5.2.2 Bacteriome Sequencing 
Microbiome processing of samples requires swift preservation of the 
collected samples. Placing samples on ice during collection is generally 
considered good practice. If the experimental design is focused on certain 
bacteria, understanding of oxygen exposure and freezing method must be 
considered (Fouhy, Deane et al. 2015). Anaerobic bacteria viability and 
abundance can be altered with prolonged exposure to oxygen. Freezing 
methods affect cell viability in many Lactobacillus species - for improved 
survival, methods includes a 6-hour period at low temperatures (~20C) 
before transferring to -80C freezer (Bâati, Fabre-Gea et al. 2000, Volkert, 
Ananta et al. 2008). With all microbiome samples, care must be taken to 
minimize exposure to light, most importantly ultraviolet, heat, air, and 
contaminants. 
In animal models, caecum or freshly collected faeces may be used for 
bacteriome sequencing. While caecum may provide a more representative 
picture of bacterial abundance in the host, caecum can only be collected at 
time of culling and thus is not practical for longitudinal studies. Furthermore, 
most sample collection in clinical studies are faecal, unless a biopsy is 
performed. Certain bacteria, and not others, can differ between caecal and 
faecal samples from the same subject.  
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If a DNA extraction kit is used, all samples or randomized groups of samples 
should be extracted with the same kit(s). Minor variations in kit reagents and 
protocol, notably the Qiagen InhibitEX reagent which absorbs DNA 
degrading substances and heating of lysis buffer, can affect microbiome 
results. Vigorous vortexing or bead-beating can potentially sheer DNA, also 
altering results. Randomized samples should undergo extraction and library 
preparation in batches to eliminate the confound of batch-effects. Similarly, 
sample order should be randomized in the 96 well plates to control for time 
effect. Microbiome DNA extraction and library preparation must be performed 
in a sterile environment, using sterile equipment. Primer selection for 
amplification of the 16S rRNA gene hypervariable region will be discussed 
further in 1.6.2 Sequencing subsection. During 16S rRNA gene amplification, 
ideally, a separate sterile hood and pipettes should be used to prevent 
amplicon contamination in subsequent DNA sample extractions.   
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Figure 2.5: How the microbiome is analysed. Flow chart (left to right) of 
how a patient’s sample is processed to obtain microbiota data. Following 
DNA extraction, the microbiome can either be sequenced by 16S ribosomal 
RNA gene amplification, which is specific for archaea and bacteria, or 
metagenomic sequencing which sequences all genes and captures 
predominantly bacterial DNA as well as fungi, virus, and archaea. Both 
methods then undergo quality filtering and bioinformatic analysis. With 
metagenomic sequencing, bacteria can be better identified at the species 
and strain level and functional genetics can be estimated. 16S sequencing 
provides a more robust profile of overall bacterial composition. 
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1.5.2.3 Viral Sequencing 
Sample collection for refined virome sequencing varies considerably from the 
bacteriome. Published protocol for the refinement of lytic bacteriophage virus 
from faecal samples requires 2-3grams of faecal matter (Reyes, Wu et al. 
2013), a goliath task when a single fresh mouse dropping weight 
approximately 40mg. Hence, in studies collecting mouse stool at multiple 
timepoints throughout the study, with aims to sequence both bacteriome and 
virome separately, the only viable option is to collect dried pellets from 
bedding for virome analysis. Lytic bacteriophages are relatively stable under 
normal environmental conditions (Olofsson, Ankarloo et al. 2001, van Raaij, 
Schoehn et al. 2001) and their DNA/RNA is encapsulated in a protective 
protein barrier which prevents degradation in foreign environments; however 
relative abundancies likely vary compared to fresh faeces or caecum. 
Additionally, animals co-housed together in a single cage must be treated as 
a signal sample since faeces is collected from the entire cage. DNA 
extraction of refined phage/virome uses the ethanol-precipitation method to 
maximise DNA yield. Shot-gun metagenomic sequencing of phage/virome is 
performed without amplification, as this step can potentially bias results.  
 
Bioinformatic pipelines are the development and use of software programs to 
analyse genomic sequences in a biologically relevant manner. Pipelines vary 
between shot-gun metagenomic and 16S sequencing, as well as within these 
two sequencing methods. A simplified overview of a pipeline includes: i) 
filtering of raw sequence data; ii) joining or assembly of filtered sequences; 
iii) taxonomic assignment using a classifier and reference database. Various 
packages are available for performing steps in the pipeline. The redundancy 
of available packages is a major cause of variability across different pipelines 
for the same sequencing method. Additionally, packages performing the 
same task can have variations in algorithms used (Ahmed, Claesson et al. 
2009, Clooney, Fouhy et al. 2016). As stated previously, ‘proper’ pipeline 
methodology can depend on experimental design and aims.  
1.5.3 Bioinformatic Pipelines 
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 Aspects of the bioinformatic pipeline that influence microbiome results 
include a) classifiers and binning software (Ahmed, Claesson et al. 2009, 
Clooney, Fouhy et al. 2016, Walsh, Crispie et al. 2018), b) reference 
database (Ahmed, Claesson et al. 2009, Balvociute and Huson 2017), and c) 
threshold settings for filtering and accepting taxonomic assignments (Ahmed, 
Claesson et al. 2009). Classifiers and binning software implement various 
algorithms to compare sample sequences to the reference genomes in a 
database and determine taxonomic assignment at different levels (ex., 
Phylum, Family, Genus). Several reference databases are available to 
assign phylogeny to sequences. For 16S bacteriome sequences, Silva and 
Ribosomal Database Project (RDP) are two commonly used databases with 
Silva being one of the largest (Balvociute and Huson 2017). Thresholds are 
set to filter out low quality sequences and to control for false-positives during 
taxonomic assignment (Walsh, Crispie et al. 2018); changes in these 
thresholds can effect quality, reliability, and reproducibility of results. 
 
Differences in microbiome between groups can be assessed by alpha & beta 
diversity (Morgan and Huttenhower 2012). Measurements of diversity are a 
crucial part of microbiome analysis, as these measures are generally less 
sensitive to discrepancies in methodology (Ahmed, Claesson et al. 2009, 
Walsh, Crispie et al. 2018). Beta diversity measures similarities and 
differences in microbiome composition. Ordination plots are commonly used 
to measure beta diversity of the microbiome composition between samples 
or groups. Ordination plots are made from a distance matrix that is calculated 
from pairwise comparisons of the microbiome composition of each sample. 
Types of ordination plots include Principle Component Analysis (PCA), 
Principle Coordinate Analysis (PCoA), Multidimentional Scaling (MDS), and 
Canonical Correspondence Analysis (CCA), among others. Each dot in an 
ordination plot represents the entire microbiome of one sample. Dots are 
then coloured by group; an ellipsis can be calculated and drawn around the 
group. The location in space where a sample or group lies in the ordination 
plot is relative to other samples in the dataset. A statistical test can be 
1.5.4 Alpha and Beta Diversity 
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performed on the distance matrix to estimate significance of a grouping 
factor – most commonly referred to as ADONIS, ANOSIM, or PERMANOVA. 
Alpha diversity measures richness, abundance, and evenness of the 
microbiome in a single sample. Various formulas are used to measure alpha 
diversity, including: Shannon diversity index, Chao1 index, Observed 
Species, Simpson’s diversity index, and Pielou’s evenness. The most 
common alpha diversity index measures reported in the literature include 
Chao1, Observed Species. Shannon and Simpson.  Example formulas are 
shown for Simpson and Shannon index, taken from the vegan document 
(Oksanen, Blanchet et al. 2019): 
 
Where pi is the proportion of species i (or OTU in the case of 16S rRNA gene 
sequencing) and S is the total number of observed species (or OTUs). When 
all proportions for every specie is added together, it must equal 1 or 100%. 
Shannon uses the natural log numbers for the base (b), such as 2 or 2.718. 
Both Shannon and Simpson alpha diversity formulas measure richness and 
evenness. To exemplify the difference in the Shannon and Simpson a table 
is provided for two samples, where sample 1 is both richer and more even 
than sample 2: 
 
Sample 1 Sample 2 
Spp 1 0.1 0.1 
Spp 2 0.2 0.3 
Spp 3 0.2 0.4 
Spp 4 0.2 0.1 
Spp 5 0.2 0.1 
Spp 6 0.1 0 
Sum P 1 1 
Shannon 2.521928 2.046439 
Simpson 0.82 0.72 
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The index values are different between Shannon and Simpson, however 
both have a higher index value for sample 1 relative to sample 2 but the 
magnitude of the difference is greater for the Shannon measure. For group 
comparisons, the median alpha diversity index is calculated per group and 
Mann-Whitney U test is performed to determine statistical significance. Alpha 
diversity measures are commonly depicted in bar plots. Unlike beta-diversity, 
the alpha diversity measure for one sample remains the same regardless of 
what it being compared to. Therefore, alpha diversity is a measure of 
diversity within a single site, and beta diversity measures across multiple 
sites. 
 
Taxonomic composition at a certain phylogenetic level (e.g., Phylum, Family, 
or Genus) depicts the composition of a single sample or group. This analysis 
allows for identification of specific organisms in the microbiome which may 
be contributing to a phenotype. Microbiome sequences are first normalized 
relative to their total sequence counts, each sample will have a total 
sequence sum of one (100%). Highly abundant taxa are assigned unique 
colours; all remaining taxa in low abundance are assigned to Other. 
Taxonomic composition is then represented in either a bar or pie chart. 
However, this graphical representation of community composition requires 
further analysis to report significance. Taxonomic comparisons are used to 
identify certain phylogenetic organisms in the microbiome that are 
significantly different between groups. The use of proper statistical tests in 
microbiome analysis usually consists of non-parametric tests. The median 
log-relative abundance of the phylogenetic organism is calculated per group 
and either Mann-Whitney or Kruskal-Wallis test is performed and corrected 
for False Discovery Rate (FDR) to determine significance. Heatmaps depict 
pairwise comparisons between individual samples and/or measures. 
Heatmaps can be organized in a manner that reveal trends in the data set. 
Common calculations used in heatmaps include correlation, similarity (e.g., 
Beta diversity), and deviation from the mean (Z-score). These heatmaps are 
commonly used to show correlations between microbiome and biological 
1.5.5 Biostatistical Analysis  
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measures, functional changes in metabolic pathways, and how similar the 
microbiome of a single sample is to others in the same group vs. another 
group. 
  
1-55 
 
 
Figure 1.5.5: Ways to measure the microbiome. Graphs are depicted that 
are commonly used to report finding from microbiome analysis. A) Beta-
Diversity by ordination plots include Principle Component Analysis (PCA) or 
Principle Coordinate Analysis (PCoA). Each dot in an ordination plot 
represents the entire microbiome of one sample. The location in space 
where a sample or group lies in the ordination plot is relative to other 
samples in the dataset. B) Alpha diversity measures richness, abundance, 
and evenness of the microbiome in a single sample. Various formulas are 
used to measure alpha diversity, including: Shannon diversity index, Chao1 
index, Observed Species, Simpson’s diversity index, etc. Unlike beta-
diversity, the alpha diversity measure for one sample remains the same 
regardless of what it being compared to. C) Taxonomic comparisons are 
used to identify certain phylogenetic organisms in the microbiome that are 
significantly different between groups. This analysis allows for identification 
of specific organisms in the microbiome which may be contributing to a 
phenotype. D) Taxonomic composition at a certain phylogenetic level (e.g. 
Phylum, Family, or Genus) depicts the composition of a single sample or 
group, normalized relative to their total sequence counts, each sample will 
have a total sequence sum of one (100%). E) Heatmaps depict pairwise 
comparisons between individual samples and/or measures. Heatmaps can 
be organized in a manner that reveal trends in the data. 
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1.6 Primary hypothesis and aims of thesis 
 
The primary goal of this work focused on characterizing changes in gut 
microbiome between 1) drug-exposed/addiction phenotype and 2) stress 
groups compared to normal controls. The hypothesis was that microbiome 
changes are associated to different behavioural phenotypes, either inherent or 
induced through drugs/stress. These changes in microbiome are linked to 
behavioural and biological measures attributed to a behavioural phenotype. 
The purpose of these studies was to investigate if a behavioural phenotype 
was associated to the 1) bacteriome and alcohol abuse/addiction and 2) 
virome and stress. We hypothesize that bacteriophage exert an effect on 
psychological health via the microbiota-gut-brain axis by altering the dynamics 
and composition of gut microbiota, and by affecting the immune system and 
intestinal permeability. This work represents a unique facet in microbiome 
research, investigating its implication in drug addiction and virome in stress. 
 
AIM I: Does alcohol exposure alter gut microbiome composition when 
administered outside the gastrointestinal system? To answer this, a vapor 
alcohol administration mouse model was implemented to assess alterations in 
gut microbiome. 
 
AIM II:  Is the gut microbiota composition inherently different between subjects 
predisposed to addiction compared to those at lower risk? For this, we utilized 
a rat model of compulsive alcohol seeking which characterizes propensity to 
compulsively self-administer alcohol orally. This model has clinical relevance, 
as many tests of compulsive alcohol addiction simulate the DSM V criteria for 
alcohol abuse. Furthermore, low to high-risk phenotypes in this rat model fall 
along a spectrum, which is seen in many human psychological disorders. 
Furthermore, caecum samples from phenotype rats were collected after a 2-
month abstinence period. Thus, microbiome results are more representative 
1-57 
 
of the inherent associations to behavioural phenotype than that of oral alcohol 
exposure.  
 
AIM III: Is sex a significant factor that may account for some inherent 
microbiota variations associated to addiction? In our current research, 
microbiome analysis was carried out on a large cohort of female (N=101) and 
male (N=101) rats. These subjects underwent rigorous behavioural 
phenotyping, mainly comprised of tests that assess behavioural 
characteristics associated to addiction including impulsivity and dopamine-
mediated behaviour. To assess variations in microbiota, samples were 
analysed using a goal/sign-tracking phenotype while accounting for sex.  
 
AIM IV: Is the virome sensitive to chronic stress? Chronic psychosocial 
stress in mice was carried out to characterize changes in bacteriome and 
virome. Chronic stress is a contributing factor in many psychological 
disorders comorbid in addiction, such as anxiety and depression. 
Additionally, stress triggers compulsive addictive behaviour which further 
perpetuates the cycle of addiction. This exploratory study sought to breach 
the topic of gut virome in the context of the microbiome-gut-brain axis (MGB 
axis). Virome analysis focused on bacteriophage because of their direct 
influence on bacteria. Findings from this introductory research may spur 
future MGBA studies associated to stress, such as addiction.  
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2.1 Abstract 
The gut microbiota includes a community of bacteria that play an integral part 
in host health and biological processes. Pronounced and repeated findings 
have linked gut microbiome to stress, anxiety, and depression. Currently, 
however, there remains only a limited set of studies focusing on microbiota 
change in substance abuse, including alcohol use disorder. To date, no 
studies have investigated the impact of vapour alcohol administration on the 
gut microbiome. For research on gut microbiota and addiction to proceed, an 
understanding of how the route of drug administration affects gut microbiota 
must first be established. Animal models of alcohol abuse have proven 
valuable for elucidating the biological processes involved in addiction and 
alcohol-related diseases. This is the first study to investigate the effect of 
vapour route of ethanol administration on gut microbiota in mice. Adult male 
C57BL/6J mice were exposed to 4 weeks of chronic intermittent vapourized 
ethanol (CIE, N=10) or air (Control, N=9). Faecal samples were collected at 
the end of exposure followed by 16S sequencing and bioinformatic analysis. 
Robust separation between CIE and Control was seen in the microbiome, as 
assessed by alpha (Shannon and Simpson index, p<0.05) and beta 
(ANOSIM, p<0.001) diversity, with a notable decrease in alpha diversity in 
CIE. These results demonstrate that CIE exposure markedly alters the gut 
microbiota in mice. Significant increases in genus Alistipes (p<0.001) and 
significant reductions in genera Clostridium IV and XIVb (Kruskal-Wallis, 
p<0.001), Dorea (Kruskal-Wallis, p<0.01), and Coprococcus (Kruskal-Wallis, 
p<0.01) were seen between CIE mice and Control. These findings support 
the viability of the CIE method for studies investigating the microbiota-gut-
brain axis and align with previous research showing similar microbiota 
alterations in inflammatory states during alcoholic hepatitis and psychological 
stress. 
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2.2 Introduction 
 
The gut microbiota includes a community of bacteria that play an integral part 
in nutrient metabolism and absorption in addition to gating host immune 
function (Luczynski, Neufeld et al. 2016). Recently, a growing body of 
evidence points to the presence of a microbiota-gut-brain axis.  Indeed, 
preclinical studies have associated commensal bacteria to hypothalamic-
pituitary-adrenal (HPA) signalling (Luczynski, Neufeld et al. 2016), and 
neurodevelopment processes (McVey Neufeld, Luczynski et al. 2016), such 
as myelination (Hoban, Stilling et al. 2016), in addition to various behavioural 
phenotypes (Luczynski, Neufeld et al. 2016). Currently, however, there 
remains only a limited set of studies focusing on microbiota change in 
substance abuse, including alcohol use disorder (Bull-Otterson, Feng et al. 
2013, Leclercq, Matamoros et al. 2014, Llopis, Cassard et al. 2016). To date, 
no studies have investigated the impact of vapour alcohol administration on 
the gut microbiome. 
Chronic alcohol abuse can cause damage to health including nutrient 
depletion, cognitive deficits, and alcoholic liver disease.  Animal models of 
alcohol abuse have proven valuable for elucidating the biological processes 
involved in addiction, fetal alcohol syndrome, and alcohol-related diseases.  A 
widely used murine model of chronic alcohol abuse is chronic intermittent 
ethanol (EtOH) (CIE) exposure because it resembles the prolonged, repeated 
patterns of alcohol abuse seen in humans (Lopez and Becker 2005, Koob 
2013).  Prior studies using the CIE model have reported changes in a range 
of neural indices and behavioural phenotypes, including increased EtOH self-
administration (Holmes, Fitzgerald et al. 2012, DePoy, Daut et al. 2015, 
McCool and Chappell 2015, Peterson, McCool et al. 2015, Radke, Jury et al. 
2015). 
The CIE model could be advantageous for studying potential changes in the 
gut microbiome resulting from chronic EtOH exposure, as compared to other 
methods such as EtOH drinking, because 1) there is less potential for 
confounding effects of caloric intake 2) administration dose is consistent 
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among subjects, and 3) vapour administration circumvents the physiological 
effects of EtOH in the gastrointestinal tract, such as altered nutrient absorption.  
For these reasons, the current study employed the CIE method in order to 
investigate the consequences of chronic vapour EtOH on gut microbiome. 
 
2.3  Methods 
 
Adult male C57BL/6J mice were obtained from The Jackson Laboratory (Bar 
Harbor, ME, USA) at 7 weeks of age. The C57 mouse strain was selected 
because previous work from this laboratory had established a compulsive-
ethanol seeking phenotype in this strain (Radke, Jury et al. 2017). Mice were 
housed two per cage in a temperature (72±5°F) and humidity (45±15%) 
controlled SPF vivarium on a 12 hour light/dark cycle (lights on 06:00).  
Animals were allowed to acclimate to the facility for 1 week prior to CIE.  Food 
and water was provided ad libitum for the duration of the experiment.  Food, 
NIH-31 Harlan/Teklad Roden Chow, was obtained from Harlan Teklad 
(Indianapolis, IN, USA).  Cages were changed the same day each week 
(Mondays) and fresh Teklad corn cob bedding (1/8”) was also obtained from 
Harlan Teklad. Experimental procedures were approved by the NIAAA Animal 
Care and Use Committee and followed NIH guidelines.   
 
Subjects were randomly assigned to either the air (Control) or CIE group; 
N=10 for each group.  A previously described vapour inhalation procedure 
was employed (Lopez and Becker 2005, DePoy, Daut et al. 2015).  Prior to 
each session of vapour ethanol exposure, test subjects received IP injections 
of 1.5 g/kg of 20% EtOH (v/v) with 71.6 mg/kg of an alcohol dehydrogenase 
(ADH) inhibitor, pyrazole (Sigma, St. Louis, MO, USA), in a combined 
volume of 10 ml/kg body weight, to initiate intoxication and stabilize blood 
EtOH concentrations (BECs).  The average weight of mice was ~22 grams 
for both groups.  During exposure, mice were removed from their home 
cages and singly housed in clean 60×36×60 cm cages (PlasLabs, Lansing, 
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MI, USA) and placed into Plexiglas vapour chambers.  95% EtOH was 
passed through a vapourization stone at 19-22 mg EtOH/L of fresh air and 
delivered at a rate of ~10 L/min.  BECs were measured in sentinels using the 
Analox AM1 alcohol analyzer (Analox Instruments USA, Lunenburg, MA, 
USA) and achieved BECs of 175±25 mg/dL.  The protocol for Control group 
was similar to the CIE. The Control group received a 68.1 mg/ kg IP injection 
of pyrazole and was exposed to air at a rate of ~10L/min in Plexiglas vapour 
chambers directly adjacent to the EtOH vapour chambers. Pyrazole dose 
was adjusted based on solubility for mice to receive equal concentrations, 
thus dosage was higher in the CIE treated group because the solubility of 
pyrazole (a hydrophobic heterocyclic compound) is lower in EtOH than in 
saline (0.9% NaCl). Vapour exposure occurred for 16 hours per day (17:00-
09:00), 5 days a week (Monday-Friday) for 4 consecutive weeks.  Mice were 
8 weeks of age at the beginning of the study and 12 weeks of age at the end 
of the study. 
 
Immediately following the final exposure, mice from both groups were 
euthanatized via cervical dislocation and cecal and colonic contents were 
harvested, pooled and diluted 40-fold (weight: volume) in sterile water.  After 
centrifugation at 800 RPM, the supernatant was aliquoted under sterile 
conditions for storage at -80°C. 
 
The QIAamp DNA Stool Mini Kit (Qiagen, Hilden, Germany) was used to 
extract bacterial DNA from samples dilutions.  Extracted DNA was further 
concentrated using a standard EtOH precipitation protocol.  The prokaryotic 
16S ribosomal RNA gene (16S rRNA) was amplified from extracted DNA using 
amplicon PCR for the V3 and V4 regions following the Illumina 16S Sample 
Preparation Guide.  Using the Nextera XT DNA Library Prep Kit (Illumina, San 
Diego, CA, USA), 16S rRNA amplicons were further prepared for 2x250bp 
sequencing on the Illumina MiSeq platform. The Illumina V3–V4 primers were 
selected for this study because they have a high coverage (94.5% bacteria) 
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while remaining in the amplicon size necessary to sequence at 2×250 bp 
(Klindworth, Pruesse et al. 2013).  
 
All sequences in FASTQ files format were filtered using PRINSEQ.  
Sequences with length less than 150 nucleotides or with low quality at the 3’ 
end were removed.  Paired-end reads with a minimum overlap of 20 base-
pairs were joined using FASTQ-join.  Finally, all single files were processed to 
a final filtering sequence (mean quality score > 20).  Sequences from one 
sample in the control group had to be removed due to low sequencing reads, 
which resulted in a low quality score (< 20). After filtering quality and length 
trimming, the average number of high-quality sequences generated per 
sample (Control N=9, CIE N=10) was 63,600 ±25,932 SD.  The average 
number of OTUs per sample was 649±128 SD. The sequences were matched 
at operational taxonomic unit (OTU; 97% identity level) using closed-reference 
USEARCH v7.0 algorithm against The Ribosomal Database Project.  Alpha 
and beta diversity was determined using QIIME.  Additional alpha and beta 
diversity analyses were performed with the R package phyloseq. 
 
Alpha diversity was computed based on Shannon and Simpson methods and 
was visualized via the phyloseq package. Family and genera-level analyses 
were carried out using the Kruskal-Wallis method with the phyloseq package. 
Corrected p-values (q-value) adjust for multiple testing according to the 
method of Benjamini and Hochberg (Benjamini and Hochberg 1995).  Post hoc 
analysis of statistically significant taxa was performed to calculate log2 fold 
change in CIE relative to Control, p-values were estimated using negative 
binomial distribution (Gamma-Poisson).  
 
2.4 Results 
The Shannon and Simpson indexes were selected because the two are the 
most commonly used formulas for measuring evenness and richnessalpha 
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diversity of microbiota (Morgan and Huttenhower 2012).  These indexes 
showed significant (Shannon and Simpson indexes, p<0.05) differences in 
alpha diversity, with mean diversity decreased in the CIE group, relative to 
controls (Figure 2.3A).   
 
Sample distribution by sequenced OTUs using Principle Coordinate Analysis 
(PCoA) revealed phylogenetic separation between CIE and Control groups 
(Figure 2.3B).  Beta diversity analysis comparing taxonomic similarities 
between individual samples was calculated with Bray-Curtis (Figure 2.3C).  
The heatmap shows clustering of samples based on microbiota composition.  
Samples are distributed by overall taxonomic OTU similarity, regardless of 
group designation.  This method is used to assess if subjects cluster by 
exposure method, similar to a PCoA plot. Also similar to the PCoA plot, 
individual taxonomic components cannot be determined. In the Bray-Curtis 
heatmap, subjects clustered by exposure group (Figure 2.3C).  Multivariate 
analysis of beta diversity between CIE and Control groups revealed significant 
differences in total sequenced OTUs (ANOSIM, p<0.001 or adonis, p<0.001) 
and at the genus level (ANOSIM, p<0.01) but no significant difference at the 
family level (ANOSIM, p=0.157).  
 
At the family level, data revealed a significant difference in the Rikenellaceae 
family (Kruskal-Wallis, p<0.001) between groups, which remained statistically 
significant when corrected for multiple comparisons (Bonferonni, q-
value<0.05) (Figure 2.4B). Rikenellaceae was significantly increased (log2 fold 
change>3.5, p<0.0001) in CIE relative to Control (Figure 2.4B).  
At the genus level, data revealed significant differences in Alistipes (Kruskal-
Wallis, p<0.001) and Clostridium IV and XIVb (Kruskal-Wallis, p<0.001) 
between CIE mice and Control, which remained statistically significant when 
corrected for multiple comparisons (Bonferonni, q-value<0.05) (Figure 2.4B).  
A higher abundance of Alistipes (log2 fold change>3.8, p<0.0001) was seen 
in the CIE group, with decreases in Clostridium IV (log2 fold change>-1.4, 
p<0.001) and Clostridium XIVb (log2 fold change>-2.0, p<0.001) (Figure 2.4). 
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Figure 2.3: Effects of CIE vapour exposure on the microbiome. 
(A) Shannon and Simpson Index alpha diversity measures of bacterial number 
and distribution by group. Group outliers indicated with a dot, significance 
(p<0.05) indicated with an asterisk.  (B) PCA plot showing distribution of 
samples by OTUs. Clusters are coloured based on their respective 
experimental group. (C) Bray-Curtis heatmap of beta diversity clustering by 
sample. Axes indicate: i) individual sample per row (right y-axis) and column 
(bottom x-axis) and ii) dendrogram showing hierarchical relationships (not 
phylogenetic) by total OTUs composition with blue bar showing group 
assignment (left y-axis, top x-axis). Taxonomic information can not be 
determined from these figures. 
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Other changes were seen for Dorea (Kruskal-Wallis, p<0.01), Coprococcus 
(Kruskal-Wallis, p<0.01), and Propionibacterium (Kruskal-Wallis, p<0.01), 
which did not remain statistically significant when corrected for multiple 
comparisons (Bonferonni, q-value=0.23) but did remain significant when 
corrected for false discovery rate (FDR, q-value<0.05).  Akkermansia was 
visibly increased in the CIE graph of bacterial composition (Figure 2.4A), but 
significance (Kruskal-Wallis, p<0.05) did not hold after corrections 
(Bonferonni q-value=1.00).  Significant decreases in Dorea (log2 fold 
change>-2.5, p<0.01), Coprococcus (log2 fold change>-1.6, p<0.05), and 
Propionibacterium (log2 fold change>-1.7, p<0.05) were observed in the CIE 
group relative to Control (Figure 2.4).  
 
2.5 Discussion 
 
Although disturbances in the microbiome are linked to a variety of health states 
and the action of a variety of pharmacological agents, there is a paucity of 
information on the impact of chronic EtOH on microbiome composition 
(Spanogiannopoulos, Bess et al. 2016).  Here we found that the bacterial 
composition in mice exposed to CIE, as measured from Bray-Curtis and PCoA 
analyses, exhibited a clear separation from that seen in air-exposed Controls.  
These data add to a growing literature showing how changes in the 
microbiome can occur independently of direct administration of a substance 
into the gut (Bailey, Dowd et al. 2011).  They also extend the findings of a 
previous report showing reductions in alpha diversity following chronic alcohol 
feeding (Bull-Otterson, Feng et al. 2013).  Taken together with the current 
findings, these results demonstrate alterations in the gut microbiota in 
response to chronic EtOH across a range of routes of administration. 
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Figure 2.4: Effects of CIE vapour exposure on bacterial 
composition. (A) Genus level bacterial composition by group. (B) 
Statistically significant taxonomic changes in CIE exposed relative to Controls. 
Statistically significant taxa highlighted in light blue and grouped into rows 
ordered based on p-value. 
2-68 
 
 
In this study, Alistipes was the only genus of bacteria that significantly 
increased with CIE.  Increases in Alistipes and reductions in Clostridium 
cluster IV have been found in mice receiving fecal microbiota transfer from 
alcoholic patients with severe hepatitis (Llopis, Cassard et al. 2016).  An 
increased population of Alistipes has also been observed in chronic fatigue 
syndrome, inflammation, inflammatory bowel syndrome, and depression 
(Naseribafrouei, Hestad et al. 2014, Jiang, Ling et al. 2015).  We observed a 
decrease in genus Dorea in CIE relative to Control (Figure 2B).  Conversely, 
a study by Leclerq and colleagues found increases in Dorea associated with 
high intestinal permeability in alcoholics.  However, our current study found 
reductions in Clostridium cluster IV also seen in this aformentioned study 
(Leclercq, Matamoros et al. 2014).  The genus Clostridium cluster IV is 
populated by bacterial species believed to confer an anti-inflammatory effect 
and therefore beneficial to the host (Llopis, Cassard et al. 2016).   
Faecalibacterium prausnitzii and Clostridium leptum are among these 
beneficial species within this genus and are reduced in studies of alcohol 
consumption and hepatitis (Leclercq, Matamoros et al. 2014, Llopis, Cassard 
et al. 2016).  There is limited information about the functions of genra 
Propionibacterium and Clostridium XIVb within the gut microbiome though 
they are known to include species that produce short-chain fatty acids (Johns 
1952, Kelly, Kennedy et al. 2015) which are implicated in behavior and 
cognition (Kennedy, Murphy et al. 2016).  Similar reductions in Dorea and 
Coprococcus which have previously been observed in chronic social stress 
and correlated to increases in pro-inflammatory cytokines IL-6 and MCP-1 
(Bailey, Dowd et al. 2011). Future studies are needed to examine the relative 
importance of these alterations to the pathophysiology of disease states.   
 
Despite its advantage of mimicking the most common route of alcohol 
administration in humans, oral EtOH self-administration in rodents has several 
limitations, including: 1) dosage variability between test subjects, 2) 
inconsistent and unreliable self-administration in animals, 3) difficulty in 
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achieving and maintaining a desired BEC, and 4) experimental confounds 
such as caloric intake (McCool and Chappell 2015). Many of the issues with 
animal self-administration models or ethanol exposure are predominantly due 
to the fact that most animals do not enjoy the taste of alcohol nor the feeling 
of being inebriated While vapour exposure is not a common form of achieving 
intoxication in humans, this method is valuable in differentiating the underlying 
mechanisms involved in microbial changes caused by gastrointestinal EtOH 
exposure and other changes acting through the brain-gut-microbiota axis. In 
this study, we selected the vapour ethanol exposure method because it by-
passes the gastrointestinal system. A limitation in using this CIE model of 
vapor exposure is the administration of pyrazole, a known hepatoxin, which 
may confound results by having a synergistic effect with ethanol and LPS that 
may further alter liver function, inflammation, and gut microbiome. No obvious 
signs of liver damage were observed in either the AIR or CIE mice during the 
necropsies that immediately followed the respective exposures.  Selection of 
sequencing method and strain specific differences in microbiota composition 
may have also affected accurate identification of bacterial taxa and 
reproducibility of results within this study. However, current findings indicate 
changes in bacteria possessing functional traits that have been seen across a 
variety of related microbiome studies (Leclercq, Matamoros et al. 2014, Llopis, 
Cassard et al. 2016).  
 
In conclusion, the current study reveals marked changes in the bacterial 
composition of faecal microbiota in C57BL/6J mice chronically exposed to 
EtOH vapours.  These findings align with and extend a growing body of 
evidence of microbiota changes associated with inflammation and support the 
viability of the CIE method for future studies investigating the effects of EtOH 
on the microbiota-gut-brain axis.  Furthermore, the robust effects of EtOH 
vapour suggest that other substances of abuse administered outside of the 
gastrointestinal system may potentially alter gut microbiota.
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3.1  Abstract 
Identifying biological markers predicting vulnerability to develop excessive 
alcohol consumption may lead to a real improvement of clinical care.  With 
converging evidence suggesting that the gut microbiome is capable of 
influencing brain and behaviour, this study aimed at investigating whether 
changes in gut microbiome composition is associated with conditioned 
responses to alcohol. We trained Wistar rats (N=59) to self-administer 
alcohol for a prolonged period before screening those exhibiting uncontrolled 
alcohol seeking and taking by modelling diagnostic criteria for alcohol use 
disorder (AUD): inability to abstain during a signalled period of reward 
unavailability, increased motivation assessed in a progressive effortful task 
and persistent alcohol intake despite aversive foot shocks. Based on 
addiction criteria scores, rats were assigned to either Vulnerable or Resilient 
groups. Vulnerable rats not only displayed increased impulsive and 
compulsive behaviours, but also displayed increased relapse after 
abstinence and increased sensitivity to baclofen treatments compared to 
resilient animals. Then, rats underwent a 2-month wash out period before 
sacrifice. Dorsal striatum was collected to assess dopamine receptor mRNA 
expression (N=15), and 16S microbiome sequencing (N=38) was performed 
on caecal contents. Multiple significant correlations were found between gut 
microbiome and impulsivity measures, as well as augmentations in striatal 
Dopamine 1 receptor (D1R) and reductions in D2R as vulnerability to AUD 
increased. Therefore, using a singular translational approach based on 
biobehavioral dispositions to excessive alcohol seeking without heavy 
intoxication, our observations suggest an association between gut 
microbiome composition and these specific “at risk” behavioural traits 
observed in our translationally relevant model. 
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3.2  Introduction 
 
Unhealthy alcohol use is one of the world’s leading causes of death and 
diseases. Recent reports underline that approximately 3.3 million deaths 
worldwide and 139 million disability adjusted life years are attributed to 
alcohol use (World Health Organization 2014). Besides this unacceptable 
human cost, alcohol use disorder (AUD) represents a growing economic 
burden worldwide, the total cost of which is estimated in the range of US$ 
200-700 billion annually, both in Europe and in the United States (Baumberg 
2006, Sacks, Gonzales et al. 2015, Barrio, Reynolds et al. 2017). Reduction 
of heavy drinking and relapse prevention currently represents the main 
therapeutic objectives in the treatment of alcohol use disorder, but the ratio 
of good responders remains much too low to be satisfying (Mann and 
Hermann 2010). Therefore, alternative approaches should be privileged. One 
strategy would consist of better identifying "problem drinkers" in the general 
population who are not yet manifesting major symptoms of heavy intoxication 
but are drinking at levels that increase risks for medical and psychosocial 
consequences (Saitz 2005). Growing evidence points out to a role of the 
microbiota-gut-brain axis in AUD, with excessive ethanol consumption 
altering the gut microbiome, increasing the intestinal permeability and 
exacerbating systemic inflammation, ultimately amplifying comorbidities 
classically observed in alcoholic patients (Leclercq, Cani et al. 2012, Bull-
Otterson, Feng et al. 2013, Leclercq, De Saeger et al. 2014, Leclercq, 
Matamoros et al. 2014, de Timary, Leclercq et al. 2015, Gorky and Schwaber 
2016, Leclercq, de Timary et al. 2017, Temko, Bouhlal et al. 2017). 
 
Recent observations have begun to shed light on the inextricable connection 
between microbes and mammals, leading to the provocative postulate that 
humans would not have developed the current level of cognitive performance 
in absence of bacteria (Cryan and Dinan 2012, Montiel-Castro, Gonzalez-
Cervantes et al. 2013, Dinan and Cryan 2015, Sampson and Mazmanian 
2015). In support of this assertion, a current consensus has now established 
how the commensal microbiota of the intestine greatly influence all aspects 
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of physiology, including a fine tuning of brain function and behaviour (Hoban, 
Stilling et al. 2017, Dunphy-Doherty, O'Mahony et al. 2018). In this 
perspective, with the intestinal microbiome collectively encoding more than 
3.3 million of non-redundant genes (Qin, Li et al. 2010), exceeding by far, the 
number encoded by the human host genome. Moreover, there is a growing 
appreciation of the role of the gut microbiome in regulating brain and 
behaviour in health and disease (Dinan and Cryan 2017, Sherwin, Dinan et 
al. 2017). Overall, the microbiota–gut–brain axis helps maintain homeostasis 
of the brain by controlling central physiological processes including 
neurotransmission, neurogenesis, neuroinflammation and neuroendocrine 
signalling (Clarke, Stilling et al. 2014). In particular, recent reports suggest 
that alcohol exposure triggers neuroimmune and inflammatory processes in 
the brain (Crews, He et al. 2007, Crews, Qin et al. 2013, Crews, Walter et al. 
2017). Although the source of this neuroinflammation is not yet understood, 
growing evidence suggests that alterations in microbiota composition may 
contribute to neuroimmune processes and peripheral inflammation (de 
Timary, Leclercq et al. 2015, Gorky and Schwaber 2016, Rea, Dinan et al. 
2016). Changes in the gut microbiome have been reported in both human 
alcoholic individuals and murine models of chronic alcohol exposure, with 
increased intestinal permeability (causing endotoxin to escape into the 
circulation and impact the host), increased abundance of pro-inflammatory 
gut microbes, like Proteobacteria species, and decreased abundance of 
normal commensal bacteria like Bacteroidetes  (Mutlu, Gillevet et al. 2012, 
Bull-Otterson, Feng et al. 2013, Leclercq, de Timary et al. 2017, Peterson, 
Jury et al. 2017). However, if chronic excessive alcohol use seems to 
significantly impact the microbiota, it does not seem to be sufficient to cause 
gut dysfunction in all alcohol dependent patients, since altered microbiota 
composition was reported in only a subset of alcoholics. Further, alterations 
in microbial composition were not correlated to the duration of sobriety, 
suggesting alcohol-related dysbiosis is long-lasting and persists despite 
abstinent periods (Leclercq, Cani et al. 2012, Mutlu, Gillevet et al. 2012, 
Leclercq, De Saeger et al. 2014, Leclercq, Matamoros et al. 2014, Leclercq, 
de Timary et al. 2017). Meanwhile, gut microbial and peripheral metabolite 
level alterations remain narrowly linked to alcohol craving, anxiety, and 
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depression, considered important personality traits associated with the 
vulnerability to develop AUD (Leclercq, Cani et al. 2012, Leclercq, De 
Saeger et al. 2014, Leclercq, Matamoros et al. 2014, de Timary, Leclercq et 
al. 2015). 
 
The inability to control drug taking in general, and conditioned responses, in 
particular, is a complex brain disorder that affects the most vulnerable 
individuals and worsens with recurring drug consumption. Therefore, 
understanding the heterogeneity in the behavioural characteristic of patients 
with AUD is warranted for developing personalized treatments. We recently 
claimed that most preclinical studies still defend pharmacology-centered 
views that do not really capture the inter-individual vulnerability to lose 
control over alcohol consumption (Jadhav, Magistretti et al. 2017). 
Considering that preclinical investigations about genetic/temperament 
predisposition to alcohol abuse require the development of an appropriate 
and relevant animal model, we adapted to rodents a few criteria used for 
screening AUD according to the DSM-V and contributed to recognize that 
addiction is a progressive and idiosyncratic disorder. The recent reports 
suggesting that personality traits associated with risk for drug addiction may 
be linked tothe microbiome-gut-brain axis (Bravo, Forsythe et al. 2011, 
Collins, Kassam et al. 2013, McVey Neufeld, Luczynski et al. 2016, 
Golubeva, Joyce et al. 2017) calls for further investigation to determine 
whether gut microbiome diversity and composition may be associated with 
behaviors related to alcohol use disorders. To this end, we assessed if 
microbiota composition was different in rats exhibiting a biobehavioural 
disposition to lose control over alcohol consumption by comparison with 
resilient animals. Moreover, we sought to investigate if changes in the 
microbiome correlated with alterations in striatal dopamine receptor levels 
that may underlie the observed behavioural changes in the rat model of 
AUD. 
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3.3  Material and methods 
 
Male Wistar rats (N=59) were bred in-house at the Center for Psychiatric 
Neuroscience animal facility (breeders ordered from Charles River, France). 
They were approximately 7 weeks old and weighed 200–250 grams at the 
beginning of the experiment. They were kept in reversed 12-h light/dark cycle 
(lights off at 8.30 am) and housed in controlled temperature and humidity 
conditions. All experiments were performed in accordance with the Swiss 
Federal Act on Animal Protection and the Swiss Animal Ordinance and were 
approved by the cantonal veterinary office (authorization 3047 to 
B.B). 
 
The procedure for screening addiction-like behaviours has been extensively 
described elsewhere (Jadhav, Magistretti et al. 2017). Briefly, rats were first 
monitored for assessing impulsive behaviours using a 5-choice serial 
reaction time task paradigm. They were then tested in an elevated plus maze 
(EPM) for measuring their anxiety-like behaviours. Then, rats were daily 
trained for 30 min to self-administer 0.1 ml of alcohol 10% weight/volume for 
80 consecutive sessions, before being screened for addiction-like behaviour 
(see supplementary information for further detail). Test sessions aiming at 
identifying rats at risk of losing control over alcohol intake operationalized 3 
diagnostic criteria for AUD: inability to abstain during a signalled period of 
reward unavailability, increased motivation assessed in a progressive 
effortful task and persistent alcohol intake despite aversive foot shocks. Each 
rat was considered positive for one addiction-like criterion if its score reached 
the 66th-99th percentile of the total distribution. The addiction score was 
calculated as the sum of the standardized scores of each of the addiction-like 
criteria (Deroche-Gamonet, Belin et al. 2004). A total of 60 rats were trained 
(1 outlier exhibiting very high lever pressing behaviour was excluded), with 
those identified as positive for 2-3 criteria, defined as Vulnerable were 
3.3.1 Animals 
3.3.2 Behavioural phenotyping of alcohol use disorder 
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grouped together (N=19), and those with 0 and 1 criterion grouped and 
named Resilient (N=40). To further validate our model, rats were first 
exposed to a conflict situation in which they had to bear electrical foot shocks 
prior to get access to ethanol. Second, we tested baclofen responses in both 
groups of rats in order to assess whether the reinforcing and motivational 
properties of alcohol in resilient and vulnerable rats were differentially 
sensitive to an anti-alcohol effect treatment. Further details on the 
behavioural procedure are provided in Supplementary Information. 
 
All samples from the Vulnerable group (N=19) and an equivalent subset from 
Resilient group (N=19) were used for microbiome analysis. The selected 
Vulnerable rats belonged to the top 33% of the population for the three 
behaviours and the Resilient rats belonged to the lowest 33% of the 
population. Caecum was collected following two months of abstinence under 
aseptic conditions and snap-frozen on dry ice. Protocols for microbiome 
sequencing were used as previously described (Peterson, Jury et al. 2017). 
Briefly, caecal contents from frozen caecum (stored at -80ºC) was extracted 
under a sterile hood. The QIAamp DNA Stool Mini Kit (Qiagen, Hilden, 
Germany) was used to extract bacterial DNA from caecal contents using the 
manufacturer’s handbook (Second Edition 2012) Isolation of DNA from Stool 
for Pathogen Detection protocol. Samples were prepared for 16S sequencing 
using the Nextera XT DNA Library Prep Kit (Illumina, San Diego, CA, USA), 
as described in the Illumina 16S library preparation workflow. 16S bacterial 
rRNA gene was amplified using primers targeting the V3-V4 hypervariable 
region (Forward: 
5'TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCW
GCAG; 
Reverse:5'GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACH
VGGGTATCTAATCC) (Sigma Aldrich Ireland ltd., Wicklow, Ireland). The 
Illumina V3–V4 primers were selected for their high coverage (94.5% 
bacteria) while remaining in the amplicon size necessary for sequencing 
3.3.3 Ceacal microbiome collection and sequencing 
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(Klindworth et al., 2013). 16S rRNA amplicons were sequenced on the 
Illumia MiSeq platform (Teagasc, Morrepark, Ireland).  
 
Sequence reads in FASTQ files were joined using FLASH and analysed with 
QIIME(Quantitative Insights Into Microbial Ecology, v1.9.1). Sequence quality 
was checked, and chimeras removed, remaining sequences were clustered 
into Operational Taxonomic Units (OTUs) using USEARCH (Version 7.0-
64bit). The average number of high-quality sequences generated per sample 
was 150,707 ± 69,666 SD. Taxonomy was assigned to OTUs using Silva 
version 123. Alpha diversity indices were calculated with Qiime. 
 
Samples from 0Crit (N=8) and 3Crit (N=7) group were selected for gene 
expression analysis. Whole brains were extracted and rapidly sliced into 2 
mm-thick coronal sections in a rat brain stainless steel matrix. Slices 
containing dorsal striatum were used for micro-punch dissection (0.98 mm 
diameter micro-punch, Stoelting, Dublin, Ireland). RNA was extracted with an 
RNeasy Plus Minikit (Qiagen, Valencia, CA, USA) and converted into cDNA 
by reverse transcription reaction using TaqMan Reverse Transcriptase 
Reagents (Applied Biosystem, Foster City, CA, USA). Real-time PCR 
amplification was performed with an ABIPRISM 7500 cycler and SYBER 
green PCR Master Mix (Applied Biosystem, Foster City, CA, USA) using 
specific sets of primers (Microsynth AG, 9436 Balgach, Switzerland). 
Forward and reverse primers for the tested genes are the following: β-actin = 
forward: 5′-GCTTCTTTGCAGCTCCTTCGT-3′, reverse: 5′-
ATATCGTCATCCATGGCGAAC-3′; D1 receptor = forward: 5’-
GGAGGACACCGAGGATGA-3’, reverse: 5’-ATGAGGGACGATGAAATGG-
3’, D2 receptor = forward: 5’-TGGGTCAGAAGGGAAGG-3’, reverse: 5’-
GATGATAAAGATGAGGAGGGT-3’. All samples were analysed in triplicates. 
Relative gene expression was measured with the comparative ΔΔCt 
method24 and normalized with β-actin transcript levels. 
 
3.3.4 Microbiome Sequence Processing 
3.3.5 Gene expression analysis 
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For behavioural & mRNA Analysis, data was tested for normality (Shapiro-
Wilks test) and equality of variances (Levene’s Test). Data are expressed as 
mean ± standard error (SE). Parametric data were analysed by one way- and 
two-way ANOVAs followed by Bonferroni corrections, respectively. 
Homoscedastic, parametric measures were evaluated with two sample T-
test. Unpaired T test was used to analyse the anxiety data. Nonparametric 
measures were evaluated with Mann–Whitney test. Baclofen response was 
calculated with a Wilcoxon sign-ranks test. The level of significance was set 
at 0.05, and analyses were performed using IBM SPSS Statistics. Microbiota 
analysis was performed in R (v3.3.3) and RStudio (v1.0.136). Plots were 
generated in R using ggplot2 package (v2.2.1). Mann–Whitney test was used 
to assess statistical significance in alpha diversity indices and taxonomic 
comparisons between groups. Beta diversity was visualized and analysed by 
OTU counts normalized using the wisconson function from vegan community 
ecology package (v2.4-3). Adonis (PERMANOVA, permutations=999) vegan 
function assessed beta diversity significance between groups. Spearman 
correlation was performed on genus and family level bacterial abundance, 
behavioural measures, and dopamine receptor mRNA relative-expression 
levels. Since dopamine mRNA expression data was only available for 15 
subjects due to the remainder of cortical samples used for other analyses not 
reported in this manuscript, correlations to microbiome only included these 
15 subjects. In all other behaviour correlations, all samples were used 
(N=38). All correlations and taxonomic comparisons were corrected for 
multiple testing using the Benjamini and Hochberg method (Benjamini and 
Hochberg 1995), with the critical value for false discovery rate (Q) set at 
0.25. A less stringent Q value was selected due to the exploratory nature of 
this study and because the total number of tests (n>23,000) created a 
restrictively conservative FDR-corrected p value at Q=0.05. Log2 fold ratio 
calculated mean genus-level change in abundance for the 3.Vulnerable 
group relative to Resilient group. 
 
3.3.6 Statistical Analysis 
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3.4  Results 
 
3.4.1.1 Identification of rats at risk of alcohol use disorder 
After 80 sessions of operant conditioning (fixed ratio 1, time out 4 sec to get 
0.1 mL of 10% w/v ethanol, Figure 3.3), rats underwent a procedure for 
screening evidence for addiction-like behaviour. A rat was considered 
positive for an addiction-like criterion when its score was in the 66th to 99th 
percentile of the distribution. Hence, of the total 59 rats, we obtained 4 
groups, 26 rats with 0 criterion, 14 rats with 1 criterion, 12 rats with 2 criteria 
and 7 rats with 3 criteria (Figure 3.3).  
 
One-way ANOVAs revealed significant differences in the inability to abstain 
during a signalled period of reward unavailability (F3,55 = 17.436, p < 0.0001, 
Figure 3.3), in the motivation to seek for ethanol in a progressive effortful 
task (F3,55 = 23.23, p < 0.0001, Figure 3.3), in the persistence in ethanol 
seeking despite aversive foot shocks (F3,55 = 22.55, p < 0.0001, Figure 3.3), 
and finally in the vulnerability to relapse after a period of abstinence 
(F3,55=6.13, p=0.0012, Figure 3.3). Further statistical analyses are provided 
in Supplementary Information.  
 
The addiction scores, calculated as the sum of the standardized scores of 
each of the addiction-like criteria, were significantly different from each other 
(F3,55 = 67.20, p<0.0001), and were linearly increasing from 0crit to 3crit rats 
(Figure 1 F). We therefore clubbed 0 and 1 crit rats together and named 
them Resilient, while 2 and 3 crit rats were grouped and named Vulnerable. 
Further statistical analyses (available in the Supplementary Information) 
showed increased compulsive behaviour and increased sensitivity to 
baclofen treatments (Figure 3.3H, I and J), as well as increased impulsivity 
measures taken from the 5 Choice Serial Reaction Time Task (5CSRTT) 
(Figure 3.3K) in Vulnerable rats compared to Resilient. Factor analysis 
revealed that the three addiction-like criteria, the reinstatement and the pre-
existing trait of impulsivity loaded on one construct accounting for 50% of the 
variance, and therefore measuring one single underlying factor. Overall, 
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these series of observations served as a strong rationale for identifying rats 
with a loss of control-prone phenotype, without heavy ethanol intoxication 
given their history of brief exposures to alcohol used in this procedure. 
  
3-81 
 
 
Figure 3.3: Identification of rats at risk of alcohol use disorder. (A) 
Flowchart of the experimental procedure. (B) Distribution of ratsinto criteriom 
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group 0, 1,2, and 3. (C) Persistence in lever pressing during no-drug period. 
* Significant compared to 0Crit and 1Crit rats. (D) Motivation on progressive 
ratio. * Significant compared to 0Crit and 1Crit rats. # Significant compared to 
0Crit rats. (E) Alcohol seeking in presence of shock. # Significant compared 
to 0Crit rats. @ Significant compared to 0Crit, 1Crit and 2Crit rats. (F) 
Addiction Score measure. *Significant compared to 0Crit and 1Crit rats. 
#Significant compared to 0Crit rats. @Significant compared to 0Crit, 1Crit 
and 2Crit rats. (G) Reinstatement of ethanol seeking following a period of 
abstinence. * Significant compared to 0Crit and 1Crit rats. (H) Partial grid 
paradigmby intensity of the shock. (I) Effect of Baclofen on progressive ratio 
(J) Effect of Baclofen on Reinstatement. ^ Significant compared to 0Crit rats. 
(K) Impulsivity on 5CSRTT. (L) Factor Analysis of all the five variables 
included loaded on one construct (Persistence in drug seeking during the no-
drug period, Excessive motivation for alcohol seeking, Resistance to 
punishment, reinstatement, and impulsivity). 
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Nineteen Resilient (eighteen 0Crit and one 1Crit rats) and nineteen 
Vulnerable (twelve 2Crit and seven 3Crit rats) animals among the 59 rats 
initially screened were selected for microbiome analyses (see supplementary 
information). A brief presentation of their respective behaviours is 
summarized on Figure 3.3.2.1.  
 
Vulnerable rats exhibited increased alcohol seeking behaviours, in the 
presence of shock (Mann–Whitney U = 14, p<0.001, Figure 3.3.2.1A) and 
absence of ethanol (Mann–Whitney U = 15, p<0.001, Figure 3.3.2.1B), and 
increased motivation assessed in a progressive ratio schedule of 
reinforcement (Mann–Whitney U = 11, p<0.001, Figure 3.3.2.1C). Addiction 
score and reinstatement of a lever pressing behaviour after a period of 
abstinence were significantly higher in Vulnerable rats compared to Resilient 
(Mann–Whitney U = 0, p<0.001, Figure 3.3.2.1D and T-Test t(36)=-4.50, 
p<0.001, Figure 3.3.2.1E, respectively). Vulnerable rats’ response to 
baclofen treatment (1mg/kg) was enhanced, with a breaking point for ethanol 
seeking significantly reduced compared to resilient rats (Mann–Whitney Z=-
2.24, p<0.05, Figure 3.3.2.1F).  
  
3.4.2 Behavioural profiling of selected resilient and 
vulnerable rats 
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Figure 3.3.2.1: Selection of most Resilient (grey, n=19, combining eighteen 
0Crit and 1 1Crit rats) and most Vulnerable (red, n=19, combining twelve 
2Crit and seven 3Crit rats) animals among the 59 rats screened, according to 
(A) Alcohol seeking in presence of shock (B) Persistence in lever pressing 
during no-drug period, (C) Motivation on progressive ratio schedule, (D) 
Addiction Score, (E) Reinstatement and (F) Response to baclofen assessed 
in a progressive ratio schedule. Resilient group (grey) is plotted on left, 
Vulnerable group (red) on right. Significance codes: *** p<0.001, ** p<0.01, * 
p<0.05. 
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Vulnerable rats exhibited enhanced motor impulsivity, reflected by the 
percentage of premature responses in a 5-choice serial-reaction time task 
(5CSRTT) (T-test, t(36)=-2.74, p<0.01, Figure 3.3.2.2A). They did not display 
any anxiety-like behaviour on the elevated plus maze (EPM) (Mann–Whitney 
U = 136, p>0.05, Figure 3.3.2.2B), but increased novelty induced locomotor 
activity (Mann–Whitney U = 99, p<0.05, Figure 3.3.2.2C) compared to 
resilient animals. 
 
Total ethanol consumed over the entire 80 self-administration sessions was 
analysed for subjects used in microbiome analysis. There was no significant 
difference between groups (t(36)=-1.73, p>0.05). Although the Vulnerable 
group had significantly higher body weight compared to Resilient (t(36)=-
2.38, p<0.05), cecum weight was not significantly different between groups 
(t(36)=0.40, p>0.05). 
 
Finally, given the importance of the dopaminergic system in the striatum and 
the pivotal role it plays in the reward circuitry, we investigated the expression 
of the D1receptor and D2 receptor in the dorsal striatum. D1 receptor 
expression was significantly higher (t(13)=-2.88, p<0.05) and D2 receptor 
expression significantly lower in the Vulnerable group (t(13)=5.54, p<0.001) 
compared to the  Resilient group (Figure 3.3.2.2E-F).
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Figure 3.3.2.2: Selection of most Resilient (grey, n=19, combining 
eighteen 0Crit and 1 1Crit rats) and most Vulnerable (red, n=19, combining 
twelve 2Crit and seven 3Crit rats) animals among the 59 rats screened, 
according to a posteriori analyses revealed that Vulnerable rats, compared to 
Resilient rats, exhibited (A) increased impulsivity (B) exploration in an 
elevated plus maze (C) increased novelty induced locomotion (D) non-
significant increase in alcohol intake after prolonged conditioning (E) 
increased D1R mRNA (F) and decreased D2R mRNA expression in the 
dorsal striatum. In bar graphs all samples are plotted as grey dots. In box-
and-whisker plots outliers are indicated with a black dot. Resilient group 
(grey) is plotted on left, Vulnerable group (red) on right. Significance codes: 
*** p<0.001, ** p<0.01, * p<0.05. 
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3.4.3.1 Alpha and Beta Diversity 
Alpha and beta diversity analysis revealed no significant difference between 
Vulnerable and Resilient group, but a trend towards increased richness and 
evenness in the Vulnerable group (Figure 3.3.3.1A-B). 
 
3.4.3.2 Taxa Level Relative Abundance 
Compositional comparisons at the phylum, family, and genus level showed 
no significant difference between Vulnerable and Resilient group after FDR 
correction (p>0.05). At phylum level, a trend towards increased Firmicutes 
and decreased Actinobacteria in Vulnerable group (p>0.05) were seen. 
Comparisons at the family level revealed trends of increased 
Ruminococcaceae and decreased Bacillales Family.XI and 
Deferribacteraceae in Vunerable group. Additionally, changes in many 
genera of Lachnospiraceae and Ruminococcaceae were observed, however 
did not pass FDR significance testing (p>0.05) (Figure 3.3.3.2). 
 
3.4.3 16S microbiome analyses in caecal contents of resilient 
and vulnerable rats 
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Figure 3.3.3.1: Microbiome Diversity. A) Alpha diversity index measures of 
bacterial richness (chao1 index and observed_species index). B) Alpha 
diversity index measure of bacterial richness and evenness (shannon index). 
In box-and-whisker plots outliers are indicated with a black dot. C) PCoA 
ordination plot of orthogonal taxonomic unit (OTU) beta diversity. Percent 
explained variance reported on first (x-axis) and second (y-axis) principal 
component axis. Density of cluster indicated for the y-axis (right) and x-axis 
(bottom) by group. 
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Figure 3.3.3.2: Genus Level Relative Abundance. The mean of the 22 
most abundant bacteria are plotted by group, with the inner ring representing 
Vulnerable and outer ring representing Resilient group. Legend displays 
bacterial name with taxonomic designation at each level down to genus; 
bacteria are listed by order of appearance starting with Bacteroides (blue) at 
top. 
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3.4.3.3 Microbiome, Behaviour, and mRNA expression Correlation 
Analysis 
The strongest correlations were seen between D2R mRNA expression and 
low abundance bacteria belonging to phylum Firmicutes (|rho|>0.55, p<0.05), 
comprised mainly of positive correlations. The largest decrease in Vulnerable 
relative to Resilient group was observed in genus Veillonella (log2 ratio=-
4.6), which was negatively correlated to D1R mRNA expression (rho<-0.58, 
p<0.05). Other significant correlations to D1R mRNA expression include 
genera Gemella (rho<-0.61, p<0.05), and two from family Ruminococcaceae 
(rho<-0.57, p<0.05) (Figure 6). 
 
AUD behaviour showed a significate positive correlation to bacteria in order 
Clostridiales (rho>0.35, p<0.05), including many genera from family 
Ruminococcaceae and Lachnospiraceae. Significant, negative correlations 
were seen between AUD behaviour and genera Desulfovibrio (rho<-0.45, 
p<0.01), Gemella (rho<-0.43, p<0.01), uncultured Coriobacteriaceae (rho<-
0.40, p<0.05), and Hydrogenoanaerobacterium (rho<-0.36, p<0.05). The 
5CSRTT measure of impulsivity showed significant positive correlations to 
two genera of Lachnospiraceae (rho>0.34, p<0.05), Lachnospiraceae 
uncultured and Lachnospiraceae UCG-005, and significant negative 
correlation to bacteria in family Ruminococcoceae (rho<-0.35, p<0.05), an 
uncultured bacterium in the Eubacterium coprostanoligenes group. Anxiety 
measures (percentage time on open arms) from the EPM test were 
significantly positively correlated to the genus level bacteria Lachnospiraceae 
UCG-006 (rho>0.41, p<0.01) and Papillibacter (rho>0.34, p<0.05), in family 
Ruminococcoceae. On the other hand, EPM anxiety measure was negatively 
correlated to genus Anaerofilum (rho<-0.42, p<0.01), in family 
Ruminococcoceae. OFT measure of novelty induced locomotion negatively 
correlated to genera Lachnospiraceae UCG-007 (rho<-0.44, p<0.01) and an 
uncultured bacterium in the Ruminococcoceae Eubacterium 
coprostanoligenes group (rho<-0.40, p<0.05). Total ethanol (EtOH) 
consumption (TotEtOH) significantly correlated with Gemella 
(rho<-0.37, p<0.05) (Figure 3.3.3.3). 
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Most correlations are seen in low abundance bacteria (mean abundance < 
0.001%) however most of these low abundance genus level bacteria are 
present in the majority of samples (Supplementary Table 3). At the family 
level, Bacillales Family XI is most frequently correlated to behaviour 
measures. Both at the genus and family level this bacterium is in very low 
abundance and only present in 9 of  the 38 samples. Family level 
correlations, relative abundance and presence in samples of bacteria 
correlating to addiction measures is listed in Supplementary Tables 3-5. 
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Figure 3.3.3.3: Left panel - Correlations (positive in red, negative in blue) 
between genus level bacteria (y-axis) and addiction measures (x-axis); Right 
panel – Log2 fold change ratio showing changes in Vulnerable group relative 
to Resilient (increases in red, decreases in blue) for genera corresponding to 
correlation heatmap (left panel). Abbreviations (left to right x-axis): active 
lever presses without ethanol (LP.woEtOH), active lever presses with shock 
(LP.wShock), progressive ratio breaking point (PR), addiction score 
(Addiction.score), criteria designation 0Crit-3Crit (Criteria), percentage of 
premature responses in 5 choice serial reaction time task (5CSRTT), percent 
time in open arm in elevate plus maze (EPM), locomotor activity in open field 
test (OFT), total ethanol consumed over 80 sessions (TotEtOH), dopamine 1 
receptor mRNA expression (D1R), dopamine 2 receptor mRNA expression 
(D2R), change in progressive ratio breaking point between 0mg/kg dosage 
and 1mg/kg dosage baclofen (dPR.baclofen), active lever presses during 
reinstatement (Reinstatement). * indicate correlations that pass FDR at 
Q=0.25 (p<0.05). 
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3.5  Discussion 
 
A link between alterations in microbiota and alcohol-related behavioural 
changes has remained relatively unexplored. Here we show for what is to our 
knowledge the first time microbiota composition is associated to addiction 
measures in a realistic animal model of AUD. Moreover, low abundance 
bacteria coincided with changes in central gene expression.  
 
Converging evidence suggests that for some alcoholics (probably 30–50% of 
the total), ethanol consumption alters the gut microbiome by depleting 
protective bacteria, increasing intestinal permeability and releasing 
inflammation factors like bacterial peptidoglycans and lipopolysaccharide, 
which ultimately amplifies the psychopathology of alcoholism (Leclercq, Cani 
et al. 2012, Leclercq, De Saeger et al. 2014, Leclercq, Matamoros et al. 
2014, de Timary, Leclercq et al. 2015, Gorky and Schwaber 2016, de 
Timary, Starkel et al. 2017). However, authors suggested that alterations in 
microbiota composition could be responsible for the ‘leaky gut’ upon alcohol 
consumption, as no increase in permeability was observed in alcoholic 
patients which were resilient to microbiota changes, despite their alcohol 
consumption (de Timary, Leclercq et al. 2015). With alterations in microbial 
composition reported in only a subset of alcoholic patients and not correlated 
to the duration of sobriety, alcohol-related microbial imbalance is considered 
a long-lasting consequence that persists despite abstinent periods (Mutlu, 
Gillevet et al. 2012). Also, personality traits associated with the vulnerability 
to develop AUD have been consistently linked to gut microbial and peripheral 
metabolite level alterations. In particular, alcoholic patients without overt 
microbiota disturbances showed less severe levels of depression, anxiety 
and craving which almost disappeared after nearly 3 weeks of withdrawal, 
whereas these clinical signs persisted in abstinent patients with concurrent 
microbial changes (Leclercq, Cani et al. 2012, Leclercq, Matamoros et al. 
2014, de Timary, Leclercq et al. 2015). 
  
This intriguing observation poses the question of whether the gut microbiome 
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composition could represent a biological marker of the vulnerability to 
develop AUD. Intriguingly, we report here, for the first time to the best of our 
knowledge, that many of the biobehavioural traits associated with a loss of 
control-prone phenotype, without heavy ethanol intoxication, correlate with 
microbiome composition.  
 
It is important to note that rats in this study underwent a 2-month period of 
abstinence before microbiome analyses in caecal contents and measures of 
mRNA in striatal areas of the brain. Samples were received after a prolonged 
wash-out period because the aim of this study was to assess inherent 
differences in microbiome composition between groups of low- and high-risk 
addiction, this wash-out period reduces the confound of ethanol or baclofen 
affecting microbiome composition. Therefore, measures reported here do not 
correlate with acute ethanol intoxication, but rather reflect long-lasting 
behavioural traits, i.e., the loss of control-prone phenotype observed in 
vulnerable rats versus the temperate behavioural profile reported in resilient 
animals. Our observations are in line with those reported above regarding a 
role for microbiota composition in negative reinforcement processes driving 
alcohol consumption (de Timary, Leclercq et al. 2015, de Timary, Starkel et 
al. 2017). However, our study presents two limitations that need to be 
addressed in the near future, 1) faecal analyses before alcohol training would 
inform on pre-existing compositional differences in microbiome in rats 
developing uncontrolled alcohol seeking behaviour over time, and 2) 
measures of peripheral markers would inform on systemic inflammation 
occurring in vulnerable rats compared to resilient ones. Nevertheless, this is 
the first study reporting that microbiome composition is associated to 
addictive behavioural traits as opposed to acute effects of drug exposure. 
 
Here we took advantage of normal variation in behavioural traits relevant to 
addiction to stratify an outbred cohort into either Vulnerable or Resilient. Not 
surprisingly, rats with impulsive traits were at higher risk of developing AUD, 
and this pre-existing impulsive trait shifted towards a compulsive-like 
behaviour after extensive instrumental conditioning, associated with 
increased relapse rates after a period of protracted abstinence. Of particular 
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relevance, these animals still exhibited higher mRNA expression of D1 
receptors and lower mRNA expression of D2 receptor within the dorsal 
striatum after a prolonged period of abstinence. The striatum is mainly 
composed of medium spiny neurons (MSN), typically divided into those 
expressing dopamine receptor D1, forming the so-called direct pathway, and 
those expressing D2 receptor (indirect pathway). Whereas D1-MSNs 
mediate reinforcement and reward, D2-MSNs have been associated with 
aversion and avoidance. A current consensus suggests that D1-MSNs may 
facilitate the selection of rewarding actions encoded in the cortex, while D2-
MSNs may help to suppress cortical patterns that encode maladaptive or 
nonrewarding actions. Therefore, positive reinforcement learning would be 
modulated by signalling within the D1 direct pathway while negative 
reinforcement learning would be modulated by signalling within the D2 
indirect pathway (Volkow, Wang et al. 2013, Cox, Frank et al. 2015, Soares-
Cunha, Coimbra et al. 2016). As a consequence, it is postulated that 
dopamine-related impulsive phenotype partly relies on impaired negative 
feedback learning (Dagher and Robbins 2009). Functionally, in humans, the 
A1 (T) allele of the dopamine D2 receptor/ankyrin repeat and kinase domain 
containing 1 (DRD2/ANKK1) TaqIA (rs1800497) single nucleotide 
polymorphism has been associated with reduced striatal D2 receptor av-
ailability (Eisenstein, Bogdan et al. 2016), and a recent large-scale meta-
analysis confirmed the association between the ANKK1/DRD2 Taq1A 
polymorphism and alcoholism (Wang, Simen et al. 2013). Therefore, the 
lower expression of striatal D2 receptors, concomitant with higher expression 
of D1 receptors, in Vulnerable rats long after their last alcohol consumption 
confirms the construct validity of our model, and questions on the 
significance of those persistent brain adaptations occurring concomitantly 
with gut microbiota composition. 
 
The most profound correlations were seen in D2R mRNA expression 
corresponding to the inhibitory, indirect pathway. Significant correlations 
revealed changes in low abundance genera Lachnospiraceae UCG-006, 
Syntrophococcus, Shuttleworthia, Gemella, Allobaculum, uncultured rumen 
bacterium from Clostridiale vadinBB60 group, and 
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Hydrogenoanaerobacterium associated to reductions in D2R. This novel 
finding indicates that gut microbiota composition may contribute to inhibitory 
innervations in brain circuits associated to addiction. The capability of gut 
microbiota to influence inhibitory circuits is not surprising given the fact that 
administration of Lactobacillus rhamnosus (JB-1) reduces anxious behaviour 
by altering cortical GABAergic innervations (Bravo, Forsythe et al. 2011).  
 
Many genus level bacteria in order Clostridiales, family Ruminococcaceae 
and Lachnospiraceae, were positively associated to AUD severity, and also 
correlated to decreased D2R mRNA expression. Correlations between genus 
level bacteria and addiction measures would indicate that although these 
genera are not significantly different by group, subtle variations in abundance 
may potentially coincide with differences in addictive behaviour. While such a 
correlation opens a debate and requires further investigation on the 
mechanism linking gut microbiota to cortical D2R mRNA expression, recent 
evidence offers a partial explanation with the demonstration that gut 
microbiota regulate microRNA expression in the amygdala and prefrontal 
cortex. In particular, antibiotic treatment was shown to decrease miR-206-3p, 
a microRNA implicated in the regulation of brain-derived neurotrophic factor, 
essential in synaptic plasticity (Hoban, Stilling et al. 2017). Rare are the 
studies showing that altered microbiome impacts reward seeking behaviours, 
but a recent study reports that microbiome-depleted animals (following 
antibiotic treatment) exhibited an enhanced sensitivity to cocaine reward 
(Kiraly, Walker et al. 2016). Therefore, a link most likely exists between the 
microbiota, the brain and the vulnerability to drug abuse. Interestingly, this 
finding indicates that supplementation of these low abundance bacteria may 
have potential for treatment in AUD, but future studies are required to 
investigate if probiotic/prebiotic intervention targeting the gut-brain axis (aka. 
psychobiotics) is capable of reducing alcohol-seeking behaviors (Dinan, 
Stanton et al. 2013, Hoban, Stilling et al. 2017). 
 
The lack of significant differences in microbiome composition may be due to 
the 2-month abstinence period, however this wash-out period was chosen to 
ensure observed differences were not due to drug administration. Non-
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significant trends in altered microbiome composition between Vulnerable and 
Resilient group were seen in bacteria from family Ruminococcaceae and 
Lachnospiraceae. These findings are in line with alcohol studies showing 
reductions in bacteria from family Ruminococcaceae, increases in bacteria 
from family Lachnospiraceae, and increased alpha diversity associated to 
alcohol severity and altered intestinal permeability (Leclercq, Matamoros et 
al. 2014, Llopis, Cassard et al. 2016). Interestingly, it has been shown in 
patients with hepatic encephalopathy that the levels of Ruminococcaceae 
correlate negatively to inflammation (Bajaj, Hylemon et al. 2012). Behavioral 
traits, such as impulsivity, predispose individuals to addiction and other 
neuropsychiatric conditions, such as Attention Deficit Hyperactivity Disorder 
(ADHD) and autism. Previous work showed that reductions in genera 
Instestimonas (family Ruminococcaceae) and Desulfovibrio (family 
Desulfovibrionaceae) were associated with gastrointestinal dysfunction, 
altered metabolism, as well as anti-social, anxious, and compulsive 
behaviours in a mouse model of autism (Golubeva, Joyce et al. 2017). 
With current pharmacotherapies largely unsatisfactory, discovering novel 
alternatives to prevent AUD becomes a priority. Hence, identifying biological 
markers predicting vulnerability to develop excessive alcohol consumption 
may lead to a real improvement of clinical care. In this study, we report that 
gut microbiome composition is associated with specific “at risk” behavioural 
traits in a translationally relevant model of alcohol use disorder. These 
preclinical observations open a debate on the possible role of gut 
microbiome in predisposing individuals to AUD and offers a perspective on 
understanding alcohol addiction the etiology of which remains partially 
unknown. While addressing addiction-related associations to gut microbiome 
composition is probably not a panacea, it offers itself as an important 
underappreciated additional component in favour of better identifying those 
at risk of losing control over their alcohol intake. 
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3.6  Supplementary information 
 
3.6.2.1 Self-administration (SA) chambers 
Twelve operant chambers (305 x 241 x 210 mm, Med Associates, St. 
Albans, Vermont, USA) were used for the experiment. The chambers were 
housed in larger sound attenuated cubicle, equipped with exhaust fans for air 
renewal, also used for masking the background noise. The floor was made of 
a grid capable of delivering electrical shock. Each operant panel contained 
two retractable levers 60 mm above the grid and 35 mm equidistant from the 
midline, with a white light diode mounted 30 mm above each lever. Between 
the two levers was the delivery section which delivered 0.1mL of the fluid by 
means of a dipper. 
 
3.6.2.2 Chambers for testing impulsivity 
Six operant chambers (305 x 241 x 292 mm) were used for the 5-CSRTT 
experiment (Med Associates Inc., St-Albans, Vermont, USA). Each chamber 
was enclosed in wooden cubicles equipped with an exhaust fan for 
ventilation. Each cage contained a stainless-steel grid floor spaced by 
18mm, allowing waste collection in a removable tray containing sawdust. 
Front and back wall of the cage were in Plexiglas, while left and right wall 
were made of steel. Five nosepoke cavities (25x25 mm) were located on the 
left side of the cage, each spaced by 25mm. A food tray located 20 mm 
above the grid was available on the right side. Nosepoke cavities and food 
tray were equipped with a light and an infrared beam to monitor activity. 
Each cage was also equipped with a house light fixed on the ceiling, and a 
tone device. All the operant cages were linked to a common interface, and to 
a computer that controlled experimental procedures through Med associates 
software (Med-PC IV). 
 
3.6.1 Material and methods  
3.6.2 Apparatus: 
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Before the rats were exposed to alcohol, their impulsivity profile was 
ascertained by testing them on the 5 Choice serial reaction time task 
(5CSRTT). Rats were food restricted and maintained at 90% of their initial 
weight. For the whole experiment, sucrose food pellets (Dustless precision 
pellet 45 mg, rodent purified diet, BioServ, Frenchtown, NJ, USA) were given 
as a “reward” for correct responses, i.e., when the rat correctly poked its 
nose into the hole that had the illuminated light. Sucrose-laced food pellets 
were selected as sucrose provides higher motivational value (incentive 
salience) than normal, low sucrose, food.  
 
3.6.3.1  5CSRTT Training Procedure 
Rats were first trained to nose poke in the food tray to get a “reward” pellet. 
The training session stopped when rats collected 50 pellets of after 30 min. 
Then, on each trial, rats were trained to nose poke first in the food tray to 
start a trial and later nose poke in one of the five holes, randomly illuminated 
in order to get a “reward” pellet (recorded as a correct response). Nose 
poking in a different hole was recorded but had no consequence. The trial 
session stopped when rats collected 40 pellets of after 30 min. The next 
training phase was similar to the previous ones, but a 5-sec inter-trial interval 
(ITI) delay preceded the random illumination. Nose poking in a non-
illuminated hole was recorded as an incorrect response, triggering a 5-sec 
time out period signalled by the illumination of the house light. Then, a 5 
second tone was introduced to indicate the 5-sec delay before the random 
illumination. At the end of the tone, one of the 5 holes was briefly illuminated 
for 2 seconds. Any response during the tone, i.e., before the holes being 
illuminated, was recorded as a premature response but had no 
consequence. The final training session stopped when rats collected 50 
pellets of after 30 min. These training sessions follow the standard time 
interval of 30 minutes for measuring attention (Robbins 2002), however if an 
3.6.3  Impulsivity- 5 Choice serial reaction time task 
3-100 
 
animal consumed 40-50 pellets before the 30 minutes the session was 
stopped to prevent behavioural confounds due to overconsumption of 
sucrose laced food pellets, which can cause obesity and alterations in 
metabolic function. 
 
 
3.6.3.2 5CSRTT Test Procedure 
In the final test, rats were tested in the 5CSRTT paradigm during which each 
premature response was punished by a time out of 5 seconds and the 
illumination of the house light. The final test was 30 minutes or 100 trials 
(potential to receive 100 “reward” pellets), whichever came first. Absence of 
response during the 5 sec post-illumination was recorded as an omission. 
The correct, incorrect, premature and omission responses were recorded. 
 
Premature responses were calculated as a percentage: [premature 
responses / (correct + incorrect + omission + premature responses)]*100%  
3-101 
 
 
Figure 1: Process of the 5-Choice Serial Reaction Time Task (5CSRTT) for 
training and final testing. Figure adapted from previous publication (Robbins 
2002).  
 
Rats were tested in an Open Field Test (OFT) and in an Elevated Plus Maze 
(EPM) paradigm for evaluating anxiety-like behaviours after the 5CSRTT 
procedure. Both experiments were conducted under a dim light (10-15 Lx) 
during the active phase. Animal tracks were recorded by a digital video 
camera mounted above the maze and connected to a computer running a 
tracking-software (ANY-maze Video Tracking System v.4.99 – Stoelting Co., 
Wood Dale, IL, USA). 
 
3.6.4 Anxiety-related behaviors 
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3.6.4.1 Open Field Test (OFT) 
Rats were placed in a round arena (140 cm of diameter, 30 cm of depth) and 
their motor and exploratory activities (i. e., rearing) were monitored for 60 
min.  
 
3.6.4.2 Elevated Plus Maze (EPM) 
The elevated plus maze consisted of two opposite open arms (50cm L x 10cm 
W x 42.5cm H) and two opposite closed arms (50cm L x 10cm W) arranged in 
a cross and elevated 50 cm above the floor.  In the center, a small platform 
(10cm x 10cm) gave access to all arms. Rats were gently placed in the center 
of the maze face to a close arm and their behavior was monitored for 5 min. 
The time spent on open arms was used as an index of anxiety. 
 
Laboratory rodents do not voluntarily consume alcohol to intoxication, in part 
because of taste aversion. Higher levels of consumption could be achieved 
by masking the taste of alcohol with saccharine (Roberts, Heyser, & Koob, 
1999), which was faded out as alcohol concentrations increased (Dayas, Liu, 
Simms, & Weiss, 2007). Rats were trained under a Fixed Ratio 1 - Time Out 
4sec schedule of reinforcement for a total of 105 sessions, 30-min per 
weekday (25 sessions of saccharine fading + 80 sessions of ethanol self-
administration). During these baseline conditions, pressing the right (active) 
lever delivered 0.1 mL of ethanol (10%w/v in tap water, prepared from a 94% 
(vol/vol) ethanol solution) in the liquid delivery section and illuminated the 
diode above the active lever. The left lever was inactive, presses were 
recorded but had no consequence. 
 
Between test sessions aiming at scoring addiction-like behaviours (3 daily 
consecutive sessions each time), rats underwent 2 consecutive sessions of 
3.6.5 Animal’s training for alcohol self-administration  
3.6.6 Screening for addiction-like behaviour 
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basic training during which they were trained again under the same baseline 
conditions (Jadhav et al., 2017). 
 
3.6.6.1 Inability to abstain during a signalled period of reward 
unavailability 
Rats underwent 3 daily consecutive sessions; each one consisted of an 8 
minute-period of reward availability, followed by a 4 minute-period of 
signalled unavailability. Repeated three times, this sequence resulted in a 
total of 36 min. The period of unavailability was signalled by lighting up the 
self-administration chamber house light and interrupting the cubicle fan. The 
light diode above the active lever remained off after lever presses, and 
alcohol was not delivered. The average number of active lever presses 
during the signalled unavailability periods indicated the persistence in drug 
seeking during the no drug period. 
 
3.6.6.2 High motivation for alcohol seeking 
Rats were required to progressively increase the number of active lever 
presses between two successive rewards based on the progression 
sequence given by the following formula: response ratio = (5e(reward× 
0.2)) − 5. Hence, the progressive-ratio schedule followed the progression: 1, 
2, 4, 6, 9, 12, 15, 20, 25, 32, 40, 50, 62, 77, 95, 118, etc. Each session lasted 
90 min, or automatically shut down following 20 consecutive minutes of 
inactivity on the active lever. The maximal number of active lever presses 
performed to reach the final ratio was defined as the breakpoint, a value 
reflecting animals’ motivation to get the reward. The breaking point across 3 
consecutive daily sessions was averaged and considered as marker of 
motivation for alcohol seeking. 
 
3.6.6.3 Resistance to punishment 
In this paradigm, each lever press delivered 0.1 mL of 10% w/v ethanol by 
means of a dipper, followed by mild electric foot shocks (0.22 mA for 
0.5 second) through the grid of the SA chamber when the dipper retracted. 
This was conducted for 3 consecutive daily sessions, and the average 
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number of active lever presses across these 3 consecutive trials was 
considered as a marker of resistance to punishment, reflecting a compulsive 
reward seeking and taking behavior. 
 
In this paradigm, the rats must press the active lever once to gain access to 
0.1mL of 10% ethanol. The grid was divided into thirds, 2/3rd of the grid 
closest to the lever and delivery section delivered shock continuously, 1/3rd 
of the grid farthest from the lever was not electrified. Test rats had to bear 
shock before and during lever presses to administer ethanol. The rats were 
exposed to this paradigm for 30 mins for 3 sessions of increasing shock 
strength of 0.1mA, 0.15mA and 0.2mA. The number of active lever presses 
was recorded. 
 
At the end of all behavioral paradigm tests, rats were subjected to 
approximately 45 days of forced abstinence after which they were re-
exposed to the self-administration chambers. The rats were given access to 
the same conditions as the training sessions, where one active lever presses 
esulted in lighting up of the cue light above the lever, however ethanol was 
not delivered. The number of active lever presses during this period of 30 
minutes measured propensity to relapse. 
 
3.6.9.1 Persistence in lever pressing during the no-drug period 
The mean number of lever presses for each group were 6.03 ± 0.43 (0Crit), 
8.43 ± 0.79 (1Crit), 12.28 ± 1.16 (2Crit) and 12.33 ± 0.93 (3Crit), respectively. 
A one-way ANOVA showed a significant difference between groups 
(F3,55 = 17.436, p < 0.0001). Post hoc Bonferroni’s test revealed that, during 
the no-drug period, the 3Crit rats exhibited higher lever presses compared to 
0Crit (p < 0.0001) and 1Crit (p<0.01) groups, but not 2Crit (p>0.05). The 2 
criteria rats differed from 0 criteria rats (p < 0.001) and 1 criteria rats 
(p <0.01). The 0 and 1 criterion rats had similar performances (p>0.05). 
3.6.7 Partial grid paradigm 
3.6.8 Reinstatement paradigm 
3.6.9 Results 
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3.6.9.2 Increased motivation for alcohol seeking and drinking in an 
effortful condition 
The average breaking points for the four groups were 26.34 ± 1.37 (0Crit), 
37.21 ± 2.43 (1Crit), 49.33 ± 4.06 (2Crit) and 51.57 ± 3.27 (3Crit). One-way 
ANOVA showed a statistically significant difference among the groups 
(F3,55 = 23.23, p < 0.0001). Post hoc Bonferroni’s tests revealed that the 
3Crit rats displayed an increased motivation for ethanol seeking compared to 
0Crit (p < 0.0001) and 1crit (p>0.01) groups, but not compared to 2Crit 
(p>0.05). The 2Crit rats displayed a higher breaking point compared to 0Crit 
(p < 0.001) and 1Crit (p<0.01) groups. Finally, even the 1Crit rats exhibited a 
higher breaking point compared to the 0Crit rats (p < 0.001). 
 
3.6.9.3 Resistance to punishment 
The average lever presses for each group when each lever press was 
associated with a mild shock were 6.84 ± 0.6 (0Crit), 21.23 ± 3.6 (1Crit), 
20.36 ± 3.58 (2Crit) and 43.62 ± 7.28 (3Crit) (Fig. 2D). One-way ANOVA 
showed a statistically significant difference among the groups (F3,55 = 22.55, 
p < 0.0001). Post hoc Bonferroni’s tests that 3Crit rats accepted more shocks 
than 2Crit (p<0.0001), 1Crit (p < 0.0001), and 0Crit rats (p<0.01). Whereas 
2Crit rats were not different from 1Crit rats (p>0.05), they exhibited 
resistance to punishment as compared to the 0Crit rats (p<0.01). The 2Crit 
rats had higher lever presses as compared to 0Crit rats (p<0.001), but not 
1Crit rats (p>0.05). Finally, even the 1Crit rats had higher lever presses than 
0Crit rats (p<0.001). 
 
3.6.9.4 Addiction score and vulnerability to relapse after protracted 
abstinence 
The scores for the four groups were -2.06 ± 0.16 (0Crit), 0.23 ± 0.28 (1Crit), 
2.04 ± 0.4 (2Crit) and 3.68 ± 0.6 (3Crit). A one-way ANOVA revealed a 
significant difference between groups (F3,55 = 67.20, p<0.0001). A post hoc 
Bonferroni’s test showed that each group was significantly different every 
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other group. Pearson’s correlation analysis showed that the three criteria 
scores were highly correlated with the addiction score (persistence in drug 
seeking in absence of alcohol [r=0.77, p<0.0001], excessive motivation for 
alcohol seeking and drinking [r= 0.836, p<0.0001] and resistance to 
punishment [r=0.536, p<0.0001]). 
 
Rats were subjected to a 45-day period of forced abstinence, followed by 
which the rats were exposed to the reinstatement paradigm. A one-way 
ANOVA revealed a significant difference between criterion groups 
(F3,53=6.13, p<0.01). A post hoc Bonferonni’s test showed that the 3Crit and 
2Crit rats had higher active lever presses compared to 0Crit (p<0.001) and 
1Crit (p<0.01). A two-way repeated measures ANOVA with repetition in one 
factor identified a significant group effect (F1,56 = 16.62, p<0.0001) and a 
significant effect in intensity of shock (F2,116 = 105.89, p<0.001). Once the 
four groups were identified, we analysed their lever pressing behavior during 
the training sessions. 
 
 
Session 6-
10 
Session 21-
25 
Session 41-
45 
Session76-80 
0Crit 39.20 ± 3.59 30.26 ± 2.10 30.56 ± 1.88 43.67 ± 2.74 
1Crit 41.40 ± 4.48 37.77 ± 2.58 44.82 ± 4.64 46.31 ± 3.08 
2Crit 35.25 ± 2.95 37.86 ± 3.59 37.41 ± 3.62 49.32 ± 4.78 
3Crit 41.05 ± 3.44 41.17 ± 3.16 50.40 ± 3.69 64.46 ± 2.94 
Table1: Evolution of lever pressing behavior over the course of the 
operant conditioning 
 
A two-way repeated measures ANOVA with repetition in one factor identified 
a significant group effect (F3,55 = 4.93, p=0.0042), a significant effect of 
number of training sessions (F3,177 = 14.03, p<0.001) and a significant 
effect of group X number of training session interaction (F9,165 = 2.05, 
p=0.0361). A post hoc Bonferroni’s test to compare the difference between 
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subjects at a particular training session revealed that all the groups were 
comparable to each other at training session 6-10 and training sessions 21-
25. The number of lever presses between groups were significantly different 
at session 41-45 (0crit vs 3crit, p=0.0004). Also, the number of lever presses 
between groups were significantly different at session 76-80 (0crit vs 3 Crit, 
p=0.0007 and 1crit vs. 3crit, p= 0.0053). A post hoc Bonferroni’s test to 
compare the differences within a group of rats, showed that for all the groups 
the active lever presses at session 76-80 were significantly higher than the 
lever presses at session 6-10 (p<0.01) and at session 21-25 (p<0.01). This 
shows at all the groups showed a steady increase in their lever pressing 
behaviour as compared to their baseline lever pressing behaviour. However, 
since the interaction effect is significant, it shows that magnitude of change 
was higher in the 2crit and 3crit rats. 
 
 
Average active 
lever presses for 
saccharine only 
Average active 
lever presses for 
ethanol only 
(Session 6-10) 
Average active 
lever presses for 
ethanol only 
(Session 41-45) 
Average active 
lever presses for 
ethanol only 
(Session 76-80) 
Persistence in 
drug seeking 
during the no-drug 
period 
-0.04 -0.085 0.23 0.206 
Excessive 
motivation for 
alcohol seeking 
and drinking 
0.126 -0.013 0.497* 0.446* 
Resistance to 
punishment 
0.192 0.062 0.536* 0.27* 
Table 2:Table of lever press averages for different conditions. *p < 0.05 
Significant using Pearson’s correlational analysis (2 tailed). 
 
One argument against the model could be that some rats are inherently good 
at pressing the lever and the final output observed with the 3 behaviours is a 
reflection of their motor abilities and not their conditioning for lever pressing 
for alcohol. Hence, we ran a correlational analysis between the three criteria 
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scores used to define the addiction vulnerability and the lever presses for 
saccharine and for ethanol (at 3 time points: session 6-10, session 41-45 and 
session 76-80). As can be seen from Table 2, the lever presses for 
saccharine were not correlated with the three criteria scores. Similarly, the 
lever pressing for ethanol at the beginning of the training did not correlate 
with the three criteria scores. The persistence in lever pressing never 
correlated with the lever pressing at any time point. The motivation and 
resistance to punishment started showing significant correlations with the 
lever pressing for ethanol only after prolonged training.  
 
3.6.9.5 Effect of Baclofen 
Baclofen, a GABA-B receptor agonist, was tested on the progressive ratio 
paradigm to determine whether it could decrease the motivation for ethanol 
(Figure 1I). Two doses of baclofen were tested (1mg/kg and 2 mg/kg).  A 
two-way repeated measures ANOVA with repetition in one factor identified a 
significant group effect (F1,56 = 11.09, p<0.01), a significant effect of dosage 
(F2,116 = 25.71, p<0.0001) and a significant interaction effect (F112,173 = 
10.46, p<0.0001). A group-wise post hoc Bonferroni’s test showed that both 
the doses of baclofen reduced ethanol intake in the Vulnerable group, while 
only the 2 mg/kg dose had an effect in the Resilient group.  
Additionally, the effect of baclofen in the reinstatement paradigm was tested 
using the more effective 2mg/kg dosage (Figure 1J). A two-way repeated 
measures ANOVA with repetition in one factor identified a significant group 
effect (F1,55 = 9.25, p<0.01), a significant effect of intensity of dose of 
baclofen (F1,55 = 67.81, p<0.0001) and a significant interaction effect 
(F55,113 = 7.55, p<0.01).  
 
3.6.9.6 Factor analysis-figure 
A factor analysis was conducted for the three addiction-like criteria, 
reinstatement and impulsivity to determine whether they loaded on the same 
underlying construct (Figure 1L). The eigenvalue was kept as 1. The 
sampling adequacy score were also all around 0.75 as measured by the 
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KMO test (Persistence in drug seeking during the no-drug period: 0.768, 
Excessive motivation for alcohol seeking: 0.732, Resistance to punishment: 
0.793, reinstatement: = 0.786 and impulsivity: 0.802) which indicates that five 
variables included are suited for testing factor analysis. All the five variables 
included loaded on one construct (Persistence in drug seeking during the no-
drug period: r = 0.719, Excessive motivation for alcohol seeking: r = 0.832, 
Resistance to punishment: r = 0.715, reinstatement: r = 0.658 and impulsivity: 
r=0.65) accounting for 50% of the variance, further supporting that the three 
addiction-like criteria, reinstatement and the pre-existing trait of impulsivity 
are measures of a single underlying factor.  
 
3.6.9.7 Microbiome Correlation Tables 
Significant correlated genera 
presence and abundance  
Relative 
Abundanc
e (%) 
All 
Samples 
Re
sili
ent 
Vul
ner
abl
e 
Taxa 
Med
ian 
Mea
n 
Pre
sen
ce 
Pre
sen
ce% 
Pre
sen
ce  
Pre
sen
ce  
Proteobacteria.Deltaproteobacteria.D
esulfovibrionales.Desulfovibrionacea
e.Desulfovibrio 
1.07
6% 
1.56
9% 38 
100.
0% 19 19 
Firmicutes.Negativicutes.Selenomon
adales.Veillonellaceae.Veillonella 
0.00
0% 
0.01
2% 10 
26.3
% 7 3 
Firmicutes.Erysipelotrichia.Erysipelotr
ichales.Erysipelotrichaceae.Erysipelo
trichaceae.UCG.003 
0.00
2% 
0.00
5% 26 
68.4
% 13 13 
Firmicutes.Erysipelotrichia.Erysipelotr
ichales.Erysipelotrichaceae.Allobacul
um 
0.00
0% 
0.01
0% 19 
50.0
% 11 8 
Firmicutes.Clostridia.Clostridiales.Ru
minococcaceae.Papillibacter 
0.12
3% 
0.13
0% 38 
100.
0% 19 19 
Firmicutes.Clostridia.Clostridiales.Ru
minococcaceae.Intestinimonas 
0.10
3% 
0.10
8% 38 
100.
0% 19 19 
Firmicutes.Clostridia.Clostridiales.Ru
minococcaceae.Hydrogenoanaeroba
cterium 
0.00
0% 
0.00
1% 18 
47.4
% 9 9 
Firmicutes.Clostridia.Clostridiales.Ru
minococcaceae.Eubacterium.coprost
anoligenes.group 
2.35
1% 
2.89
3% 38 
100.
0% 19 19 
Firmicutes.Clostridia.Clostridiales.Ru
minococcaceae.Anaerofilum 
0.00
6% 
0.00
7% 35 
92.1
% 19 16 
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Firmicutes.Clostridia.Clostridiales.Lac
hnospiraceae.uncultured 
4.01
7% 
4.53
9% 38 
100.
0% 19 19 
Firmicutes.Clostridia.Clostridiales.Lac
hnospiraceae.Syntrophococcus 
0.00
6% 
0.01
0% 35 
92.1
% 18 17 
Firmicutes.Clostridia.Clostridiales.Lac
hnospiraceae.Shuttleworthia 
0.01
4% 
0.02
8% 38 
100.
0% 19 19 
Firmicutes.Clostridia.Clostridiales.Lac
hnospiraceae.Lachnospiraceae.UCG
.007 
0.00
1% 
0.00
2% 24 
63.2
% 12 12 
Firmicutes.Clostridia.Clostridiales.Lac
hnospiraceae.Lachnospiraceae.UCG
.006 
0.07
7% 
0.08
3% 38 
100.
0% 19 19 
Firmicutes.Clostridia.Clostridiales.Lac
hnospiraceae.Lachnospiraceae.UCG
.005 
0.14
2% 
0.17
8% 38 
100.
0% 19 19 
Firmicutes.Clostridia.Clostridiales.Lac
hnospiraceae.Lachnospiraceae.NK4
B4.group 
0.01
6% 
0.02
5% 37 
97.4
% 18 19 
Firmicutes.Clostridia.Clostridiales.Lac
hnospiraceae.Eubacterium.oxidoredu
cens.group 
0.12
5% 
0.15
5% 38 
100.
0% 19 19 
Firmicutes.Clostridia.Clostridiales.Clo
stridiales.vadinBB60.group.unculture
d.rumen.bacterium 
0.00
9% 
0.01
8% 34 
89.5
% 15 19 
Firmicutes.Bacilli.Bacillales.Family.XI
.Gemella 
0.00
0% 
0.00
1% 9 
23.7
% 8 1 
Actinobacteria.Coriobacteriia.Corioba
cteriales.Coriobacteriaceae.unculture
d 
0.10
9% 
0.12
1% 38 
100.
0% 19 19 
Table 3: Relative abundance and sample presence of genus level bacteria 
shown in correlation results - Figure 6 of manuscript.   
 
Taxa 
Behav
iour rho 
Pva
lue q 
D_0__Bacteria.D_1__Firmicutes.D_2__Bacilli.D
_3__Bacillales.D_4__Family.XI 
LP.w
Shock 
-
0.5
257
2 
0.0
007 
0.0
311
14 
D_0__Bacteria.D_1__Proteobacteria.D_2__Delt
aproteobacteria.D_3__Desulfovibrionales.D_4__
Desulfovibrionaceae 
LP.wo
EtOH 
-
0.4
694
7 
0.0
029
44 
0.0
794
96 
D_0__Bacteria.D_1__Firmicutes.D_2__Bacilli.D
_3__4.15.D_4__uncultured.bacterium 
TotEt
OH 
0.4
432
16 
0.0
053
22 
0.1
215
37 
D_0__Bacteria.D_1__Firmicutes.D_2__Bacilli.D
_3__Bacillales.D_4__Family.XI 
Criteri
a 
-
0.4
0.0
055
96 
0.1
243
31 
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408
9 
D_0__Bacteria.D_1__Firmicutes.D_2__Bacilli.D
_3__Bacillales.D_4__Family.XI PR 
-
0.4
358
1 
0.0
062
39 
0.1
323
15 
D_0__Bacteria.D_1__Firmicutes.D_2__Bacilli.D
_3__Bacillales.D_4__Family.XI 
Addict
ion.sc
ore 
-
0.4
305 
0.0
069
76 
0.1
409
72 
D_0__Bacteria.D_1__Firmicutes.D_2__Bacilli.D
_3__Bacillales.D_4__Family.XI 
D1.m
RNA 
-
0.6
141
9 
0.0
148
54 
0.2
223
95 
D_0__Bacteria.D_1__Firmicutes.D_2__Clostridi
a.D_3__Clostridiales.D_4__Peptococcaceae OFT 
-
0.3
956
2 
0.0
169
25 
0.2
409
16 
D_0__Bacteria.D_1__Firmicutes.D_2__Clostridi
a.D_3__Clostridiales.D_4__Defluviitaleaceae 
dPR.b
aclofe
n 
0.3
839
65 
0.0
173
18 
0.2
441
05 
D_0__Bacteria.D_1__Firmicutes.D_2__Negativi
cutes.D_3__Selenomonadales.D_4__Acidamino
coccaceae 
Addict
ion.sc
ore 
-
0.3
804
7 
0.0
184
52 
0.2
545
55 
D_0__Bacteria.D_1__Firmicutes.D_2__Bacilli.D
_3__Bacillales.D_4__Family.XI 
D2.m
RNA 
0.5
958
54 
0.0
190
77 
0.2
552
58 
Table 4: Family level correlations to behavioural measures. Green highlights 
indicate correlations that pass FDR with a q value set to 0.25.    
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Relative 
Abundan
ce (%) 
All 
Samples 
Re
sili
ent 
Vul
ner
abl
e 
Taxa 
Me
dia
n 
Me
an 
Pr
es
en
ce 
Pre
sen
ce
% 
Pr
es
en
ce  
Pre
sen
ce  
D_0__Bacteria.D_1__Firmicutes.D_2__
Bacilli.D_3__Bacillales.D_4__Family.XI 
0.0
00
% 
0.0
01
% 9 
23.
684
% 8 1 
D_0__Bacteria.D_1__Proteobacteria.D_
2__Deltaproteobacteria.D_3__Desulfovi
brionales.D_4__Desulfovibrionaceae 
1.1
89
% 
1.7
14
% 38 
100
.00
0% 19 19 
D_0__Bacteria.D_1__Firmicutes.D_2__
Bacilli.D_3__4.15.D_4__uncultured.bact
erium 
0.0
00
% 
0.0
01
% 10 
26.
316
% 3 7 
D_0__Bacteria.D_1__Firmicutes.D_2__
Clostridia.D_3__Clostridiales.D_4__Pep
tococcaceae 
0.7
37
% 
0.7
52
% 38 
100
.00
0% 19 19 
D_0__Bacteria.D_1__Firmicutes.D_2__
Clostridia.D_3__Clostridiales.D_4__Defl
uviitaleaceae 
0.0
04
% 
0.0
04
% 32 
84.
211
% 15 17 
Table 5: Relative abundance and sample presence of family level bacteria 
shown in correlation results - Table 4 above.   
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4.1 Abstract 
Introduction: Multiple factors contribute to the etiology of addiction, including 
genetics, sex, and a number of addiction-related behavioral traits. One 
behavioral trait where individuals assign incentive salience to food stimuli 
(“sign-trackers”, ST) are more impulsive compared to those that do not 
(“goal-trackers”, GT), as well as more sensitive to drugs and drug stimuli. 
Furthermore, this GT/ST phenotype predicts differences in other behavioral 
measures. Recent studies have implicated the gut microbiota as a key 
regulator of brain and behavior, and have shown that many microbiota-
associated changes occur in a sex-dependent manner. However, few studies 
have examined how the microbiome might influence addiction-related 
behaviors. To this end, we sought to determine if gut microbiome 
composition was correlated with addiction-related behaviors determined by 
the GT/ST phenotype. Methods: Outbred male (N=101) and female (N=101) 
heterogeneous stock rats underwent a series of behavioral tests measuring 
impulsivity, attention, reward-learning, incentive salience, and locomotor 
response. Cecal microbiome composition was estimated using 16S rRNA. 
Behavior and microbiome were characterized and correlated with behavioral 
phenotypes. Robust sex differences were observed in both behavior and 
microbiome; further analyses were conducted within sex using the pre-
established goal/sign-tracking (GT/ST) phenotype and partial least squares 
differential analysis (PLS-DA) clustered behavioral phenotype. Results: 
Overall microbiome composition was not associated to the GT/ST 
phenotype. However, microbial alpha diversity was significantly decreased in 
female STs. On the other hand, a measure of impulsivity had many 
significant correlations to microbiome in both males and females. Several 
measures of impulsivity were correlated with the genus Barnesiella in 
females. Female STs had notable correlations between microbiome and 
attentional deficient. In both males and females, many measures were 
correlated with bacterial the family Ruminocococcaceae and 
Lachnospiraceae. Conclusions: These data demonstrate correlations 
between several addiction-related behaviors and the microbiome specific to 
sex.   
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4.2  Introduction 
 
Addiction is a complex disorder; many factors modulate addiction severity 
and treatment efficacy. Extensive research has identified socioeconomic 
status (Heilig, Epstein et al. 2016), childhood trauma (Enoch, Hodgkinson et 
al. 2010, Schwandt, Heilig et al. 2017), genetics (Palmer and de Wit 2012), 
sex (Becker and Hu 2008), and psychological comorbidities as factors that 
contribute to addiction risk and severity (Grant, Goldstein et al. 2015). Due to 
the complex etiology of addiction, treatment is a trial and error process, 
frequently requiring a combination of therapies (Heilig, Goldman et al. 2011). 
More research is necessary to investigate how genetic and environmental 
factors contribute to addiction. Additionally, new factors such as the effect of 
diet, microbiome, and social interventions require greater attention. In 
particular, manipulation of the gut microbiome offers an intriguing target for 
new addiction treatments (Temko, Bouhlal et al. 2017).  
 
The gut microbiota consists of a myriad of bacteria, archaea, fungi, and 
viruses colonizing the host gastrointestinal tract and influencing many host 
systems, such as metabolism (Barton, Penney et al. 2017, Ryan, Patterson 
et al. 2017), immune function (Kau, Ahern et al. 2011, Kundu, Blacher et al. 
2017), hypothalamic-pituitary-adrenal axis response, and brain (Collins, 
Kassam et al. 2013, Hsiao, McBride et al. 2013, Mayer, Tillisch et al. 2015, 
Sherwin, Dinan et al. 2017). The gut microbiota is defined as the community 
of microbes residing in the intestines; the microbiome is the genomic DNA 
from all microbes in that community. In the context of affective disorders, 
both animal and human studies have strongly linked the composition of the 
gut microbiota to the behavioral aspects of these disorders (Bercik, Verdu et 
al. 2010, Bravo, Forsythe et al. 2011, Collins, Kassam et al. 2013, Kelly, 
Borre et al. 2016, Zheng, Zeng et al. 2016). Furthermore, microbiota has 
been linked to psychiatric disorders that involve an array of behavioral 
abnormalities, such as autism spectrum disorder (Hsiao, McBride et al. 2013, 
Mayer, Padua et al. 2014, Golubeva, Joyce et al. 2017). Previous research 
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has indicated a link between gut microbiome, addiction, and drugs of abuse 
(Yan, Fouts et al. 2011, Leclercq, Matamoros et al. 2014, Scheperjans, 
Pekkonen et al. 2015, Kiraly, Walker et al. 2016, Ning, Gong et al. 2017, 
Peterson, Jury et al. 2017).  
 
Drugs of abuse activate ‘the reward pathway’, which includes cortical 
innervations in the ventral tegmental area (VTA), striatum, and prefrontal 
cortex (PFC). Behavioral measures that have been developed in rodents to 
explore this pathway, include: locomotor response to novelty (Flagel, Clark et 
al. 2011), measures of impulsivity (Reynolds, Ortengren et al. 2006), 
attention (Gancarz, Robble et al. 2012), and reward-stimulus learning (Flagel 
and Robinson 2017). In the case of reward-stimulus learning, the 
unconditioned stimuli (USs) and the conditioned stimuli (CSs) can activate 
this reward pathway (Schultz, Dayan et al. 1997). Individual differences in 
the activation of this pathway promote differential behavioral responsivity to 
CSs (Flagel, Clark et al. 2011); "sign-tracking" rats (STs) approach CSs 
more than their "goal-tracking" counterparts (GTs)(Flagel, Watson et al. 
2007, Meyer, Lovic et al. 2012). Additionally, STs and GTs are differentially 
sensitive to the motivational properties of several abused drugs (Saunders 
and Robinson 2010, Yager, Pitchers et al. 2015, Yager and Robinson 2015, 
Versaggi, King et al. 2016). Furthermore, STs are more impulsive as 
measured by tests of impulsive action and choice (Tomie, Grimes et al. 
2008, Lovic, Saunders et al. 2011, King, Palmer et al. 2016, Meyer and Tripi 
2018). To conclude, this GT/ST phenotype predicts differences in other 
behavioral measures (Nasser, Chen et al. 2015). Interestingly, sign-tracking 
behavior is more frequent in female than male rats (Pitchers, Flagel et al. 
2015, King, Palmer et al. 2016). Impulsivity has also been associated with 
increases in addiction-related behavior, as well as attention deficit disorder in 
both rodents (Gancarz, San George et al. 2011, King, Palmer et al. 2016) 
and humans (Sanchez-Roige, Fontanillas et al. 2018).   
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The relationship between sex hormones, microbiome and behavior is gaining 
attention (Amato, Leigh et al. 2014, Chaban, Links et al. 2014, Schnorr, 
Candela et al. 2014, Jasarevic, Morrison et al. 2016). During development 
factors like genetics and hormones, contribute to sexual dimorphism and 
associated to sex-differences in microbiome (Jasarevic, Morrison et al. 
2016). Clinical and pre-clinical research has shown differences in microbiota 
composition associated with altered metabolism of essential vitamins and 
nutrients from the diet, with increased metabolic function seen in females 
compared to males (Amato, Leigh et al. 2014, Bolnick, Snowberg et al. 2014, 
Zhernakova, Kurilshikov et al. 2016). Worldwide, illicit drug use is 
significantly lower in females compared to males (World Health Organization 
2012). However, females self-administer drugs more readily than males and 
are more vulnerable to addiction to a variety of licit and illicit drugs (Becker 
and Hu 2008, Yang, Han et al. 2017).  
 
This study, to our knowledge, is the first to investigate sex-specific 
relationships between addiction-related behavioral measures and the 
microbiome in a large dataset. The pre-established GT/ST phenotype was 
characterized for this study, as it predicts differences in other addiction-
related behavioral measures.These results are presented alongside a 
clustered behavioral phenotype constrained by goal/sign-tracker phenotype. 
Differences in behavioral measures and microbiome was characterized for 
each phenotype, within sex.  
 
4.3  Methods 
 
Male and female heterogenous stock (HS) rats were bred at Medical College 
of Wisconsin and then shipped to the University at Buffalo for behavioral 
testing. This National Institutes of Health (NIH)-derived outbred rat colony 
shows broad phenotypic and genotypic variation (Parker, Chen et al. 2014), 
4.3.1 Animals 
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making it an ideal choice for the study of individuals differences. Rats 
(N=202) were housed in pairs in plastic cages (42.5 cm × 22.5 cm × 19.25 
cm); males and females housed in the same room in alternating cages in 
testing order. In the event of odd numbers of rats, rats were housed 
individually. Animals were kept in reversed 12-h light/dark cycle and housed 
in controlled temperature and humidity conditions. Lights were on in the 
colony room from 19:00 pm to 07:00 hours. Behavioral testing occurred 6 
days/week between of 08:30 and 12:30 hours during the dark phase of the 
light cycle. Food (#8604, Harlan Inc., Indianapolis, IN) was available ad 
libitum in the home cage. Animals were treated in compliance with the 
National Institutes of Health Guide for the Care and Use of Laboratory 
Animals and the experiments were conducted in accordance with a protocol 
approved by the Institutional Animal Care and Use Committee (IACUC) at 
the University at Buffalo, The State University of New York.   
 
Behavioral testing was carried out on rats beginning at 63 days of age (see 
Table 1).  All behavioral tests were conducted in the dark phase of the light 
cycle. Epochs for behavioral tests consisted of consecutive 3-minute 
intervals across a test session.  
 
4.3.2.1 Locomotor Response to Novelty (Loco) 
To assess locomotor response to novelty, rats were placed in a 24x45cm 
clean plastic standard laboratory cage. A Hamilton Kinder motor monitor 
frame contained infrared photo detectors which measured locomotor activity 
by beam breaks. Rats were placed into the test cages for one hour. Only the 
first 18 minutes of the 1-hour test session were used for analysis. Each rat 
was tested only once. Measures used for this test included total locomotor 
activity (Loco.Activity), epoch with the greatest activity (Loco.MaxAct), total 
distance travelled (Loco.Distance), epoch with the greatest distance travelled 
(Loco.MaxDist), time in center (Loco.Center), total number of rears 
(Loco.Rear), epoch with the greatest number of rears (Loco.MaxRear). 
4.3.2 Behavioral tests 
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Age Procedure 
 
0-
21 
Rats reared in Medical College of Wisconson 
Rats arrive in Buffalo, NY (21 days old). 
 
 
60 Rats housed until they are young adults (60 days of age)  
63 Locomotor Response to Novelty  
86 Light Reinforcement  
129 Choice Reaction Time Task  
154 Delay Discounting  
171 
Pavlovian Conditioned Approach (1+5 days), then Conditioned Reinforcement 
(1 day) 
 
185 Cocaine Cue Preference   
200 Rats sacrificed; cecal samples collected  
Table 1: Study design flow chart – Age in days (first column), Procedure 
(second column). 
 
4.3.2.2 Light Reinforcement (LR) 
In-house constructed operant chambers were used for testing (see Supp. 
Methods Fig 2). The visual stimulus (VS) reinforcer used in the experiment 
was the onset of the light located in the middle of the back wall of the test 
chamber. Onset of the VS reinforcer produced an illuminance of 68 lx, as 
measured from the center of the test chamber. The VS reinforcer was 
illuminated for 5 s each time it was presented.  Each test chamber was 
housed in a Coleman Cooler (Model # 3000000187), which blocked external 
audiovisual sources of stimulation. The pre-exposure phase consisted of six 
18 min sessions. Light reinforcement testing took place immediately after 
pre-exposure testing with one day off in-between. The light reinforcement 
phase consisted of six 18 min sessions. During light reinforcement testing, 
rats were placed in dark experimental chambers and snout pokes into the 
aperture designated as ‘active’ resulted in 5 s illumination according to a 
variable interval 1-minute (VI1) schedule of reinforcement. Measures from 
light reinforcement testing included total number of light reinforcers 
(LR.Reinforcers), total number of InActive responses during test 
(LR.InActive), total number of Active and InActive responses during test 
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(LR.Total), epoch with greatest total responses (LR.TotMax) and epoch with 
greatest InActive responses (LR.InActMax). 
 
4.3.2.3 Choice Reaction Time Task (RT) 
Locally constructed experimental chambers were used for the choice 
reaction time task. The test panel had two water dispensers located on either 
side of a centrally located snout-poke hole (see Supp. Methods Fig 3). The 
water dispenser and stimulus lights were arranged so that they were level 
with the rat’s eyes when the rat’s snout interrupted an infrared beam in the 
center snout-poke hole. Rats were placed into the test cages for 18 minutes 
for each test session. Rats initiated trials by holding their snout in the center 
snout hole until the left stimulus light was turned on (hold time). Once the 
hold time criterion was reached and the imperative stimulus was presented, 
the rat had 3 seconds to respond by removing its snout and inserting it into 
the left feeder hole (reaction time), or the trial ended and the trial was 
counted as an omission. If the rat made a correct response, the rat received 
a water reinforcer (30 μl) and the trial ended. A false alarm was recorded 
when the rat pulled its snout out of the center hole to respond to the left 
water feeder hole prior to the onset of the imperative stimulus.  Premature 
initiations are defined similar to a false alarm, except that the rat pulls out of 
the center snout poke hole before the imperative stimulus occurs and then 
puts its snout back into the center hole without going to the left water feeder 
hole.  The final 3 test sessions were used for analysis. Measures for this test 
included total number of correct responses (RT.Corr), mean reaction time 
(RT.MeanRT), per opportunity (trial) premature initiations (RT.PerOPInit), per 
opportunity false alarms (RT.POFA), and total omissions (RT.Omissions). 
 
4.3.2.4 Delay Discounting (DD) 
Delay Discounting was measured using a sequential patch depletion 
procedure. This procedure mimics naturally occurring choice problems 
confronting animals while foraging in resource scarce environments (i.e., 
travel delays and patch depletion). Water was restricted and only made 
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available for 20 minutes following testing. Behavior was measured in in-
house constructed operant chambers (see Supp. Methods Fig 2). In the 
laboratory patch depletion procedure rats drink water at both the left and 
center water feeders. Rats receive successively smaller amounts of water 
every 4 s by remaining at the same feeder.  The amount of water is initially 
150 µL and is then decreased by 20% after each delivery from the same 
feeder. The rats can reset the amount of water to the initial maximum of 150 
µL by switching to the alternative water feeder.  However, changing to a new 
patch results in a delay to activation of the new feeder (travel time delay). 
During the delay, water is not available at either feeder. A change in patch is 
indicated by a snout poke into the alternative non-active feeder (patch).  The 
indifference point (IDPt) is defined as the amount of water available at the 
current feeder (or patch) when the rat chose to switch to the new patch. Test 
sessions last for 10 minutes or until the rats consumed a cumulative total 5 
ml of water, which ever occurred first. The area under the curve (AUC) was 
calculated for successive session measures. Behavioral measures from this 
test included indifference point area maximum (DD.IDPMax) and under the 
curve (DD.IDPtAUC), patch change rate area under the curve 
(DD.PCRateAUC), and average reinforcer rate (DD.RFRate). 
 
4.3.2.5 Pavlovian Conditioned Approach (PavCA) and Conditioned 
Reinforcement (CRF) 
To examine individual differences in the propensity to attribute incentive 
salience to reward cues, HS rats were first exposed to a Pavlovian 
conditioning paradigm wherein a cue (lever) is repeatedly paired with 
presentation of a reward (food). Before animals undergo the standard PavCA 
procedure, they receive ~25 banana-flavored food pellets (Envigo, #F0059) 
in their homecages for 2 days. Then they undergo one day of magazine 
training, during which they are placed into Med-associates conditioning 
chambers and food pellets are delivered on a VI 30 s (1-60 s) schedule. For 
the subsequent 5 PavCA conditioning days, rats receive 25 CS-->US 
conditioning trials, presented on a VI 90 s (30-150 s) schedule. During each 
trial, an 8-s presentation of an illuminated lever CS preceded the delivery of 
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a food pellet. On the day following the final session of PavCA, we perform 
conditioned reinforcement (CRF) in which rats can nose poke for 
presentations of the lever CS.  All variables are derived from lever presses 
and magazine entries, including latencies and probability. Measures for 
PavCA included index scores on day 4 and 5 [see (Meyer, Lovic et al. 2012) 
for a description of this index]; briefly, scores range from -1 to 1 with negative 
numbers indicating magazine directed responses (goal-tracking), and 
positive numbers indicating lever-CS directed responses (sign-tracking). 
CRF measures used were total number of lever presses 
(CRF.LeverPresses), total number of active nose-poke port entries 
(CRF.ActivePort) and total number of CS lever presentations 
(CRF.Reinforcers). 
 
4.3.2.6 Cocaine Cue Preference (CCP) 
To examine the individual differences in approach to a cocaine-associate 
cue, HS rats were tested for their response to a cocaine-paired tactile cue 
[see (Meyer, Ma et al. 2012) for details]. Briefly, testing chambers were 
constructed with black acrylic walls (47.5 cm length x 15.5 cm width x 30 cm 
height) with black spray-painted textured floors that were either stainless 
steel rods (“grid”) or perforated steel (“hole”), or half grid and half hole. After 
one day of habituation to the chamber and one "pre-test" day to determine 
grid-hole preferences, rats were given four conditioning trials. Each trial was 
two days, one saline-paired day and one cocaine-paired day. On saline-
paired days, rats were given an injection of saline (i.p.) and placed into a 
chamber with either a uniform grid or hole floor (whichever was their 
preferred floor). On the cocaine-paired day, rats are given an injection of 
cocaine (10 mg/mL; Nat. Inst. Of Drug Abuse, Bethesda, MD) and placed in 
a chamber with the opposite uniform floor (i.e., non-preferred floor). On the 
last "post-test" day, rats were given a saline injection, and presented with 
both cocaine- and saline-paired floors. The time spent on each floor was 
analyzed to determine cocaine cue preference. The primary dependent 
measures are change in time spent on the cocaine-paired floor from pre-test 
to post-test (CCP.PreTest.Time.CS - CCP.PostTest.Time.CS = CCP.dtCS). 
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Secondary measures include cocaine change in locomotor activity on trails 1 
and 4 (CCP.T1.Cocaine.Dist CCP.T4.Cocaine.Dist). 
 
Cecum was collected and snap-frozen on dry ice. Protocols for 16S rRNA 
microbiome sequencing were used as previously described (Peterson, Jury et 
al. 2017). Briefly, cecal contents from frozen cecum (stored at -80ºC) were 
extracted under a sterile hood. The QIAamp DNA Stool Mini Kit (Qiagen, 
Hilden, Germany) was used to extract bacterial DNA from cecal contents using 
the manufacturer’s handbook (Second Edition 2012). Samples were prepared 
for 16S sequencing using the Nextera XT DNA Library Prep Kit (Illumina, San 
Diego, CA, USA), as described in the Illumina 16S library preparation 
workflow. 16S bacterial rRNA gene was amplified using primers targeting the 
V3-V4 hypervariable region (Forward: 
5'TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCW
GCAG; Reverse: 
5'GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTA
TCTAATCC) (Sigma Aldrich Ireland ltd., Wicklow, Ireland). The Illumina V3–
V4 primers were selected for their high coverage (94.5% bacteria) while 
remaining in the amplicon size necessary for sequencing to sequence at 2 × 
250 bp (Klindworth, Pruesse et al. 2013). 16S rRNA amplicons were 
sequenced on the Illumina MiSeq platform, multiplexed on 4 separate runs 
(~50 samples per run) (Teagasc, Moorepark, Ireland). No negative control was 
used in processing of DNA or sequencing.  
 
4.3.3.1 Microbiome Sequence Processing 
All sequences in FASTQ files format were filtered using PRINSEQ. 
Sequences with length less than 150 nucleotides or with low quality at the 3’ 
end were removed. Paired-end reads with a minimum overlap of 20 base-
pairs were joined using FASTQ-join and analyzed with QIIME (Quantitative 
Insights Into Microbial Ecology, v1.9.1). Sequence quality was checked and 
chimeras removed, remaining sequences were clustered into Operational 
4.3.3 Cecal microbiome collection and sequencing 
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Taxonomic Units (OTUs ; 97% identity level) using USEARCH (Version 7.0-
64bit). The average number of high-quality sequences generated per sample 
was 153,561 ± 84,269 SD. Taxonomy was assigned to OTUs using Silva 
version 123. Alpha diversity (Observed, Chao1, Shannon, Simpson) indices 
were calculated with QIIME.  
 
Data was analyzed in R (v3.3.3) and RStudio (v1.0.136). Plots were 
generated in R using ggplot2 package (v2.2.1). All testing was corrected for 
multiple comparisons using the qvalue R package (v2.6.0). For OTU 
correlations to behavior, q-value confidence interval was set to 0.15. For 
within-sex correlations, the q-value of 0.15 was accepted due to the 
exploratory nature of this study. In this dataset, q=0.15 indicates that of the 
30 reported significant correlations within sex, only 4-5 of them may be false 
positives. For all other analyses, q-value was set to 0.05. 
 
4.3.4.1 Behavioral Analysis 
A total of 54 behavioral measures were selected for analysis based on 
relevance to addiction. Behavioral differences were assessed by behavioral 
cluster and goal/sign-tracking phenotype within sex using Kruskal-Wallis and 
Wilcoxon test. Behavioral measures significantly different by group were 
plotted by z-score to visualize trends between grouping phenotypes. Factor 
analysis was performed to test influence of weight and age at time of 
dissection, generation, and goal/sign-tracker phenotype using the ADONIS 
(PERMANOVA) function of the vegan (2.4-3) R package.  
 
4.3.4.2 Sign-tracker/goal-tracker classification 
Rats were classified as sign/goal-trackers based on PavCA Index Score (= 
[PavCA Score (Day 4) +PavCA Score (Day 5)]/2; see Meyer et al. 2012 for 
details (Meyer, Lovic et al. 2012). Subjects were classified as sign-tracker (ST) 
(PavCA Index Score between +0.5 and +1), goal-tracker (GT) (PavCA Index 
4.3.4 Statistical Analysis 
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Score between -0.5 and -1), and  intermediate (IN) (PavCA Index Score 
between -0.49 and 0.49), based on the classification method previously 
described (Meyer, Lovic et al. 2012). 
 
4.3.4.3 Behavioral Cluster Analysis 
All behavioral measures (total=54) were used for cluster analysis using the 
KODAMA package (v1.4). Behavioral data within sex was normalized using 
probabilistic quotient normalization and centered to zero. Data was clustered 
using PLS-DA (partial least squares differential analysis) grouped by 
goal/sign-tracking phenotype and using multiple levels of cross-validation. 
Entropy was tested on point values for each cross-validation level to find 
optimal cluster. For both the female and male behavioral data set, the lowest 
entropy cluster was found with PLS-DA set to parameter (f.par) 100. 
Hierarchical cluster analysis was performed to select optimal number of 
clusters and to assign samples to cluster. Results were then plotted using PCA 
and colored based goal/sign-tracking phenotype.  
 
4.3.4.4 Microbiome analysis  
Microbiome was assessed by behavioral cluster and goal/sign-tracking 
phenotype within sex. Kruskal-Wallis and Wilcoxon test were used to assess 
statistical significance in alpha diversity indices and taxonomic comparisons 
between groups. Beta diversity was calculated using Euclidian distance 
visualized and analyzed using the vegan community ecology package (v2.4-
3). Adonis (PERMANOVA) function from vegan assessed beta diversity 
significance by generation, behavioral phenotype, sign/goal-tracker 
phenotype (GT, ST, IN), age and weight at time of dissection. For Spearman 
correlations and taxonomic comparisons, Phylum, Family, Genus, and OTUs 
(Operational Taxonomic Units) were filtered by median >0.01%. For 
Spearman correlations this filtering resulted in sequences only present in 
>50% of samples and normalized to relative abundance. Correlations were 
performed between OTU-level bacterial abundance and behavioral measures, 
subset by grouping phenotype within sex. For correlation analysis, all 
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behavioral measures were classified into 3 major categories: reward-learning, 
impulsivity, and locomotion (Suppl. Table 1A). For Spearman correlations 
within sex, the qvalue R package (v2.60) was used to select false discovery 
rate. Due to the exploratory nature of this study, the q-value of 0.15 was 
accepted as it allowed reporting of interesting trends while still maintaining a 
low rate of false positives (4-5 total). 
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Figure 1 – Flow Diagram of how behavioral measures are used to create 
goal/sign-tracking phenotype and behavioral cluster phenotype. 
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4.4  Results 
 
Preliminary analysis showed that all non-PavCA behavioral measures clustered by 
the goal/sign-tracking phenotype (GT/ST)(Fig. S1). Thus, we sought to evaluate 
the goal/sign-tracking phenotype, within sex, alongside a novel group cluster 
constrained by this pre-established grouping. Partial least squared 
differential analysis (PLS-DA) of all 54 behavioral measures (Fig. 1) within 
sex show a separation along the x-axis (Fig. 2A & 3A). In both males and 
females, the sign-tracking phenotype clusters in the negative (left) side of the 
x-axis (Fig. 2A & 3A). Behavioral clusters that contained the sign-tracking 
phenotype were labeled F.Behav.Clust.1 for female sup-population and 
M.Behav.Clust.1 for males. Samples clustering to the right of the x-intercept 
were labeled F.Behav.Clust.2 and M.Behav.Clust.2, for females and males, 
respectively. 
 
Factor analysis of 54 behavioral measures revealed that weight at the end of 
the experiment was the only significant contributing factor in both females 
(R2=0.036, p=0.028) and males (R2=0.037, p=0.018). Goal/sign-tracker 
phenotype, generation, and age at time of dissection were not significant 
factors (p>0.05) contributing to variations in all behavioral measures.  
 
All 54 behavior measures were tested within sex by goal/sign-tracker 
phenotype (GT, IN, ST) and behavioral cluster (Behav.Clust.1, 
Behav.Clust.2). Females tested by goal/sign-tracking phenotype, 15 
behavioral measures were significantly different (Kruskal-Wallis, p<0.05), 
with 13 of these measures due to differences in GTs compared to STs 
(Wilcoxon, p<0.01). In males tested by goal/sign-tracking phenotype, 11 
behavioral measures were significantly different (Kruskal-Wallis, p<0.001), 
with 8 of these measures due to differences in GTs compared to STs 
4.4.1 Behavioral cluster analysis 
4.4.2 Behavioral differences by behavioral cluster within sex 
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(Wilcoxon, p<0.001). Behavioral measure comparisons by behavioral cluster 
revealed 18 significant measures in females and 28 significant measures in 
males (Wilcoxon, p<0.05). Z-score was used to visualize behavioral 
comparisons by groups, behavioral cluster and GT/ST phenotype, within sex 
(Fig. 2B & 3B). See supplementary material for behavioral comparisons 
between sex (Supp. Section 1.2 and Fig. 1B). 
 
Within both sexes and grouping phenotypes, significant differences were 
seen in measure for nose pokes in reinforcing port (CRF.Active.Port) and 
number of lever presses (CRF.Lever.Presses).  In both male and female, 
significant differences in CRF.Active.Port were seen in goal-tracking (GT) 
phenotype compared to sign-tracking (ST) (Wilcoxon, p<0.001) and 
behavioral cluster grouping (Behav.Clust.1 vs. Behav.Clust.2) (Wilcoxon, 
p<0.001). Differences in CRF.Lever.Presses were explained by GT 
compared to ST group (Wilcoxon, p<0.001) and behavior cluster (Wilcoxon, 
p<0.001), in both sexes. Additionally, number of nose pokes into active port 
for presentation of lever reinforcer (CRF.Number.Reinforcers) was 
significantly different in both male and female by GT compared to ST 
phenotype (Wilcoxon, p<0.001).  
 
Only the male behavioral cluster showed significant differences in cocaine-
induced locomotor activity in Trial 1 measured by distance travelled 
(CCP.T1.Cocaine.Dist) (Wilcoxon, p<0.001). This difference was explained by 
the increases in M.Behav.Clust.1 compared to M.Behav.Clust.2 (Fig. 2B). 
 
4.4.3 Group differences in Pavlovian Conditioned 
Reinforcement (CRF)  
4.4.4 Group differences in Cocaine Cue Preference (CCP)  
4.4.5 Group differences in Choice Reaction Time Task (RT) 
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Reaction time (RT) measures of standard deviation of reaction time per epoch 
(RT.SDRT) and number of failed responses defined as omissions 
(RT.Omissions) were significantly different by female goal/sign-tracking 
phenotype. For both measures, this result was explained by increases in IN 
group compared to GT (Wilcoxon, p<0.01) (Fig. 3B). 
 
Similar to measures from CCP, M.Behav.Clust.1 had significant increases in 
distance travelled (Loco.Distance) compared to M.Behav.Clust.2 (Wilcoxon, 
p<0.01).  This was also seen in comparisons between male behavioral clusters 
in measures of exploratory rearing and maximum rears (Loco.Rear and 
Loco.MaxRear) (Wilcoxon, p<0.05), locomotor activity and maximum activity 
(Loco.Activity and Loco.MaxAct, p<0.05). 
Measures from the LR task were significantly different by behavioral cluster 
in both males and females. Total number of light onset reinforcers 
(LR.Reinforcers), total active and inactive responses (LR.Total), total active 
responses (LR.Active), and maximum active responses in an epoch (LR.Act_ 
Max) were significantly different (Wilcoxon, p<0.01). These measures were 
decreased in F.Behav.Clust.1 compared to F.Behav.Clust.2, while they were 
increased in M.Behav.Clust.1 compared to M.Behav.Clust.2 (Fig. 2B & 3B). 
 
In female behavioral cluster, F.Behav.Clust.1 had significant increases in 
changes time in patch with experimenter imposed delay across epochs 
(DD.TIPAUC) compared to F.Behav.Clust.2 (Wilcoxon, p<0.05) (Fig. 3B). In 
the male behavioral cluster, M.Behav.Clust.1 was significantly increased in 
measures of patch change rate area under the curve (DD.PCRateAUC) and 
indifference point area under the curve (DD.IDPtAUC) compared to 
M.Behav.Clust.2 (Wilcoxon, p<0.01) (Fig. 2B). 
4.4.6 Group differences in Locomotor Response to Novelty 
(Loco) 
4.4.7 Group differences in Light Reinforcement (LR) 
4.4.8 Group differences in Delay Discounting (DD) 
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Figure 2 – Male Behavioral Phenotypes and Behavioral Comparisons – 
A) Behavioral Phenotype Cluster visualized in principal coordinate analysis 
(PCA) of PLS-DA clustered behavioral measures. Each dot represents an 
individual rat, distance from one dot to another represents overall differences 
in behavioral measures.Goal-trackers (GT) colored green, intermediate (IN) 
blue, sign-trackers (ST) red. B) Z score indicate increases (red) or decreases 
(blue) in behavioral measures by behavioral cluster group and goal/sign-
tracker phenotype group compared to entire male population.   
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Figure 3 – Female Behavioral Phenotypes and Behavioral Comparisons 
– A) Behavioral Phenotype Cluster visualized in principal coordinate analysis 
(PCA) of PLS-DA clustered behavioral measures. Each dot represents an 
individual rat, distance from one dot to another represents overall differences 
in behavioral measures.Goal-trackers (GT) colored green, intermediate (IN) 
blue, sign-trackers (ST) red. B) Z score indicate increases (red) or decreases 
(blue) in behavioral measures by behavioral cluster group and goal/sign-
tracker phenotype group compared to entire female population.   
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In males, microbiome beta diversity was significant by generation (R2=0.039, 
p<0.001) and age at end of experiment (R2=0.021, p<0.001). Females were 
only significant by generation (R2=0.019, p<0.001). No significant differences 
were seen for weight, sign/goal-tracker phenotype, or behavioral cluster in 
either males or females.   
Alpha diversity analysis by female behavioral cluster revealed significant 
decreases in Shannon (Wilcoxson, p<0.001) and Simpson (Wilcoxson, 
p<0.001) index measures in F.Behav.Clust.1 compared to F.Behav.Clust.2 
(Fig. 5A & 5C). Females ST group also had significant reductions in Shannon 
measure of alpha diversity compared to GT (Fig. 5B) There were no 
significant differences in alpha diversity measures in males (Fig. 4). 
  
  
4.4.9 Microbiome diversity 
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Figure 4 – Male Alpha Diversity by Phenotype Group – A) Shannon index 
measure of alpha diversity by behavioral cluster (M.Behav.Clust 1 = orange, 
M.Behav.Clust.2 = purple). B) Shannon index by goal/sign-tracking 
phenotype: goal-tracker (M.GT = green), intermediate (M.IN = blue), and 
sign-tracker (M.ST = red). C) Simpson index measures of male alpha 
diversity by behavioral cluster. D) Simpson index of male goal/sign-tracker 
phenotype.  
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Figure 5 – Female Alpha Diversity by Phenotype Group – A) Shannon 
index measure of alpha diversity by behavioral cluster (F.Behav.Clust 1 = 
orange, F.Behav.Clust.2 = purple). B) Shannon index by goal/sign-tracking 
phenotype: goal-tracker (F.GT = green), intermediate (F.IN = blue), and sign-
tracker (F.ST = red). C) Simpson index measures of female alpha diversity 
by behavioral cluster. D) Simpson index of female goal/sign-tracker 
phenotype. Asterisks indicate significance: ‘***’ p<0.001, ‘**’ p<0.01  
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No significant differences were seen in either phenotype group by sex at the 
Phylum, Family, Genus, or OTU level after FDR correction. In the female 
behavioral cluster, genus-level Blautia (Wilcoxson, q=0.062) and OTU-level 
Papillibacter OTU_128 and Blautia OTU_160 approached significance 
(Wilcoxson, q=0.055). All other results had an FDR q-value greater than 
0.15.  
 
 
4.4.11.1 Correlations by Male and Female Goal/Sign-Tracker 
Phenotype 
In males, behaviors correlated to refined OTUs by GT/ST phenotype. The 
strongest correlation was between cocaine induced locomotor activity during 
trial 4 and Tanneralla OTU_157 (Spearman, rho=-0.976, p<0.001). Further 
correlations were seen in OTU-level bacteria belonging to family 
Lachnispiroceae and Ruminococcaceae in measures of reward learning (LR, 
PavCA, RT), in reaction time and light reinforcement measures, locomotion 
and impulsivity measures from delay discounting (Spearman, |rho|>0.722, 
p<0.001). An OTU-level bacteria from genus Thermofilum significantly 
correlated to impulsivity measures only in the male intermediate (IN) 
phenotype (Spearman, |rho|>0.709, p<0.001). Overall, the strongest 
correlations were seen in the male STs (Spearman, |rho|>0.939, p<0.001) 
(Fig. 6A). 
In females, less significant correlations between microbiome and behavior by 
GT/ST phenotype were seen. A total of 9 significant correlations were 
observed, of these 6 were significant correlations within ST phenotype. A 
strong trend was seen in ST females with correlations between reaction time 
omissions and specific OTUs assigned to genera Vampirovibrio, 
Coprococcus, and Flavinofractor (Spearman, rho>0.729, p<0.001). 
Significant correlations were also found between impulsivity measures and 
4.4.10 Bacterial differences by groups within sex 
4.4.11 OTU level bacterial correlations to behavior 
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OTU bacteria assigned to genera Clostridium XIVa and Barnesiella 
(Spearman, rho>0.682, p<0.001) (Fig. 6B). 
 
4.4.11.2 Correlations by Male and Female Behavioral Cluster 
No significant correlations were seen between microbiome and behavior 
when analyzed by male behavioral cluster (Fig. 7A). In females, impulsivity 
measures and attention measures were significantly correlated with OTUs 
assigned to genus Barnesiella (Spearman, |rho|>0.620, p<0.001) (Fig. 7B). 
 
4.4.11.3 Correlations by Male and Female  
Spearman correlations were performed within the entire male and female 
sub-populations between behaviors and OTU-level bacteria (N=101, Males 
and Females) (Fig. 8). Impulsivity measures of indifference point area under 
the curve and patch change rate area under the curve was significantly 
correlated with Lachnospiracaea_incertae_sedis OTU_3469 
(Impulsivity.DD.IDPtAUC and Impulsivity.DD.PCRateAUC, rho<-0.393, 
p<0.001) in males. In females, indifference point area under the curve and 
locomotor activity were negatively correlated to Barnesiella OTU_114 
(Impulsivity.DD.IDPtAUC and Loco.Activity, rho<-0.407, p<0.001). In males, 
exploratory rearing was positively correlated to Clostridium XlVa OTU_3855; 
additionally, males had many OTU correlations to sensory preference for 
CPP floor before testing (see Supp. Materials). A positive correlation 
between reward learning and Lachnospiracea incertae sedis OTU_152 was 
observed in females (Reward.Learning.LR.Active, rho=0.407, p<0.001) (Fig. 
8). 
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Figure 6 – Correlation Analysis in Male and Female Goal/Sign-Tracking 
Phenotype. A) Correlations between OTU-level bacteria and behavior in 
male goal/sign-tracking phenotype. B) Correlations between OTU-level 
bacteria and behavior in female goal/sign-tracking phenotype. Positive 
correlations indicated in red, negative correlations indicated in blue. 
Significance that passes FDR indicated by asterisk: ‘***’ q<0.05, ‘**’ q<0.10, 
‘*’ q<0.15 
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Figure 7 – Correlation Analysis in Male and Female Behavioral Clusters. 
A) Correlation between OTU-level bacteria and behavior in male behavioral 
cluster phenotype. B) Correlation between OTU-level bacteria and behavior 
in female behavioral cluster phenotype. Positive correlations indicated in red, 
negative correlations indicated in blue. Significance that passes FDR 
indicated by asterisk: ‘***’ q<0.05, ‘**’ q<0.10, ‘*’ q<0.15  
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Figure 8 – Correlation Analysis by sex. Correlations between OTU-level 
bacteria and behavior in entire female and male populations. Positive 
correlations indicated in red, negative correlations indicated in blue. 
Significance that passes FDR indicated by asterisk: ‘***’ q<0.05, ‘**’ q<0.10, 
‘*’ q<0.15 
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4.5  Discussion 
 
Growing evidence suggests that understanding the complex relationship 
between addiction-related behaviors and microbiome is important in 
illuminating factors associated with addiction vulnerability. Overall 
microbiome composition, as measured by beta-diversity, was not associated 
to the goal/sign-tracking (GT/ST) phenotype. However, correlations revealed 
novel sex-dependent links between addiction-associated behavior and 
microbiome. In females, operational taxonomic units (OTUs) from bacteria 
Barnesiella repeatedly correlated with behavioral measures of impulsivity, 
measured by indifference point area under the curve in delay discounting 
task (DD.IDPtAUC) (Fig. 7-8). Moreover, alpha diversity was reduced in 
female behavioral phenotypes associated to increased addiction vulnerability 
(Fig. 5). Female PLS-DA cluster phenotype (F.Behav.Clust.1 and 
F.Behav.Clust.2, Fig. 3A) revealed that behavioral differences followed 
trends similar to the GT/STphenotype. Most behavioral measures in 
F.Behav.Clust.1 aligned with sign-trackers (STs) and F.Behav.Clust 2 similar 
to goal-tracking (GTs) phenotype (Fig. 3B). In males, fewer trends were seen 
in both microbiome and behavior. All groups had significant correlations 
between OTU-level bacteria, predominantly belonging to families 
Ruminococcaceae and Lachnospiraceae, and behavioral measures of 
impulsivity, attention, reward-learning, and locomotor response to novelty.   
 
Sign-tracking (ST) is defined as the propensity to imbue a conditioned 
stimulus with incentive salience (Flagel, Watson et al. 2008, Meyer, Lovic et 
al. 2012). STs are more responsive to both food and drug CSs than GTs and 
tend to engage in addiction-related behaviors. Increased ST behavior is 
positively correlated to increased dopamine levels in the nucleus accumbens 
during amphetamine self-administration (Tomie, Grimes et al. 2008). 
Additionally, in selectively bred high/low response (HR/LR) rats, both male 
and females HR rats sign-track while LR counterparts goal-track. HR females 
have a greater propensity to self-administer cocaine than LR females and 
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HR & LR male rats (Davis, Clinton et al. 2008).  In line with previous work 
(Pitchers, Flagel et al. 2015, King, Palmer et al. 2016), this study had more 
females assigned to the addictive-associated ST phenotype, compared to 
males.  
 
There is contradictory data in humans with regard to gender differences in 
the incidence of addiction. However, research of both humans and other 
animal species indicates that females may, in some cases, display a greater 
propensity for addiction. A human genome-wide-association study (GWAS) 
showed females having greater impulsive behavior, as measured by delay 
discounting (Sanchez-Roige, Fontanillas et al. 2018). Furthermore, GWAS 
studies suggest that opioid dependence is linked to sex specific single 
nucleotide polymorphisms (Yang, Han et al. 2017). In Cloninger’s typology, 
Type II alcoholism has an early onset, a genetic propensity, and more 
common in males, while Type I has a late onset and is seen in both females 
and males (Cloninger, Sigvardsson et al. 1996). Differences in hormones 
underlie some sex differences in addiction-related behavior. Furthermore, 
intensity of drug usage and drug withdrawal vary depending on menstrual 
cycle. In the striatum, dopamine levels are higher during estrus in rats, when 
estradiol is elevated. Estradiol is known to increase positive affect, locomotor 
sensitization, and acquisition of self-administration to psychomotor stimulants 
in female rats (Becker, Lopez et al. 2011).  
 
Measures of impulsivity, attention, reward-learning, and locomotor response 
to novelty were significantly different by behavioral phenotypes and 
correlated to microbiome. In delay discounting, the indifference point/area 
under the curve measure (DD.IDPtAUC) has previously been linked to 
addiction in humans (Reynolds, Richards et al. 2004). This impulsivity 
measure correlated to OTUs assigned to family Lachnospiraceae in males 
and OTUs assigned to genus Barnesiella in females. The divergence in gut 
bacteria correlated to impulsivity indicates that sex-specific commensal 
bacteria may have similar effects on behavior. In males and females, 
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measures of Pavlovian Conditioned Approach (PavCA) were significantly 
correlated with bacterial OTUs in family Ruminococcaceae. In males, 
reaction time (RT) measures correlated to bacterial OTUs in family 
Ruminococcaceae. Intriguingly, female STs revealed strong correlations 
between reaction time attention measure (RT.Omissions) and OTUs in family 
Ruminococcaceae, including genus Flavonifrator, and family 
Lachnospiraceae, as well as two OTUs in genus Vampirovibrio. 
Vampirovibrio, which preys on algae, and is capable of replacing taxa in the 
microbiome via competition (Baer and Williams 2015, Soo, Woodcroft et al. 
2015). Significant correlations were seen in light reinforcement (LR) and 
locomotor response (Loco) measures and bacterial OTUs in family 
Ruminococcaceae, including genus Flavonifrator,  and Lachnospiraceae in 
the male GT/ST phenotype. In the present study, taxonomic differences 
between bacterial composition in GT/IN/ST phenotypes did not reach 
significance. However, the observed correlations repeatedly associated to 
Ruminococcaceae align with previous addiction research showing reductions 
in Ruminococcaceae in opioid users (Acharya, Betrapally et al. 2017), 
alcohol consumption (Bull-Otterson, Feng et al. 2013, Llopis, Cassard et al. 
2016), and alcohol addiction severity (Leclercq, Matamoros et al. 2014). 
Research investigating alcohol consumption and microbiome has also 
previously reported changes in Lachnospiraceae in mice receiving oral and 
vapor alcohol (Bull-Otterson, Feng et al. 2013, Peterson, Jury et al. 2017) 
and alcohol addiction severity in humans (Leclercq, Matamoros et al. 2014). 
Our recent work on microbiome and addiction phenotype has illuminated 
intriguing trends in bacteria from families Ruminococcaceae and 
Lachnospiraceae correlating to dopamine receptor expression in the striatum 
and measures of anxiety, novelty induced locomotor activity, impulsivity, and 
compulsive alcohol seeking in male rats (Jadhav, Peterson et al. 2018). 
Sex and/or gender are significant factors to consider when investigating the 
microbiome-gut-brain axis (Jasarevic, Morrison et al. 2016). Previous 
research reveals sex-associated microbiota differences are strongly linked to 
metabolic processes (Davey, O'Mahony et al. 2012, Markle, Frank et al. 
2013, Amato, Leigh et al. 2014, Zhernakova, Kurilshikov et al. 2016) and to 
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influences on brain and behavior (Clarke, Grenham et al. 2013, Hoban, 
Stilling et al. 2016). Segregation of male and female rats by same sex co-
housing may confound and/or inflate sex differences observed, especially in 
light of coprophagic behavior in rats - an environmental factor that may 
influence microbiota more than host genetics (Rothschild, Weissbrod et al. 
2018). Although, in a study of howler monkeys microbiome continued to be 
distinct between sex despite shared environment and parent (Amato, Leigh 
et al. 2014). Clearly, further investigation is necessary to elucidate the 
connections between sex and microbiome composition as well as factors 
such as genotype (Palmer and de Wit 2012) and cagemates (Baud, Mulligan 
et al. 2017). 
 
Females associated to a ST phenotype had decreased alpha diversity 
compared to GTs (Fig. 5). No difference was seen in alpha diversity between 
GT/IN/ST phenotypes in males (Fig. 4). Reduced alpha diversity is 
commonly associated to poor health, often the result of common factors, with 
reductions reported in mental health conditions including stress and 
depression (Bailey, Dowd et al. 2011, Kelly, Borre et al. 2016). Reduced 
alpha diversity has also been shown in chronic-intermittent vapor ethanol 
exposure (Peterson, Jury et al. 2017) and antibiotic depletion is linked to 
increased locomotor response to cocaine (Kiraly, Walker et al. 2016). 
Alterations in Ruminococcaceae and Lachnospiraceae have been 
characterized in many health conditions. Importantly, reduced intestinal 
permeability, liver damage, and inflammation (Bailey, Dowd et al. 2011, 
Bajaj, Hylemon et al. 2012, Bull-Otterson, Feng et al. 2013, Leclercq, De 
Saeger et al. 2014, Llopis, Cassard et al. 2016, Acharya, Betrapally et al. 
2017, Leclercq, de Timary et al. 2017, Petrov, Saltykova et al. 2017) have 
been implicated to alterations in these two family-level bacteria in conditions 
of psychological stress (Bangsgaard Bendtsen, Krych et al. 2012, Dunphy-
Doherty, O'Mahony et al. 2018), depression (Naseribafrouei, Hestad et al. 
2014, Jiang, Ling et al. 2015, Chen, Zheng et al. 2018), autism (Hsiao, 
McBride et al. 2013, Golubeva, Joyce et al. 2017), and dopaminergic-
mediated disorders (Leclercq, Matamoros et al. 2014, Petrov, Saltykova et 
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al. 2017).   Many novel bacteria were identified in this study in relation to 
addictive phenotype and microbiome. OTUs associated to genus 
Flavonifractor were correlated to locomotor activity in males and RT 
omissions in females. Increased abundance of Flavonifractor is linked to 
major depressive disorder (Jiang, Ling et al. 2015) and bipolar disease 
(Coello, Hansen et al. 2018); the mechanism of how Flavonifractor effects 
brain is not well known, though it is believed to cause oxidative stress and 
inflammation. Furthermore, OTUs associated to Barnesiella were repeatedly 
correlated to behaviors in females, particularly impulsivity measures. In a 
human study comparing microbiota composition of alcohol drinkers and non-
drinkers, a top differentiated OTU increased with alcohol consumption 
belonged to an uncharacterized Barnesiella (Kosnicki, Penprase et al. 2018).  
Genus Barnesiella has also previously been characterized as preventing 
colonization of infection bacteria (Ubeda, Bucci et al. 2013, Steinway, Biggs 
et al. 2015), thus reducing inflammatory profile in the gastrointestinal tract. In 
this study, we see two novel taxa which have been characterized as 
replacing taxa in the microbiome, Barnesiella and Vampirovibrio. These 
novel taxa were also related to measures of attention and impulsivity. 
Previous research in humans reported a negative relationship between 
Clostridium XIVa and depression in females (Chen, Zheng et al. 2018). 
Further investigation is necessary to determine if these identified bacteria 
preferentially colonize certain sexes, the mechanism for the preference, in 
addition to how these certain bacteria are influencing brain and behavior. 
Furthermore, the impact of immune function must be investigated in these 
behavioral phenotypes associated with specific bacteria (Rea, Dinan et al. 
2016). Research has shown that gut bacteria impact neuroimmunology 
(Braniste, Al-Asmakh et al. 2014, Scott, Ida et al. 2017), and 
neuroimmunology has been linked to addiction (Hofford, Russo et al. 2018). 
Future studies should also examine how the neurobiological substrates of 
the behavioral changes observed are regulated by the microbiome. Indeed, 
the gut microbiome has been shown to regulate cortical morphology and 
neurotransmitter expression, notably in the prefrontal cortex which is 
involved in impulsivity behaviors (Hoban, Stilling et al. 2016, Luczynski, 
Whelan et al. 2016, Hoban, Stilling et al. 2017). Moreover, investigations into 
4-146 
 
the role of the vagus nerve as a conduit of signals from the gut to the brain is 
also warranted (Bravo et al., 2011).  
 
4.6 Conclusion 
 
This is the first time, to our knowledge, that extensive characterization of 
within sex addiction-phenotype and behavioral measures have been 
associated to microbiome. Overall microbiome composition was not capable 
of predicting addiction phenotype. The most robust findings in this study 
indicate that microbiome is associated to locomotor response, reward-
stimulus learning, impulsivity and attention. Notably, impulsivity measures 
were repeatedly correlated to certain bacteria in males and females. This 
novel work impresses facts that sex as a factor must be considered in both 
behavior and microbiome research.  Further investigation is necessary to 
elucidate factors that contribute to sex differences in microbiome, and how 
these differences influence other addiction-related measures like drug-self 
administration and relapse. 
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4.7  Supplementary documentation 
 
 
4.7.1.1 Behavioral cluster analysis 
To assess the ability for the goal/sign-traking phenotype to predict 
differences in other behavioural measures associated to addiction, an 
unsupervised ordination plot was generated. A bray-curtis dissimilarity matrix 
was created from a total of 48 behavioral measures, with the 6 behavioral 
measures related to PavCA removed. Points were colored and shaped by 
Behav.Cluster and Tracker group by sex, respectively. Results indicated that 
differences in non-PavCA behavioural measures separated by this grouping 
designation on the x-axis (Fig. S1), while females and males separated on 
the y-axis (Fig. S1A). 
Partial least squares differential analysis (PLS-DA) of all 54 behavioral 
measures constrained by sex and goal/sign tracking (GT/ST) phenotype 
resulted in a separation between males and females (Fig. S2A). 81% of 
males are present in the left cluster (L.Behav.Clust = Behav.Clust.1), while 
only 26% of females are present in the L.Behav.Clust. In the right behavioral 
phenotype cluster (R.Behav.Clust = Behav.Clust.2), 74% of females are 
present while only 19% of males are present. Interestingly, the majority of 
female and male sign-trackers (ST) congregated in the lower right quadrant 
of this cluster.  
 
4.7.1.2 Behavioral differences between sex and behavioral cluster 
Factor analysis (PERMANOVA) of 54 behavioral measures revealed that sex 
was the only significant contributing factor (R2=0.301, p=0.0002). To ensure 
this observation was not due to sex differences in weight, factor analysis was 
also performed for animal weights at experiment endpoint. Weight was not a 
significant factor contributing to behavior (R2=0.006, p=0.173). Additionally, 
4.7.1 4.7.1 Preliminary results of Sex Differences (Male vs 
Female) 
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sign/goal tracker phenotype was not a significant factor for all behavioral 
measures (R2=0.007, p=0.371). Of 54 behaviors tested, 32 were significantly 
different when compared by sex, 34 between left and right behavioral cluster, 
17 when females only where compared by behavioral cluster, and 20 when 
males only were compared by behavioral cluster. Z-score was used to 
represent behavioral differences by sex, behavioral cluster (R.Behav.Clust 
and L.Behav.Clust), and behavioral cluster by sex (Fig S2B).  
 
4.7.1.3 Sex differences in Pavlovian Conditioned Approach (PavCA) 
Females had significantly increased sign-tracking behavior compared to 
males (Fig. S2A-B). This was evident by significant increases in Pavlovian 
Index score on day 4 (PavCA.D4.Index, p<0.0001) and day 5 
(PavCA.D5.Index, p<0.01) in females compared to males. Pavlovian Index 
score was also significant between behavior cluster (PavCA.D4.Index and 
PavCA.D5.Index, p<0.001) and when males and females were compared 
individually by behavioral cluster (PavCA.D4.Index and PavCA.D5.Index, 
p<0.001). Sign-tracking behavior, as measured by lever-cue associations, 
was significantly increased in females, R.Behav.Clust,  and R.Behav,Clust.F  
on day 1, 4, and 5 (PavCA.D1.Lever_CS, p<0.001; PavCA.D4.Lever_CS, 
p<0.001; PavCA.D5.Lever_CS, p<0.001). Male right behavioral cluster 
(R.Behav.Clust) was also significantly increased on day 4 and 5 
(PavCA.D4.Lever_CS, p<0.001; PavCA.D5.Lever_CS, p<0.001) compared 
to left behavioral male cluster (L.Behav.Clust). These finding show that sign-
tracking behavior is increased in all females compared to males, as well as 
right and left behavioral cluster, either compared with all samples or within 
sex.  
 
4.7.1.4 Sex differences in Pavlovian Conditioned Reinforcement (CRF)  
Females had significant increases in reinforcement behavior compared to 
males (Fig. S2B). Number of CS lever presentations was significantly 
different between sex, behavioral cluster, and behavioral cluster by sex 
(CRF.Number.Reinforcers, p<0.001), and total number of lever presses 
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(CRF.LeverPresses, p<0.001). These measures were significantly increased 
in females vs. males. L.Behav.Clust vs. R.Behav.Clust, and left behavioral 
clusters within both sexes (Fig. S2B).  
 
4.7.1.5 Sex differences in Cocaine Cue Preference (CCP)  
Females had an overall significant increase in locomotor distance travelled 
compared to males following cocaine administration at both trial 1 and 4 
(CCP.T1.Cocaine.Dist and CCP.T4.Cocaine.Dist, p< 0.001) (Fig. S2B). 
Significant differences in cocaine-induces locomotor travel was also 
observed between behavioral clusters, however when behavioral clusters 
were compared within sex, only significant differences were seen within 
females at trial 1 (CCP.T1.Cocaine.Dist, p< 0.01). Behavioral cluster 
comparisons in all samples (L.Behav.Clust vs. R.Behav.Clust) showed 
significant differences in locomotor behavior between cocaine administration 
and saline (CCP.dtLoco, p<0.01). 
There were no significant sex differences in the primary measures of change 
in time (s) in cocaine-paired (CS+) floor between the post-test and pre-test 
(CCP.dtCS, p>0.05).  
 
4.7.1.6 Sex differences in Choice Reaction Time Task (RT) 
Reaction time (RT) measures of impulsivity total number of per opportunity 
false alarms was not significant (RT.POFA, p>0.05). A significant increase in 
total number of per opportunity premature initiations (RT.PerOPInit, p<0.001) 
was observed in females compared to males and left behavioral cluster 
compared to right (Fig. S2B). 
 
4.7.1.7 Sex differences in Locomotor Response to Novelty (Loco) 
Similar to measures from CCP, females had significant increases in distance 
travelled (Loco.Distance, p<0.001).  This was also seen in comparisons 
between behavioral cluster and within the male behavioral cluster 
(Loco.Distance, p<0.05). Additionally, there was significant increases in 
4-150 
 
maximum exploratory rearing measures in females, R.Behav.Clust, 
R.Behav.Clust.F and R.Behav.Clust.M (Loco.MaxRear, p<0.01). Significant 
decreases in total locomotor activity (Loco.Activity, p<0.001) in females 
compared to males.  
 
4.7.1.8 Sex differences in Light Reinforcement (LR) 
Total Light Reinforcement LR.Reinforcers, p<0.01) and total inactive 
responses (LR.InActive,p<0.05) were significantly different by sex, behavioral 
cluster, and within the male behavioral cluster. Significant increases in 
measures total active and inactive responses in females, R.Behav.Clust, 
R.Behav.Clust.F and R.Behav.Clust.M (LR.Total , p<0.01) were observed 
(Fig. S2B). 
 
4.7.1.9 Sex differences in Delay Discounting (DD) 
Females had significant increases in impulsivity measure of patch change 
rate area under the curve (DD.PCRateAUC, p<0.01). This was also seen in 
comparisons between behavioral cluster (p<0.05). Primary measures of 
indifference point area under the curve was not significantly (DD.IDPtAUC, 
p>0.05). 
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Supplementary Figure 1 – Behavioral dissimilarity in Non-PavCA 
Measures - A) in all samples, B) in male subjects, C) in female subject. 
Shapes on plot indicate tracker and sex designation, red color indicated 
Behav.Clust.1 (L.Behav.Clust) and blue color Behav.Clust.1 (R.Behav.Clust). 
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Supplementary Figure 2– Behavioral differences – A) Behavioral 
Phenotype Cluster visualized in principal coordinate analysis (PCA) of PLS-
DA clustered behavioral measures. Goal-trackers (GT) colored green, 
intermediate (IN) blue, sign-trackers (ST) red; females in dark colors, and 
males light colors. B) Z score indicate increases (red) or decreases (blue) in 
behavioral measures compared to population.   
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4.7.1.10 Microbiome diversity 
Microbiome beta diversity was significantly different by sex (R2=0.016, 
p=0.002) and generation (R2=0.032, p=0.0002) (Fig. S3A). Age was also a 
significant factor contributing to microbiome variance (R2=0.017, p=0.001). 
No significant differences were found for weight (R2=0.005, p=0.312) or 
sign/goal-tracker phenotype (R2=0.011, p=0.285).  OTU assignments of 
sign/goal-tracker phenotype only clustered by sex in PLS-DA (Fig 3A). Alpha 
diversity analysis by sex revealed significant differences in Shannon 
(p=0.0001) and Simpson (p=0.001) index measures (Fig. S3B). There were 
no significant differences in alpha diversity measures between behavioral 
cluster within sex (p>0.05). 
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Supplementary Figure 3 – Genus Differences in Microbiome by Sex and 
Behavioral Phenotype – A) PCA beta diversity plot of PLS-DA clustered 
microbiome by sign/goal-tracker phenotype and sex (blue circle = female 
goal-tracker (F_GT), orange triangle = female intermediate (F_IN), grey plus 
= female sign-tracker (F_ST), green x = male goal-tracker (M_GT),purple 
diamond = male intermediate (M_IN), yellow triangle = male sign-tracker 
(M_ST).   B) Log-fold change differences at genus level between females vs 
males and behavioral phenotype clusters (R.Behav.Clust vs. L.Behav.Clust); 
asterisks indicates significance after FDR corrections (p>0.05) 
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Supplementary Figure 4 – Microbiome Diversity – A) NMDS plot of beta 
diversity by sex (Female = yellow, Male = blue) and by generation (circles = 
Batch02, and triangles = Batch03); stress value in lower left corner indicates 
how well the data is representation in reduced the dimensions. B & C) Alpha 
diversity of B) Shannon and C) Simpson index measures between males 
(blue) and females (yellow); asterisks indicate significance p>0.001.  
 
4.7.1.11 Taxonomic differences between sex 
At the phylum level, Tenericutes was significantly greater in females 
compared to males and (p<0.001) (Fig. S3B). Among females and 
R.Behav.Clust, significantly greater proportions of Peptococcaceae 
(p<0.001) and the corresponding genus Peptococcus (p<0.001), 
Rikenellaceae (p<0.001) and the genera Alistipes (p=0.01) and Rikenella 
(p<0.001), Desulfovibrionaceae (p<0.01) and the genus Desulfovibrio 
(p<0.01), and in family Erysipelotrichaceae (p>0.05) genus Allobaculum 
(p<0.01). In females compared to males, greater abundance of 
Gracilibacteraceae (p=1.24e-4) and the genus Gracilibacter (p=1.24e-4), as 
well as Enterobacteriaceae (p=0.002). Significantly lower Streptococcaceae 
(p=0.002) and the genus Streptococcus (p=0.004) were observed (Fig. S3B). 
Other significant differences were found at the genus level, including several 
genera from the families Lachnospiracea, Ruminococcaceae, 
Veillonellaceae, and Anaeroplasmataceae (Fig. S3B). 
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4.7.1.12 Microbiome correlations to Behavior 
Spearman correlations were performed on all 54 behavioral measures and 
OTU-level bacterial abundance filtered at >0.01% median abundance, 
presence greater >50% all samples. For all samples qvalue=0.05, within sex 
qvalue=0.15.  
 
4.7.1.12.1 Correlations to Behavioral Measures in All Samples 
Spearman correlations were performed between behaviors and OTU-level 
bacteria for all samples (N=202) (Fig. S4A). In all samples, significantly 
correlations were positively correlated to Anaeroplasma OTU_55, 
Peptococcus OTU_80, Allobaculum OTU_60 and OTU_129, and 
Lachnospiraceae_incertae_sedis OTU_117, Allobaculum OTU_129 were 
positively correlated to goal tracking behavior on day 1 
(Reward.Learning.PavCA.D1.Magazine_CS, rho>0.262, p<0.001);  
Anaerovirbrio OTU_89, Oscillibacter OTU_185, and Prevotella OTU_327 and 
OTU_27 were negatively correlated to in goal tracking behavior on day 1 
(Reward.Learning.PavCA.D1.Magazine_CS, rho<-0.254, p<0.001).  Distance 
travelled following cocaine administration during trial 1 and 4 was positively 
correlated to Allobaculum OTU_129, Anaeroplasma OTU_55, Peptococcus 
OTU_80, Clostridium XIVa OTU_983, among others (Loco.CCP.T[1or4]. 
CocaineDist, rho>0.2.55, p<0.001). Total number of presentations of lever 
(Reward.Learning.CRF.Number.of.Reinforcers, rho>0.280, p<0.001), and 
maximum exploratory rears per epoch (Loco.MaxRear, rho>0.282, p<0.0001) 
were positively correlated to Anaeroplasma OTU_55, Peptococcus OTU_80, 
and Lachnospiracea_incertae_sedis OTU_389. Significant negative 
correlations to impulsivity measures of indifference point area under the 
curve and patch change rate area under the curve (Impulsivity.DD.IDPtAUC 
and Impulsivity.DD.PCRateAUC, rho<-0.303, p<0.001) was observed with 
Lachnospiracea_incertae_sedis OTU_3469. Correlations to locomotor 
activity (Loco.Activity) and other locomotor response to novelty measures 
were significantly (p<0.05) associated to Peptococcus OTU_80, 
Lachnospiracaea_incertae_sedis OTU_389, and Allobaculum OTU_129.  
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4.7.1.12.2 Correlations to Behavioral Measures within Sex 
Spearman correlations were performed between behaviors and OTU-level 
bacteria within sex (N=101, Males and Females) (Fig. S5B). Impulsivity 
measures of indifference point area under the curve and patch change rate 
area under the curve was significantly correlated to 
Lachnospiracaea_incertae_sedis OTU_3469 (Impulsivity.DD.IDPtAUC and 
Impulsivity.DD.PCRateAUC, rho<-0.393, p<0.001) in males. In females, 
indifference point area under the curve and locomotor activity were 
negatively correlated to Barnesiella OTU_114 (Impulsivity.DD.IDPtAUC and 
Loco.Activity, rho<-0.407, p<0.001). In males, exploratory rearing was 
positively correlated to Clostridium XlVa OTU_3855; additionally, males had 
many OTU correlations to sensory preference for CPP floor before testing A 
positive correlation between reward learning and Lachnospiracea incertae 
sedis OTU_152 was seen in females (Reward.Learning.LR.Active, 
rho=0.407, p=2.44e-05) (Fig. S5B). 
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Supplementary Figure 5 – Correlation Analysis. A) Correlations between 
OUT-level bacteria and behavior in all subjects. Significance that passes 
FDR indicates by asterisk (q<0.05) B) Correlation between OTU-level 
bacteria within sex and behavior. Significance that passes FDR indicates by 
asterisk (q<0.15). Positive correlations indicated in red, negative correlations 
indicated in blue. 
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4.7.1.12.3 Correlations to Behavioral Phenotype Cluster X-axis and OTUs 
Behavioral Phenotype Cluster (Fig. S2A) separated into two clusters along 
the X-axis. These X-axis values were correlated to OTU abundance. For all 
samples qvalue=0.05, within sex qvalue=0.15.  
 
4.7.1.12.4 Correlations to Behavioral Phenotype Cluster X-axis and OTUs 
in All samples 
In all samples, X-axis behavioral phenotype cluster values positively 
correlated to Peptococcus OTU_80, Anaeroplasma OTU_55, Allobaculum 
OTU_33 and OTU_129, Lachnospiracaeae_incertae_sedis OTU_389, Dorea 
OTU_2348, and Acetivibrio OTU_586 (rho>0.241, p<0.001) (Table S1). X-
axis phenotype cluster was negatively correlated to Anaerostipes 
OTU_5419, Tannerella OTU_1263, Barnesiella OTU_871 and OTU_726, 
and Lachnospiracea incertae sedis OTU_3 (rho<-0.240, p<0.001) (Table 
S1). 
 
4.7.1.12.5 Correlations to Behavioral Phenotype Cluster X-axis and OTUs 
within Sex 
In males, X-axis behavioral phenotype cluster values positively correlated to 
alpha diversity measures (Observed and Chao1, rho=0.236, p<0.5). In 
females, X-axis values behavioral phenotype cluster (Fig. S2A) negatively 
correlated to Shannon index alpha diversity measure and Barnesiella 
OTU_253 (rho<-0.231, p<0.05).  
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OTU rho Pvalue 
Firmicutes.Peptococcaceae 1.Peptococcus.OTU_80 0.34596 4.58E-07 
Tenericutes.Anaeroplasmataceae.Anaeroplasma.OTU_55 0.324795 2.40E-06 
Firmicutes.Erysipelotrichaceae.Allobaculum.OTU_33 0.308244 8.08E-06 
Firmicutes.Lachnospiraceae.Lachnospiracea_incertae_sedis.OTU_389 0.276757 6.69E-05 
Firmicutes.Erysipelotrichaceae.Allobaculum.OTU_129 0.265397 0.000135 
Firmicutes.Lachnospiraceae.Anaerostipes.OTU_5419 -0.25981 0.000188 
Bacteroidetes.Porphyromonadaceae.Tannerella.OTU_1263 -0.25524 0.000246 
Bacteroidetes.Porphyromonadaceae.Barnesiella.OTU_871 -0.2534 0.000274 
Firmicutes.Lachnospiraceae.Dorea.OTU_2348 0.247933 0.000374 
Firmicutes.Lachnospiraceae.Lachnospiracea_incertae_sedis.OTU_3 -0.24325 0.000486 
Firmicutes.Ruminococcaceae.Acetivibrio.OTU_586 0.241062 0.000548 
Bacteroidetes.Porphyromonadaceae.Barnesiella.OTU_726 -0.24049 0.000566 
 
Supplementary Table 1: OTU Correlations to Behavioral Cluster x-axis in 
all samples – OTU correlations to x-axis correlations in behavioral cluster that 
pass FDR corrections (Q<0.05). OUT (first column), rho value (Spearman, 
second column), Pvalue (raw, third column) 
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5.1  Abstract 
Current research indicates that the microbiome-gut-brain axis (MGBA) plays 
a role in stress response. The number of viruses in the gut, notably 
bacteriophage, vastly outnumber bacteria in the microbiome. Changes in gut 
bacteria have previously been seen during chronic stress and hypothalamic-
pituitary-adrenal (HPA) axis dysfunction. The present study sought to 
investigate if viruses is the gut microbiome were altered during psychological 
stress, alongside changes in gut bacteria. Stressed animals were exposed to 
3 weeks of chronic social stress. Control and Stress samples (N =20) were 
sequenced for bacteria (16S) and viruses (metagenomic). Stressed animals 
had significant increases in depression measures, basal corticosterone, and 
cytokine IL-6 compared to controls. Bioinformatic analysis revealed marked 
differences in bacteriome and virome between control and stressed animals. 
Viral species richness increased in the stress group alongside reductions in 
bacterial richness. Increased trends of viral and bacterial evenness alpha 
diversity measures, Shannon and Simpson, were observed following chronic 
social stress. Significant correlations were observed between viral 
sequences and Bacteroidetes bacteria belonging to families S24-7 and 
Rikenellaceae. This is the first study, to our knowledge, to investigate 
changes in virome in relation to MGBA. Findings from this research further 
elucidates the impact of psychological stress on the microbiome and 
suggests that viruses may play a role in HPA axis function. 
 
5.2  Introduction 
 
Every gut contains billions of organisms that contribute to digestion, 
metabolism, immune function, and even the stress response (Bastiannsen et 
al 2018). Research into the role of microbiota in health focuses almost 
exclusively on bacteria yet the number of commensal viruses, most notably 
bacteriophage (viruses that target bacteria), outnumber bacteria in the gut. 
Indeed, we are slowly appreciating the significant role that gut bacteriophage 
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play a role in host immunity, intestinal permeability, and maintaining a 
healthy microbiome (Dalmasso, Hill et al. 2014, De Paepe, Leclerc et al. 
2014). Alterations in bacteriophage have been associated with disease 
states such as Crohn’s disease (Perez-Brocal, Garcia-Lopez et al. 2015), 
immunodeficiency syndrome (Monaco, Gootenberg et al. 2016, Monaco and 
Kwon 2017), and Clostridium difficile infection (Broecker, Klumpp et al. 
2016). Bacteriophage contribute to the stability and dynamics of bacterial 
populations and may represent a targeted approach to influencing specific 
populations of bacteria in the gut (Forde and Hill 2018).   
 
A growing body of evidence suggests that the microbiome-gut-brain axis 
plays a critical role in mood and behavior. Changes in gut bacteria 
composition are seen during chronic stress, hypothalamic-pituitary-adrenal 
(HPA) axis dysfunction, and psychiatric disorders such as anxiety and 
depression (Dinan and Cryan 2012). Previous research has shown that 
chronic social stress alters microbiome composition (Bailey, Dowd et al. 
2011, Bharwani, Mian et al. 2016, Burokas, Arboleya et al. 2017) 
Furthermore, intervention of probiotic bacteria can produce anxiolytic activity 
in rodent models (Bravo, Forsythe et al. 2011). Further research is necessary 
to understand the bi-directional communication between the microbiota-gut-
brain axis and how these alterations may, potentially, affect stress response.  
 
To date, there are no published studies investigating the role of 
bacteriophage composition in association withbrain and behavior. This study 
sought to investigate changes in viral and bacterial gut composition following 
chronic social stress.  
 
5.3 Methods 
Male C57BL/6J mice (n=20; Harlan, Cambridgeshire, UK; 8 weeks of age on 
arrival) were housed in SPF, temperature and humidity-controlled environment 
5.3.1 Animals 
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on a 12 hour light/dark cycle. All procedures were performed during the light 
phase. Experiments were conducted in accordance with European Directive 
86/609/EEC, Recommendation 2007/526/65/EC, and approved by the Animal 
Experimentation Ethics Committee of University College Cork. 
 
Weight-matched animals were randomly assigned to either Stress or Control 
group. Stress group (N=10) were singly housed and exposed to 3 consecutive 
weeks of chronic unpredictable social stress and overcrowding, as outlined in 
Figure 1. Control group (N=10) were group housed (3-4 per cage) and left 
undisturbed. Procedure for chronic social stress was carried out as previously 
described (Finger, Dinan et al. 2011, Burokas, Arboleya et al. 2017). Briefly, 
social defeat was performed by placing test mouse into the homecage of a 
larger CD1 mouse strain. Once submissive posturing (exposing stomach) was 
displayed animals were separated by a plexiglass divider for 2 hours. 
Following the 2-hour period, the divider was removed and following a second 
defeat the test animal was returned to its homecage. For overcrowding 
procedure, all ten mice in the stress group were placed in a single cage for 24 
hours. 
 
Following chronic social stress, mice underwent social interaction test to 
validate stress protocol. This procedure was carried out as previously 
described (Finger, Dinan et al. 2011, Burokas, Arboleya et al. 2017). In short, 
test subjects were placed in an open container with a novel CD1 mouse under 
a metal, mesh cage. Interaction ratio was calculated by the total time spent 
near the CD1 mouse divided by total time spent by the mesh cage with no 
CD1 mouse. 
 
 
5.3.2 Chronic Social Stress 
5.3.3 Social interaction test 
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To assess despair behavior, Forced Swim Test (FST) was used to measure 
immobility time. This procedure was carried out as previously described 
(Finger, Dinan et al. 2011, Burokas, Arboleya et al. 2017). In short, animals 
were placed into a water filled (15-cm depth) clear glass cylinder (24 × 21 cm 
diameter) for 6 minutes. Water was changed in between individual trials and 
each trial was video-recorded for later analysis. Immobility time (s) was 
assessed for the last 4 minutes of the test, with immobility being defined as a 
total absence of movement except slight motions to maintain the head above 
the water.  
 
Spleens were collected immediately following sacrifice and cultured by 
homogenizing in media [RPMI (with l-glutamine and sodium bicarbonate, 
R8758 Sigma) + 10% FBS (F7524, Sigma) + 1% Penicillin/Streptomycin 
(P4333, Sigma)]. The homogenate was then filtered over a 70um strainer and 
centrifuged at 200 g for 5 min. Red blood cells were lysed with buffer (R7757, 
Sigma), cell culture was then centrifuged and resuspended in media. Cells 
were counted and seeded (4,000,000/mL media). After 2.5 h of adaptation, 
cells were stimulated with lipopolysaccharide (LPS-2 μg/ml), concanavalin A 
(ConA-2.5 μg/ml) or vehicle (RPMI media) for 24 h. Following stimulation, the 
supernatants were harvested to assess the cytokine release using 
Proinflammatory Panel 1 (mouse) V-PLEX Kit (Meso Scale Discovery, 
Maryland, USA) for TNFα, IL-10, IL-1β and IL-6. The analyses were performed 
using MESO QuickPlex SQ 120, SECTOR Imager 2400, SECTOR Imager 
6000, SECTOR S 600. 
 
Tail blood samples were taken one-week prior culling and truck blood collected 
45 minutes following forced swim test at the time of cull. Serum corticosterone 
levels were assayed in duplicate using a Corticosterone Immunoassay Kit 
5.3.4 Forced Swim test 
5.3.5 Splenocyte stimulation and Cytokine analysis 
5.3.6 Corticosterone analysis 
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according to the manufacturer’s instructions (Enzo Life Sciences, UK) in a 
single assay using 20 μL plasma per sample with the threshold detection > 32 
pg/mL (coefficient of variation limit=20%). Light absorbance was read with a 
multi-mode plate reader (Synergy HT, BioTek Instruments, Inc.) at 405 nm. 
Concentrations are expressed in ng/mL. 
 
 The QIAamp DNA Stool Mini Kit (Qiagen, Hilden, Germany) was used to 
extract bacterial DNA using the manufacturer’s handbook (Second Edition 
2012). Samples were prepared for 16S sequencing using the Nextera XT DNA 
Library Prep Kit (Illumina, San Diego, CA, USA), as described in the Illumina 
16S library preparation workflow. 16S bacterial rRNA gene was amplified 
using primers targeting the V3-V4 hypervariable region (Forward: 
5'TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCW
GCAG; Reverse: 
5'GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTA
TCTAATCC) (Sigma Aldrich Ireland ltd., Wicklow, Ireland). 16S rRNA 
amplicons were sequenced on the Illumina MiSeq platform (Teagasc, 
Morrepark, Ireland). 
 
Faecal processed using a previously described protocol (Reyes, Wu et al. 
2013, Shkoporov, Ryan et al. 2018). Briefly, samples from control and stress 
groups were collected before (T0) and after (T1) experiment , virome faecal 
samples were pooled by cage and timepoint (N=3-4 per pool) to create a 1-
2g faecal samples. Pooled samples at each timepoint were resuspended in 
10 ml saline magnesium buffer, vortexed for 5 minutes, cooled for 5 minutes 
on ice, and centrifuged twice at 4,7000 rpm for 10 min at 4oC to remove large 
particles and bacterial cells. Supernatant was filtered twice through a 0.45 
µm pore ceramic filter. Following further refinement and treatment with 
proteinase K and Phage Lysis Buffer, sample DNA was extracted using the 
5.3.7  Feacal bacteriome collection and sequencing 
5.3.8  Feacal virome collection and sequencing 
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phenol-chloroform method. After DNA extraction, samples were processed 
for shot-gun metagenomic sequencing using the Nextera XT DNA Library 
Prep Kit (Illumina, San Diego, CA, USA). Virome metagenomic sequencing 
was performed on the Illumina MiSeq platform (Teagasc, Morrepark, 
Ireland). 
 
 
5.3.9.1 Bacteriome Sequence Pipeline 
Sequence reads in FASTQ files were filtered using PRINSEQ (Schmieder 
and Edwards 2011). Sequences with length less than 150 nucleotides or with 
low quality at the 3’ end were removed. Paired-end reads with a minimum 
overlap of 20 base-pairs were joined using FASTQ-join and analyzed with 
QIIME (Quantitative Insights Into Microbial Ecology, v1.9.1). Sequence 
quality was checked, filtered the dereplicates and chimeras removed against 
gold database, remaining sequences were clustered into Operational 
Taxonomic Units (OTUs; 97% identity level) using Usearch v7.0 algorithm 
(Edgar 2010). The average number of high-quality sequences generated per 
sample was 150,707 ± 69,666 SD. Taxonomy was assigned to OTUs using 
Ribosomal Database Project (RDP) (Cole, Wang et al. 2014). Alpha and 
Beta diversity indices were calculated with vegan (v2.5-1). 
 
5.3.9.2 Virome Sequence Pipeline 
Shot-gun metagenomic viral sequences were processed using a previously 
published pipeline (Draper, Ryan et al. 2018, Guerin, Shkoporov et al. 2018, 
Shkoporov, Ryan et al. 2018). Briefly, sequences underwent quality filtering 
and trimming using Trimmomatic v0.36. High-quality sequences were then 
assembled into contigs using metaSPAdes v3.10.1. Contigs were then 
filtered to only include sequences from viruses using Virsorter.  
 
5.3.9  Bacteriome and Virome Sequence Pipeline 
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Data was analyzed in R (v3.5.2) and RStudio (v1.1.463). Plots were 
generated in R using ggplot2 package (v2.2.1). Beta Diversity between 
groups (Control and Stress) and factor (NoStress and Stress) was calculated 
using Adonis (PERMANOVA) vegan function. Sample clustering was 
visualized with a Non-Metric Multidimentional Scaling (NMDS) plot. 
Wilcoxson test was used in the analysis of alpha-diversity index comparisons 
by factor. Spearman correlations were performed on bacteriome and virome 
count tables filtered to >0.01% relative abundance. In the virome count table, 
viral contigs were also filtered so that only contigs present in at least 3 were 
retained. FDR was performed to correct for multiple comparisons using the 
qvalue package (v2.14.1) with a threshold q<0.05 reported as significant.  
5.3.10 Statistical Analysis 
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5.4 Results 
 
 
5.4.1.1 Social interaction test (SIT) 
Social interaction behavioral test for novel CD1 mouse, as measured by 
percentage of time spend in interaction zone with CD1 divided by time spend 
in interaction zone without CD1. A significant reduction was observed in Stress 
group (t(18)=3.317, p=0.004) (Figure 1C). 
 
5.4.1.2 Forced Swim test (FST) 
Forced Swim test behavioral measure of despair behavior, measured by 
immobility time. A significant increase in immobility time was observed in 
Stress group (t(18)=-4.946, p=0.0001) (Figure 1A). 
 
Inflammatory cytokine measures revealed significant increases in IL-6 
Concanavalin A (ConA) and IL-10 in Stress group compared to Control 
(t((18)=-2.316, p=0.032 ;t(18)=-2.257, p=0.037, respectively) (Figure 1F-G). 
No significant differences were seen in ConA stimulated splenocytes 
between Stress and Control group in TNF-alpha (t(18)=-1.036, p=0.314) and 
IL-1beta (t(18)=-1.885, p=0.076). Vehicle stimulated splenocytes (baseline) 
showed no significant differences in Stress vs. Control groups in TNF-alpha 
(U=42, p=0.579), IL-1beta (t(18)=-0.597, p=0.155), IL-6 (t(18)=-1.800, 
p=0.089) (Figure 1D), and IL-10 (t(18)=-0.916, p=0.372) (Figure 1E). 
Lipopolysaccharide (LPS) stimulated splenocytes between groups showed 
no significance difference: TNF-alpha (U=34, p=0.248), IL-1beta (t(18)=-
1.256, p=0.225), IL-6 (t(18)=-1.752, p=0.097), IL-10 (t(18)=-0.916, p=0.372). 
   
5.4.1 Behaviour Measures 
5.4.2 Splenocyte stimulation and Cytokine analysis 
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5.4.2.1 Corticosterone Analysis 
Corticosterone analysis was at performed one week before (Basal) final 
timepoint and at final timepoint (after FST). A significant increase in Stress 
group in basal corticosterone was observed one week before culls compared 
to Controls (t(15.68)=-2.224, p=0.041) (Figure 1B). Corticosterone measures 
45 minutes after FST was near significant between groups (t(18)=-2.077, p 
=0.052). 
 
 
5.4.3.1 Alpha and Beta Diversity of Bacteriome and Virome 
Viriome beta diversity was significantly different by group (ADONIS, r2= 
0.682, p=0.001) and factor (ADONIS, r2= 0.504, p=0.002) (Figure 2A). 
Bacteriome beta diversity was significantly different by group (ADONIS, r2= 
0.287, p=0.001) and factor (ADONIS, r2= 0.172, p=0.001) (Figure 2B). 
Virome alpha diversity measures of richness and evenness were increase 
following stress, however did not reach significance (Chao, Wilcoxson, 
p=0.710; Shannon, Wilcoxson, p=0.282; Simpson, Wilcoxson, p=0.145) 
(Figure 3A-C).There was a trend towards reduced alpha diversity richness in 
the bacteriome following stress, which did not reach significance (Chao, 
Wilcoxson, p= 0.710) (Figure 3D). Alpha diversity measures of evenness 
revealed increases in bacteriome following stress (Shannon, Wilcoxson, 
p=0.06; Simpson, Wilcoxson, p=0.009) (Figure 3E-F)  
 
5.4.3.2 Correlation between Virome and Bacteriome 
Spearman correlations between viral contigs and bacterial OTUs were 
performed within factor group (NoStress and Stress). Significant positive 
correlations to uncultured bacteria belonging to phylum Bacteroidetes, 
families S24-7 and Rikenellaceae (Spearman, rho>0.9, q<0.05)(Figure 4).   
5.4.3 Microbiome 
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Figure 1 – Effects of Chronic Stress on Behavioural & Immune 
Parameters (A), Behavioral (B-D) and Cytokine Measures (E-H) and– A) 
Stress schedule used in chronic unpredictable social defeat model. Red 
blocks indicate social defeat (SD) and grey block indicate overcrowding (OC) 
procedure in stress group only. Circle indicates social interaction test 
(SIT)and hexagon indicates forced swim test (FST) immediately followed by 
culling on the same. B) Forced Swim behavioral test C) Basal corticosterone 
levels 1 week before culls. D) Social Interaction behavioral test E) 
Unstimulated splenocytes (vehicle) IL-6 levels F) Unstimulated splenocytes 
(vehicle) IL-10 levels G) Concanavalin A (ConA) stimulated splenocytes IL-6 
levels H) Concanavalin A (ConA) stimulated splenocytes IL-10 levels H) day 
in all subjects. Control group in blue and Stress group in red; significance 
indicated with asterisks:  *** (p<0.001), ** (p<0.01), * (p<0.05).  
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5.5 Discussion 
 
This is to our knowledge the first study to investigate changes in the virome 
in relation to the microbiota-gut-brain axis. Here we show that there are 
marked differences in both the bacteriome and virome between control and 
stressed animals. Viral alpha diversity increased following stress, alongside 
reductions in bacterial richness. Furthermore, we observed a strong 
correlation between increased alpha diversity in virome and reduced 
bacterial richness, however this observation did not pass significance after 
FDR corrections(Supp. Fig. 6A)  
 
These results would indicate a change in dynamic between bacteria and 
bacteriophage in the microbiome.This is particularly evident in the 
correlations between viral contig and bacteria belonging to two families, S24-
7 and Rikenellaceae. Previous research has shown that these bacteria are 
altered in chronic social stress (Watanabe, Arase et al. 2016) and 
inflammation (Scott, Ida et al. 2017). Bacteriophage that do not immediately 
kill their bacterial host, lysogenic, can make up a substantial amount of 
bacterial DNA, which are also capable of altering dynamics of their host 
bacteria (Baugher, Durmaz et al. 2014, Barr, Auro et al. 2015, Knowles, 
Silveira et al. 2016). In some pathogenic bacteria virulence factors may be 
carried on lysogenic phage DNA (Mirzaei and Maurice 2017). These can 
include genes encoding toxins (Joossens, Huys et al. 2011, Melton-Celsa 
2014). In some ways it could be said that the bacteria causing infections are, 
in their own fashion, also infected by their phage (Mills, Shanahan et al. 
2013). In addition, stress imposed on bacterial species may potentially lead 
to the transfer of antibiotic resistance (Baugher, Durmaz et al. 2014, 
Dalmasso, Hill et al. 2014) and production of toxins that can result in 
heightened pro-inflammatory state (Van Belleghem, Merabishvili et al. 2017). 
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There are excessive limitations in the virome database, which may result in 
unidentified viruses and/or misclassification of viral sequences. Therefore, 
taxonomy characterization of viruses was not reported in the main 
manuscript. Further research is necessary to identify changes in specific 
viruses and bacteria, particularly bacteriophages, in the microbiome affected 
by chronic social stress. Firstly, it will be important to determine whether a 
purified virome faecal transfer is capable of conferring stress-susceptibility or 
stress-resilience in a pre-clinical model. Thereafter, identification of any 
responsible viruses or bacteria may assist in developing treatments that may 
potentially reduce stress-susceptibility, thus promoting stress-resilience 
through reduction of a systemic inflammation.  
 
Exposure to a chronic social stress paradigm significantly increased 
measures of immobility time during FST, basal corticosterone, and cytokines 
IL-6 and IL-10 in splenocytes following incubation with Concanavalin 
A (ConA). The increase of these stress measures in this study aligns with 
previous studies of chronic social stress (Bailey, Dowd et al. 2011, Finger, 
Dinan et al. 2011, Finger, Dinan et al. 2012). Findings from this research 
further elucidates the impact of psychological stress on the microbiome and 
suggests that virome may play a role in hypothalamic-pituitary-adrenal (HPA) 
axis function. Future research is needed to elucidate whether this effect is 
due to the viruses having a direct impact on the host, or if alterations in 
viruses change bacterial composition which then impacts psychological 
stress and HPA axis function. 
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5.6  Supplementary Material 
 
Including Baseline (before stress =T0) and  Final timepoint (after stress = T1) 
 
5.6.1.1  Ceacal and feacal microbiome collection and sequencing 
Faecal and caecal samples from control and stress animals were collected 
before stress (T0) and at the end of the experiment (T1) and stored at -80ºC. 
Bacteria (16S) and viruses (metagenomic) were sequenced and sequence 
processing and bioinformatic analysis performed. 
 
5.6.1.2 Alternative Virome Sequence Processing Pipeline 
To ensure accuracy and reproducibility of virome results, sequences were 
processed and analysed with two distinct pipelines. The alternative pipeline 
and results are provided herein. Metagenomic raw sequence reads in 
FASTQ files were further filtered on the basis of quality (removal all bases at 
the 3’ end with a Phred score < 20 over a sliding window of 10 bp were 
trimmed) and length (only reads with a minimum length of 150 bases were 
considered for further analysis) with PRINSEQ. The resulting data were 
screened against the Mus musculus (mouse) reference genome downloaded 
from Illumina iGenomes 
(http://support.illumina.com/sequencing/sequencing_software/igeno me.html) 
to remove host reads using BMTagger (Rotmistrovsky and Agarwala 2011). 
Read duplicates were removed using the picard v2.7.1 MarkDuplicates tool 
(Broad Institute 2016) to create fastq files with unique reads only. Afterwards, 
a quality filtering step of the reads has been implemented, in brief, 
sequences are trimmed for low quality score using a modified version of the 
script trimBWAstyle.pl that works directly from BAM files 
(TrimBWAstyle.usingBam.pl. 2010; 
https://github.com/genome/genome/blob/master/lib/perl/Genome/Site/TGI/H
mp/HmpSraProcess/trimBWAstyle.usingBam.pl). The script is utilized to trim 
5.6.1 Supplementary Microbiota Methods: 
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bases off the ends of sequences, which show a quality value of two or lower. 
This threshold is taken to delete all the bases with an uncertain quality as 
defined by Illumina’s EAMMS (End Anchored Max Scoring Segments) filter. 
Additionally, reads trimmed to less than 160 bp are also removed. The 
resulting sequences were taxonomically assigned against the complete viral 
genomes database using BLAST. The taxonomic composition is then 
determined using either raw number of best hits or number of best hits 
normalized by genome length using GAAS (Genome relative Abundance and 
Average Size) (Angly, Willner et al. 2009). The relative abundance of virus 
among different taxa were estimated by dividing the number of reads that 
uniquely mapped to that group by the total number of reads from the sample.  
The average number of high-quality sequences generated per sample was 
990,464 ± 153,027 SD. The average number of assigned sequences was 
226,374 ± 93,569 SD, approximately 23% of sequences. The average 
number of contigs per sample was 1842 ± 499 SD.  
 
5.6.2.1  Results from Alternative Virome Pipeline 
Results from this pipeline are visualized in Supplementary Figures 1-3. 
Rarefication curves of viral sequences revealed a trend toward increased 
richness following chronic social stress (Supp. Fig. 1A). Taxonomic 
assignment of viral sequences also revealed alterations in viral composition 
between T0 and T1 (Supp. Fig. 1C) and by group (Supp. Fig. 2E), Family-
level viral composition showed a trend towards alterations in Podoviridae and 
Myoviridae following chronic social stress (Supp. Fig. 3).   
 
5.6.2.2 Correlation Results 
The following correlations were performed on viral contig data from the 
primary pipeline outlined main manuscript. Spearman correlation between 
virome and bacteriome alpha diversity measures at both timepoints (T0 & 
T1) showed no significant results before or after FDR (p>0.05, q>0.05). 
Correlations between virome and bacteriome alpha diversity measures at 
5.6.2 Supplementary Results 
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final timepoint (T1) revealed a strong negative correlation between Simpson 
alpha diversity in virome and bacteriome Chao richness (Spearman, rho=-
0.886, p=0.03), however this result did not remain significant after FDR (Fig. 
6A).  
 
5.6.2.3 Canonical Correspondence Analysis (CCA) 
To find major drivers involved in the virome beta diversity separation 
between NoStress and Stress, CCA performed on virome contigs, virome 
alpha diversity measures, and virome beta diversity. The adonis vegan 
function was used to assess viral contigs and virome alpha diversity 
measures that significantly corresponded to virome beta diversity. Three viral 
contigs and the virome Shannon Index alpha diversity measure significantly 
(p<0.05) corresponded to variance in virome beta diversity (total explained 
variance=0.622) These measures were then plotted onto a beta diversity 
ordination plot with arrows indicating direction of driver, calculated using the 
vegan ordiArrowMul function (Supp. Fig. 4C).  
 
5.6.2.4 Virome Contig Comparisons 
Using viral contig data from the primary pipeline from manuscript, 
comparisons were made between groups at timepoints T0 and T1. Contigs 
that were altered by chronic social stress and a pvalue<0.05 were visualized, 
however none passed FDR (q>0.05) (Supp. Fig. 5) 
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Supplementary Figure 1– Microbiome alpha-diversity and virome 
abundance– A) Rarefaction curve of viral sequence; green line indicate 
stress group at final timepoint (T1E1-10), red indicates control group at final 
timepoint (T1C1-10); yellow and blue lines indicate stress and control group 
at beginning timepoint (T0E1-10, T0C1-10, respectively). B) 16S microbiome 
alpha-diversity richness; red bars indicate feacal Control samples at 
beginning timepoint (T0-Control); yellow bars indicate Stress feacal samples 
at beginning timepoint (T0-Stress); green bars indicate 9Control ceacum 
samples at end timepoint (T1ceacum-Control); teal bars indicate Stress 
ceacum samples at end timepoint (T1ceacum-Stress); blue bars indicate 
Control feacal samples at end timepointv (T1- Control); pink bars indicate 
Stress feacal samples at end timepoint (T1-Stress). C) Virome abundance at 
beginning (before stress – T0) and end timepoint (after stress – T1) for 
Stress and Control group. High abundance viruses, colored individually, low 
abundance viruses colored in yellow (other).  
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Supplementary Figure 2- Microbiome diversity and virome abundance– 
A) Shot-gun metagenomic sequencing of virome faecal  samples beta 
diversity plotted in NMDS; red indicate Control; blue indicate Stress B) 16S 
microbiome faecal samples beta diversity plotted in NMDS;  red indicate 
Control; blue indicate Stress. C) Rarefaction curve of viral sequence; green 
line Stress group, red Control. D) 16S microbiome alpha-diversity richness; 
red bars indicate Stress; blue bars indicate Control. E) Virome abundance for 
Stress and Control group. High abundance viruses, colored individually, low 
abundance viruses colored in yellow (other).  
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Supplementary Figure 3: Family-Level Virome Composition: Relative 
abundance of classified bacteriophage at the family-level. T0C-10 refers to 
Control group at beginning of study.T0E1-10 refers to Stress group before 
chronic social stress protocol (beginning of study). T1C1-10 refers to Control 
group after 3 weeks experiment. T1E1-10 refers to Stress group following 3 
weeks chronic social stress. 
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Supplementary Figure 4: Virome Correlation Analyses: A) Spearman 
correlation heatmap between bacterial OTUs and viral contig. B) Spearman 
correlation between virome at T1 and measures of stress. C) Biplot of viral 
contigs and virome alpha diversity that significantly corresponded to beta 
diversity. Asterisks indicate raw p-value (none passed FDR corrections): 
*=p<0.05, **=p<0.01, ***=p<0.001 
 
 
Supplementary Figure 5: Viral Contig Comparisons by Group: Viral 
contigs that were altered by stress exposure. None passed FDR.  
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.  
Supplementary Figure 6: Alpha Diversity Correlations: A) Spearman 
correlation between bacteriome and virome alpha diversity measures at T1. 
B) Spearman correlation between virome at T0 and measures of stress. C) 
Biplot of viral contigs and virome alpha diversity that significantly correlate to 
beta diversity. Asterisks indicate raw p-value (none passed FDR corrections): 
*=p<0.05, **=p<0.01, ***=p<0.001 
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6 General Discussion 
 
6.1  Overview and Summary 
The  findings presented in this thesis show that the microbiome is influenced 
by alcohol addictionand stress. Bacterial in the gut microbiome have a 
subtle, yet significant association to addictive measures. Here, the effect of 
alcohol and chronic social stress has a more profound effect on gut 
microbiome. Importantly, sex must be considered when interpreting results 
from pre-clinical studies. The majority of pre-clinical research exclusively 
uses male animals. Findings in Chapter 4 of sex-specific associations 
between microbiome and addiction-associated behaviour illuminate the need 
to consider sex in the context of microbiome and behaviour. Intriguing results 
from this work suggest that gut microbiome may be a potential therapeutic 
target for remediation of addictive disorders. Finally, novel research into gut 
virome and psychosocial stress suggests that future research into 
bacteriophage, gut virome, and the microbiome-gut-brain axis may be a 
promising avenue of research.  
 
Here we see that both oral and vapor administration have effects associated 
to the microbiome. Notable vapor alcohol administration significantly altered 
microbiome composition in both alpha and beta diversity, as well as 
taxonomic bacteria. In our study of oral alcohol self-administration, no 
significant differences were observed  in alpha and beta diversity or at the 
taxonomic level. This lack of significance may be explained by either the 2-
month abstinence period before sample collection or variations in alcohol 
dosage - as vapor administration reached a BAC higher than most rodents 
will voluntarily drink. However, in the pre-clinical model of oral alcohol 
administration significant correlations are observed between microbiome and 
dopamine-receptor expression in the striatum as well as measures of 
6.1.1 Findings from Alcohol Studies 
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addiction severity, congruent with results seen in the addiction phenotype 
study (Chap. 5).  
 
Addiction is a multifaceted disorder affecting humans worldwide. When 
considering the microbiome, many factors must be included such as sex, 
drug, dosage, and psychological comorbidities such as anxiety and 
depression. In this body of work, we see innate addictive behaviours are 
significantly correlated to microbiome composition, however are specific to 
sex.  
 
In the alcohol severity phenotype study in male rats, microbiome correlates 
to measures of anxiety, impulsivity, dopamine-receptor expression, 
compulsive alcohol-seeking, and locomotor response to novelty. Cognate 
results are found in  heterogenous bred stock male rats, with bacterial 
correlations to measures of impulsivity, reward learning, and locomotor 
response to novelty. Furthermore, in both studies the majority of correlations 
were to phylum Firmicutes and families Ruminocococceae and 
Lachnospiracea.  
 
Females had a more robust microbiota profile between subjects displaying 
an addictive phenotype compared to others. Significant reductions in alpha 
diversity were observed in addictive phenotype, a finding that was not seen 
in males in any of the studies. Importantly, many bacterial OTUs positively 
correlated to a measure of attention (RT.Omissions) when females were 
subset by addiction phenotype. Additionally, OTUs assigned to genus 
Barnesiella repeatedly correlated to behavioural measures, mainly a primary 
measure of impulsivity.  
 
 
6.1.2 Findings from the Addiction Phenotype Studies 
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Stress has previously been shown to affect the bacteriome (Bailey, Dowd et 
al. 2011, Burokas, Arboleya et al. 2017). In this novel finding we show that 
the virome is also affected by chronic psychosocial stress. Stress measures, 
such as elevated baseline corticosterone, and measures of inflammation 
were significantly different between Stress and Control groups alongside 
significant changes in both bacteriome and virome. Intriguingly, virome 
richness was increased following stress while bacterial richness decreased. 
This finding during stress may be explained by increased lytic bacteriophage 
killing bacterial hosts and/or alterations in immunity. Due to limitations in the 
bacteriophage database, low virome sample sizes due to pooling (N=3 per 
group), and restrictions on 16S classification at the strain-level, we were 
unable to find associations between bacteriome and virome. This study is, to 
our knowledge, the first to characterize gut virome in relation to microbiome-
gut-brain axis. These preliminary results suggest that virome may also be 
changed in other psychiatric conditions linked to gut microbiome. Moreover, 
bacteriophage may be a significant factor contributing to stress-induced 
alterations in bacteriome and future microbial interventions may abate the 
cascading effects of psychological stress. Overall, understanding how both 
bacteriome and virome contribute to psychological stress is of equal 
importance. 
  
6.1.3 Findings from the Stress Study 
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6.2  Future Directions 
Follow-up studies could be performed to further elucidate factors influencing 
reported results. Since alcohol is a widely consumed product, globally, 
further understanding of dose-dependant effects on microbiome would 
illuminate impact on microbiome for all individuals who consume alcohol on 
the spectrum of acceptable consumption to problematic/severe alcohol 
abuse. Results of dose-dependant alcohol impact on gut microbiome may 
further assist in informing regulatory bodies of acceptable levels of alcohol 
consumption.  
 
Results from the addiction phenotype studies indicate there are innate 
differences in gut microbiome composition between addictive vs. normal 
subjects, independent of drug administration. Future investigation should use 
faecal microbiota transplant (FMT) to assess if: 1) an addictive phenotype in 
rats can be transferred to another rat, and if the phenotype can be 
transferred between sexes; 2) if clinical samples from addiction patients can 
confer an addictive phenotype in rodents of the same and alternate sex. If an 
addictive phenotype can be established via FMT, further intervention studies 
using psychobiotics could be implemented.  
 
Gut bacteria have previously been shown to influence neurotransmitter 
receptor expression, resulting in behavioural alterations (Bravo, Forsythe et 
al. 2011). The novel associations between dopamine receptor expression in 
striatum and microbiome composition merits further investigation into the 
mechanisms behind this correlation. Work from Bravo et. al. showed GABA 
receptors expression are altered by the administration of Lactobacillus 
6.2.1 Alcohol and Gut Microbiome 
6.2.2 Mechanism of Microbiome Influence on Addiction and 
Dopamine 
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rhamnosus GG, resulting in an anxiolytic phenotype. This effect was negated 
in vagotomised mice, implicating vagal nerve innervations in the mechanistic 
action. A similar experimental design could be implemented to investigate if 
the vagus nerve regulates dopamine receptor alterations associated to an 
addictive microbiota composition.  In female rats, addictive phenotype was 
repeatedly correlated to bacteria belonging to genus Barnesiella. In male rats 
displaying compulsive alcohol seeking behaviour, bacteria from genus 
Gemella correlated to alterations in both D1 and D2 dopamine receptors as 
well as a majority of the addictive behaviours. Follow-on experiments would 
administer single cultures of these bacteria, to assess if these identified 
bacteria increase addiction-associated behavioural measures and dopamine 
receptor expression.  
 
Investigation into the dynamics of bacteriophage and commensal gut 
bacteria and their association to the microbiota-gut-brain axis may be 
harnessed to provide future therapeutic targets to treat mental health 
disorders. Initial work to establish this field must first prove that a refined 
faecal phage transplant is capable of conferring a behavioural phenotype. 
Thus, the first follow-on experiment must administer refined virome from both 
stressed and non-stressed subjects to a naïve experimental cohort of mice. 
An additional positive control necessary for this experiment includes 
inactivated viruses from stressed donor faecal fraction. Importantly, stress 
hormones and anxiety/depressive behaviour need to be assessed in the 
virome recipient groups. If transfer of a stressed phenotype is successful, 
further research would include microbial or dietary interventions to remediate 
the symptoms of stress by altering gut microbiota. 
 
Results from Chapter 4 emphasize that sex must always be considered 
when investigating microbiota associations to brain and behaviour. The 
relationship between sex hormones, microbiome and behaviour has been 
6.2.3 Stress Faecal Virome Transplant 
6.2.4 Sex Matters 
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reported in scientific literature (Amato, Leigh et al. 2014, Chaban, Links et al. 
2014, Schnorr, Candela et al. 2014, Jasarevic, Morrison et al. 2016). During 
development, factors that influence addiction, such as genetics, also 
contribute to sexual dimorphism in microbiome (Jasarevic, Morrison et al. 
2016). Clinical and pre-clinical research has shown differences in microbiota 
composition associated to altered metabolism of essential vitamins and 
nutrients from the diet, with increased functional richness seen in females 
compared to males (Amato, Leigh et al. 2014, Bolnick, Snowberg et al. 2014, 
Zhernakova, Kurilshikov et al. 2016).  
 
In sex-specific addiction worldwide, illicit drug use is significantly lower in 
females compared to males (World Health Organization 2012). However, 
research of both humans and other animal species indicates that females 
may, in some cases, display a propensity for addiction. Females self-
administer drugs more readily than males and are more vulnerable to 
addiction to a variety of licit and illicit drugs (Becker and Hu 2008, Yang, Han 
et al. 2017). A human genome-wide-association study (GWAS) showed 
females having greater impulsive behaviour, as measured by delay 
discounting (Sanchez-Roige, Fontanillas et al. 2018). Furthermore, GWAS 
studies suggest that opioid dependence is linked to sex specific single 
nucleotide polymorphisms (Yang, Han et al. 2017). In Cloninger’s typology, 
Type II alcoholism has an early onset, a genetic propensity, and more 
common in males, while Type I has a late onset and is seen in both females 
and males (Cloninger, Sigvardsson et al. 1996). Differences in hormones are 
attributed to some sex differences in addiction-related behaviour. 
Furthermore, intensity of drug usage and drug withdrawal vary depending on 
menstrual cycle. In the striatum, dopamine levels are higher during estrus in 
rats, when estradiol is elevated. Estradiol is known to increase positive 
affect, locomotor sensitization, and acquisition of self-administration to 
psychomotor stimulants in female rats (Becker, Lopez et al. 2011). It is 
important to note that despite extensive literature associating addiction-
related behaviours in rodents to drug administration, in humans these only 
appear to be potential vulnerability factors. 
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These findings indicate a need for comprehensive understanding of factors 
associated to addiction propensity, and how different sexes are affected. 
Females may not necessarily be at greater risk for addiction. Recent findings 
suggest addiction phenotype is far more complex than just reward-stimulus 
learning (Singer, Fadanelli et al. 2018). The influence of sex on the 
microbiome and reward from an evolutionary perspective must also be 
considered. For enhanced fitness females may have a heightened potential 
to assign incentive salience to a predictive cue. This would enhance mating 
with a partner that is healthier, as indicated by association to a natural 
reward such as food and water to a mate. Importantly, in many mammals 
rearing of offspring is often exclusively the responsibility of the female, thus 
heightened sensitivity to cues that predict a natural reward would ensure 
survival of offspring by enforcing feeding behaviour (Volkow and Wise 2005). 
This evolutionary advantageous reward pathway circuitry evolved to predict 
and reinforce behaviour that produced a “reward” that enhanced survival 
fitness (Newlin 2002). In this paradigm, enhanced metabolic function in the 
microbiome also has proven to be evolutionarily advantageous for females 
and in this context may be linked to reward-stimulus learning to enhance 
learned associations to naturally rewarding stimuli. 
 
Sex differences were not explored in the chronic social stress paradigm, 
vapor alcohol study, nor the pre-clinical model of alcohol abuse. Given that 
this is a significant factor in the addiction phenotype study, further research 
in necessary to investigate how the microbiome of females, compared to 
males, are affected by drugs of abuse. According to the National Institute of 
Health, the standard volume of alcohol consumption for females is lower than 
males. In follow-up research of dose-dependent effects of alcohol 
consumption on microbiome, sex must be included in the experimental 
design. Furthermore, research investigating sex differences in psychological 
stress related to bacteriome and virome should be investigated.  
6.2.5 Sex Differences in Alcohol, Stress and Virome 
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While FMT is a valuable method for conducting pre-clinical research and 
treating life-threating Clostridium difficile infection, this method is not a 
targeted psychobiotic treatment in humans (Bojanova and Bordenstein 
2016). A faecal sample contains a host of microbes (bacteria, viruses, fungi, 
etc.) along with variety of molecules (bacterial toxins, hormones, and bile 
salts) that may have undesired effects for the FMT recipient. More targeted 
therapies to treat psychological disorders via the gut microbiota include 
prebiotics, probiotics, phageome therapy, and dietary intervention.  
 
Pre-clinical work from our lab has shown that prebiotic treatment can reduce 
symptoms of stress (Burokas, Arboleya et al. 2017). Prebiotic intervention is 
suggested to affect brain and behaviour through increasing communities of 
beneficial bacteria via direct metabolization of prebiotic or secondary 
metabolites, these metabolic by-products from bacterial include short-chain 
fatty acid. This also reduces the pro-inflammatory profile associated with 
stress (Bailey, Dowd et al. 2011). Stress is a significant factor in addiction 
and previous research investigating gut microbiome and substance abuse 
has found connections to a pro-inflammatory state (Leclercq, Cani et al. 
2012, Bull-Otterson, Feng et al. 2013, Allais, Kerckhof et al. 2016, Lowe, 
Gyongyosi et al. 2017, Plein and Rittner 2018). These data would suggest 
that prebiotic treatment may also be beneficial for addiction and substance 
abuse disorders. 
 
Probiotic administration in animal studies of Lactobacillus rhamnosus has 
been shown to be effective for reducing anxiety and improving intestinal 
barrier function during alcohol exposure (Bravo, Forsythe et al. 2011, Bull-
Otterson, Feng et al. 2013). Actions of this and other probiotics include: 
altering vagus nerve signalling and brain mRNA expression (Bravo, Forsythe 
et al. 2011), improving barrier function which reduces inflammation by 
6.2.6 Can the Microbiome Treat Addiction and Stress? 
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preventing bacterial endotoxins to cross into the circulatory system (Bull-
Otterson, Feng et al. 2013), direct immune modulation (Hsiao, McBride et al. 
2013), and by altering gut microbiome community composition 
(Bastiaanssen, Cowan et al. 2018).  
 
Other potential therapeutic interventions may include diet intervention and 
targeting gut bacteriophage. A heathy diet is an age-old treatment for many 
health conditions. Diet is known to be one of the most significant factors 
influencing microbiome composition (Zhernakova, Kurilshikov et al. 2016). 
Research has shown that depression is associated with low fibre intake 
(Kelly, Borre et al. 2016), indicating that a diet high in fibre may benefit the 
brain.  Diets rich in healthy fats and phytonutrients are shown to have an 
anti-inflammatory effect (Ricker and Haas 2017).  
 
Phage therapy is an intriguing possibility for removing pathogenic bacteria 
that may contribute to a pro-inflammatory phenotype. However, in our current 
study we found that bacteriophage diversity is linked to bacterial diversity 
which indicates that therapeutic intervention requires altering community 
dynamics. An intriguing intervention to pursue, which targets phage 
populations, would be administration of polyphenols which has been shown 
to interact with bacteriophage (Catel-Ferreira, Tnani et al. 2015). Phage 
administration has also been shown to influence intestinal permeability of 
host (Tetz and Tetz 2016).  
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Route of Action: Prebiotic Probiotic  Phageome Diet 
Altering Gut Microbiome Composition XX XXX XX XXX 
Anti-Inflammatory/Immune 
Modulatory X XXX X XX 
BBB and Intestinal Barrier Integrity X XXX X XX 
Vagus Nerve Signalling/Brain mRNA 
Expression   XX   X 
 
Table 6.2: Microbiome Therapies to Treat Stress and Addiction: x’s 
indicate robustness of the literature supporting purposed the route of action. 
Prebiotic references: (Schmidt, Cowen et al. 2015, Burokas, Arboleya et al. 
2017); Probiotic references: (Whorwell, Altringer et al. 2006, Rousseaux, 
Thuru et al. 2007, Kirpich, Solovieva et al. 2008, Forsyth, Farhadi et al. 2009, 
Bravo, Forsythe et al. 2011, Messaoudi, Lalonde et al. 2011, Wang, Liu et al. 
2012, Dinan, Stanton et al. 2013, Korpela, Salonen et al. 2018); Phageome 
references: (Angly, Willner et al. 2009, Reyes, Semenkovich et al. 2012, 
Barr, Auro et al. 2013, Mills, Shanahan et al. 2013, Reyes, Wu et al. 2013, 
Dalmasso, Hill et al. 2014, Barr, Auro et al. 2015, Lim, Zhou et al. 2015, 
Knowles, Silveira et al. 2016, Silveira and Rohwer 2016, Tetz and Tetz 2016, 
Forde and Hill 2018); Diet references: (Claesson, Jeffery et al. 2012, Tuohy, 
Conterno et al. 2012, Bull-Otterson, Feng et al. 2013, Jacka, Gama et al. 
2014, Schnorr, Candela et al. 2014, Jacka, Cherbuin et al. 2015, Kelly, Borre 
et al. 2016, Lin, An et al. 2016, Zhernakova, Kurilshikov et al. 2016, Ryan, 
Patterson et al. 2017, Hassan, Mancano et al. 2018, Ma, Wang et al. 2018, 
Mulders, de Git et al. 2018, Olson, Vuong et al. 2018, Rothschild, Weissbrod 
et al. 2018) 
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6.3  Limitations of the reported studies 
 
16S sequencing is limited to the genus level (Zhernakova, Kurilshikov et al. 
2016, Cronin, Barton et al. 2018). Metabolomic sequencing would provide 
better resolution of functional profile and lower-level taxonomic 
classifications, such as bacterial species and strain. Functional profiling in 
individual studies may help further elucidate microbiome interactions in 
separate studies. 
 
The databases are a continual limitation of microbiome studies. More so for 
virome  as reference databases for taxonomic identification are very limited, 
due to a lack of whole-genome characterization. Additionally, updates to 
bacterial databases temporally affect bacterial assignments, potentially 
influencing results and data interpretations.  
 
The field of virome in relation to the microbiome and host health is currently 
in a state of development and refinement. Many of the limitations of the 
present study reflects broad limits in the field. As previously mentioned, 
virome reference databases for taxonomic identification are incomplete due 
to lack of research characterizing/classifying viral genomes. Virome 
sequencing was performed at two timepoints alongside 16S sequencing. A 
scarcity in fresh faecal samples compounded by the need to acquire 2-3 
grammes of faeces for virome analysis forced a decision to collect fresh 
faeces for 16S and dried faecal pellets, found in mouse bedding, for virome 
sequencing. Thus for virome samples, prolonged exposure of faecal pellets 
to the environment may be a confounding factor when associated with 
bacteriome at the same timepoint. Furthermore, due to housing shortages in 
6.3.1 16S Sequencing  
6.3.2 Database Limitations 
6.3.3 Limitations of Virome Analysis 
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the animal facility, control mice had to be group housed (2x cages of3 mice, 
1x cage of 4 mice). Due to coprophagia, co-housed control subjects (N=10) 
only provided 3 unique faecal virome samples for analysis. Finally, 
bacteriophage viruses are species/strain specific to their bacterial hosts. 
Thus, metagenomic analysis of bacteriome and virome would be preferable 
as bacterial metagenomic sequencing is capable of assigning bacteria to 
these lower levels of taxonomic identification. 
 
6.4 Conclusions 
 
Together this data indicates that addiction and stress measures are 
associated to microbiome composition. Moreover, this affects linked factors 
including, drug dosage, sex, and inflammation. In this current work we 
sought to characterize microbiome changes in alcohol addiction, sex 
dependent addiction-related behaviours, and stress. The main aim of this 
exploratory work assessed is 16S rRNA gene and virome shot-gun 
metagenomic sequences by comparing alpha, beta, and taxonomic 
abundance between groups as well as correlating composition to biological 
and behavioural metadata. 
 
These studies show that there is both innate and acute variations in gut 
microbiota in models of drug addiction. Furthermore, microbiome 
composition and correlations to behavioural metadata is sex-specific. 
Abundance of specific bacteria, predominantly in the phylum Firmicutes and 
families Ruminococcaceae and Lachnospiracea, correlate to behavioural 
measures of impulsivity, reward learning, compulsive alcohol seeking, 
dopamine-mediated locomotor response to novelty, and striatal dopamine 
receptor expression.  
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This is the first time, to our knowledge, that gut virome has been 
characterized in the context of the microbiome-gut-brain axis. Investigation of 
gut microbiome in a mouse model of chronic psychosocial stress revealed 
that both bacteriome and virome composition and alpha diversity are 
significantly affected in stressed mice compared to non-stressed controls. 
Here, we observe increases in virome richness and decreases in bacterial 
richness. This finding, alongside alterations in bacteriophage abundance 
between stressed and non-stressed mice, suggests that lytic bacteriophage 
may be implicated in bacteriome alterations during stress. Further research 
is necessary to elucidate if: 1) refined virome from stress mice transplanted 
into naïve mice can confer a stress phenotype; 2) if targeting virome alpha 
diversity is capable of inducing or remediating stress severity; 3) if targeting 
particular viruses are capable of altering the stress phenotype. Our 
preliminary results presented here suggest the gut virome as an intriguing 
new field to investigate for novel microbiome-gut-brain axis therapies. 
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